<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" id="cac270067" xml:lang="en" article-type="review-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with OASIS Tables with MathML3 v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archive-oasis-article1-mathml3.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jats-oasis2jats3.xsl?><?ConverterInfo.Version 1?><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Cancer Commun (Lond)</journal-id><journal-id journal-id-type="iso-abbrev">Cancer Commun (Lond)</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)2523-3548</journal-id><journal-id journal-id-type="publisher-id">CAC2</journal-id><journal-title-group><journal-title>Cancer Communications</journal-title></journal-title-group><issn pub-type="epub">2523-3548</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmcid">12629869</article-id><article-id pub-id-type="pmid">41077675</article-id>
<article-id pub-id-type="doi">10.1002/cac2.70067</article-id><article-id pub-id-type="publisher-id">CAC270067</article-id><article-categories><subj-group subj-group-type="overline"><subject>Review</subject></subj-group><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Breaking barriers: The cGAS&#x02010;STING pathway as a novel frontier in cancer immunotherapy</article-title><alt-title alt-title-type="left-running-head">YAN <sc>et&#x000a0;al.</sc>
</alt-title></title-group><contrib-group><contrib id="cac270067-cr-0001" contrib-type="author"><name><surname>Yan</surname><given-names>Yuheng</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0006-9364-9395</contrib-id><xref rid="cac270067-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="cac270067-cr-0002" contrib-type="author"><name><surname>Tan</surname><given-names>Ximin</given-names></name><xref rid="cac270067-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="cac270067-cr-0003" contrib-type="author"><name><surname>Song</surname><given-names>Bin</given-names></name><xref rid="cac270067-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="cac270067-cr-0004" contrib-type="author"><name><surname>Yi</surname><given-names>Ming</given-names></name><xref rid="cac270067-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="cac270067-cr-0005" contrib-type="author" corresp="yes"><name><surname>Chu</surname><given-names>Qian</given-names></name><xref rid="cac270067-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>qianchu@tjh.tjmu.edu.cn</email></address></contrib><contrib id="cac270067-cr-0006" contrib-type="author" corresp="yes"><name><surname>Wu</surname><given-names>Kongming</given-names></name><xref rid="cac270067-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="cac270067-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><address><email>wukm_lab@163.com</email></address></contrib></contrib-group><aff id="cac270067-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Department of Oncology</named-content>
<institution>Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology</institution>
<city>Wuhan</city>
<named-content content-type="country-part">Hubei</named-content>
<country country="CN">P. R. China</country>
</aff><aff id="cac270067-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Cancer Center, Shanxi Bethune Hospital</named-content>
<institution>Shanxi Academy of Medical Science, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University</institution>
<city>Taiyuan</city>
<named-content content-type="country-part">Shanxi</named-content>
<country country="CN">P. R. China</country>
</aff><aff id="cac270067-aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">Department of Breast Surgery</named-content>
<institution>Zhejiang University School of Medicine First Affiliated Hospital</institution>
<city>Hangzhou</city>
<named-content content-type="country-part">Zhejiang</named-content>
<country country="CN">P. R. China</country>
</aff><author-notes><corresp id="correspondenceTo">
<label>*</label>
<bold>Correspondence</bold>
<break/>Kongming Wu, Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430030, P. R. China; Cancer Center, Shanxi Bethune Hospital, Shanxi Academy of Medical Science, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, Shanxi, 030032, P. R. China.<break/> Email: <email>wukm_lab@163.com</email>.<break/>Qian Chu, Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430030, P. R. China.<break/> Email: <email>qianchu@tjh.tjmu.edu.cn</email>.<break/>
</corresp></author-notes><pub-date pub-type="epub"><day>12</day><month>10</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>11</month><year>2025</year></pub-date><volume>45</volume><issue seq="120">11</issue><issue-id pub-id-type="doi">10.1002/cac2.v45.11</issue-id><fpage>1513</fpage><lpage>1546</lpage><history>
<date date-type="rev-recd"><day>24</day><month>9</month><year>2025</year></date>
<date date-type="received"><day>28</day><month>5</month><year>2025</year></date>
<date date-type="accepted"><day>28</day><month>9</month><year>2025</year></date>
</history><permissions><!--&#x000a9; 2025 Cancer Communications published by John Wiley & Sons Australia, Ltd. on behalf of Sun Yat&#x02010;sen University Cancer Center.--><copyright-statement content-type="article-copyright">&#x000a9; 2025 The Author(s). <italic toggle="yes">Cancer Communications</italic> published by John Wiley &#x00026; Sons Australia, Ltd. on behalf of Sun Yat&#x02010;sen University Cancer Center.</copyright-statement><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non&#x02010;commercial and no modifications or adaptations are made.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:CAC2-45-1513.pdf"/><abstract><title>Abstract</title><p>Since its discovery, the cyclic GMP&#x02010;AMP synthase (cGAS)&#x02010;stimulator of the interferon gene (STING) signaling pathway has been considered a pivotal component of innate immunity and a promising target for cancer immunotherapy. Beyond its canonical role in pathogen defense, accumulating evidence has demonstrated that the cGAS&#x02010;STING pathway critically regulates diverse cellular processes, including cellular senescence, autophagy, cell death, and tumor immunosurveillance; therefore, dysregulation of this pathway correlates with the pathogenesis and progression of various human diseases, ranging from autoimmune and inflammatory disorders to cancer. Herein, we reviewed the regulatory mechanisms and cellular functions of the cGAS&#x02010;STING pathway, highlighting its essential role in maintaining immune homeostasis. We systematically discussed the dual roles of the cGAS&#x02010;STING pathway in cancer immunity, in which it triggers both antitumor and immunosuppressive effects. Finally, we summarized the recent advances and challenges in therapeutic strategies targeting the cGAS&#x02010;STING pathway and discussed the next generation of therapies, including nanomaterials, antibody&#x02010;drug conjugates, engineered bacteria, alternative strategies, optogenetic approaches, and combination strategies. We hope that our efforts will advance the understanding of the fundamental principles of innate immune recognition and response, and provide novel directions for improving the clinical outcomes of cGAS&#x02010;STING&#x02010;targeted therapies.</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="cac270067-kwd-0001">cancer immunotherapy</kwd><kwd id="cac270067-kwd-0002">innate immunity</kwd><kwd id="cac270067-kwd-0003">cGAS&#x02010;STING signaling pathway</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source>
<institution-wrap><institution>the National Natural Science Foundation of China</institution></institution-wrap>
</funding-source><award-id>82272794</award-id><award-id>82573178</award-id><award-id>82472969</award-id></award-group><award-group id="funding-0002"><funding-source>
<institution-wrap><institution>Research and Innovation Team Project for Scientific Breakthroughs at Shanxi Bethune Hospital</institution></institution-wrap>
</funding-source><award-id>2024AOXIANG04</award-id></award-group></funding-group><counts><fig-count count="8"/><table-count count="4"/><page-count count="34"/><word-count count="21025"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>November 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.6.6 mode:remove_FC converted:19.11.2025</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="cac270067-cite-0001">
<string-name>
<surname>Yan</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Tan</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Song</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Yi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Chu</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>K</given-names>
</string-name>. <article-title>Breaking barriers: The cGAS&#x02010;STING pathway as a novel frontier in cancer immunotherapy</article-title>. <source>Cancer Commun</source>. <year>2025</year>;<volume>45</volume>:<fpage>1513</fpage>&#x02013;<lpage>1546</lpage>. <pub-id pub-id-type="doi">10.1002/cac2.70067</pub-id>
</mixed-citation>
</p></notes></front><body><def-list list-content="abbreviations" id="cac270067-dl-0001"><title>Abbreviations</title><def-item><term>ABCC1</term><def><p>ATP&#x02010;binding cassette subfamily C member 1</p></def></def-item><def-item><term>ADC</term><def><p>Antibody&#x02010;drug conjugate</p></def></def-item><def-item><term>AIM2</term><def><p>Absent in melanoma 2</p></def></def-item><def-item><term>AKT</term><def><p>Protein kinase B</p></def></def-item><def-item><term>AP&#x02010;1</term><def><p>Adaptor protein complex 1</p></def></def-item><def-item><term>APC</term><def><p>Antigen&#x02010;presenting cell</p></def></def-item><def-item><term>ARF1</term><def><p>ADP&#x02010;ribosylation factor 1</p></def></def-item><def-item><term>ARIH1</term><def><p>Ariadne RBR E3 ubiquitin protein ligase 1</p></def></def-item><def-item><term>ATF6</term><def><p>Activating transcription factor 6</p></def></def-item><def-item><term>BATF3</term><def><p>Basic leucine zipper ATF&#x02010;like transcription factor 3</p></def></def-item><def-item><term>CAFs</term><def><p>Cancer&#x02010;associated fibroblasts</p></def></def-item><def-item><term>CAR&#x02010;T</term><def><p>Chimeric antigen receptor T cells</p></def></def-item><def-item><term>cGAS</term><def><p>Cyclic GMP&#x02010;AMP synthase</p></def></def-item><def-item><term>CDK1/4/6</term><def><p>Cyclin&#x02010;dependent kinase 1/4/6</p></def></def-item><def-item><term>CDN</term><def><p>Cyclic dinucleotide</p></def></def-item><def-item><term>cGAMP</term><def><p>2&#x02019;3&#x02019;&#x02010;cyclic GMP&#x02010;AMP</p></def></def-item><def-item><term>cGAS</term><def><p>cyclic GMP&#x02010;AMP synthase</p></def></def-item><def-item><term>CHK1</term><def><p>Checkpoint kinase 1</p></def></def-item><def-item><term>CIN</term><def><p>Chromosomal instability</p></def></def-item><def-item><term>COPII/COPI</term><def><p>Coat protein complex II/I</p></def></def-item><def-item><term>CTT</term><def><p>C&#x02010;terminal tail</p></def></def-item><def-item><term>DCs</term><def><p>Dendritic cells</p></def></def-item><def-item><term>DNases</term><def><p>Deoxyribonucleases</p></def></def-item><def-item><term>DNA&#x02010;PKcs</term><def><p>DNA&#x02010;dependent protein kinase catalytic subunit</p></def></def-item><def-item><term>dsDNA</term><def><p>double&#x02010;stranded DNA</p></def></def-item><def-item><term>E2F</term><def><p>Early 2 factor</p></def></def-item><def-item><term>eIF2&#x003b1;</term><def><p>Eukaryotic initiation factor 2&#x003b1;</p></def></def-item><def-item><term>EMT</term><def><p>Epithelial&#x02010;to&#x02010;mesenchymal transition</p></def></def-item><def-item><term>ENPP1/3</term><def><p>Ecto&#x02010;nucleotide pyrophosphatase phosphodiesterase 1/3</p></def></def-item><def-item><term>ER</term><def><p>Endoplasmic reticulum</p></def></def-item><def-item><term>ERGIC</term><def><p>ER&#x02010;Golgi intermediate compartment</p></def></def-item><def-item><term>ESCRT</term><def><p>Endosomal sorting complex required for transport</p></def></def-item><def-item><term>GABARAPs</term><def><p>Gamma&#x02010;aminobutyric acid receptor&#x02010;associated protein</p></def></def-item><def-item><term>GSDMD/E</term><def><p>Gasdermin D/E</p></def></def-item><def-item><term>GPX4</term><def><p>Glutathione peroxidase 4</p></def></def-item><def-item><term>HERC5</term><def><p>HECT and RLD domain containing E3 ubiquitin protein ligase 5</p></def></def-item><def-item><term>HIV</term><def><p>Human immunodeficiency virus</p></def></def-item><def-item><term>HK2</term><def><p>Hexokinase 2</p></def></def-item><def-item><term>HSV&#x02010;1</term><def><p>Herpes simplex virus&#x02010;1</p></def></def-item><def-item><term>ICIs</term><def><p>Immune checkpoint inhibitors</p></def></def-item><def-item><term>IDH1</term><def><p>Isocitrate dehydrogenase 1</p></def></def-item><def-item><term>IDO</term><def><p>Indoleamine 2,3&#x02019;&#x02010;dioxygenase</p></def></def-item><def-item><term>IFNs</term><def><p>Interferons</p></def></def-item><def-item><term>IL&#x02010;1&#x003b2;/IL&#x02010;6</term><def><p>Interleukin&#x02010;1&#x003b2;/Interleukin&#x02010;6</p></def></def-item><def-item><term>iCAFs</term><def><p>Inflammatory CAFs</p></def></def-item><def-item><term>IRE1</term><def><p>Inositol&#x02010;requiring enzyme 1</p></def></def-item><def-item><term>IRF3</term><def><p>Interferon regulatory factor 3</p></def></def-item><def-item><term>ISGs</term><def><p>Interferon&#x02010;stimulated genes</p></def></def-item><def-item><term>KAT5</term><def><p>Lysine acetyltransferase 5</p></def></def-item><def-item><term>LC3</term><def><p>Light chain 3</p></def></def-item><def-item><term>LINE&#x02010;1</term><def><p>Long interspersed nuclear element&#x02010;1</p></def></def-item><def-item><term>LRRC8A</term><def><p>Leucine&#x02010;rich repeat&#x02010;containing 8A</p></def></def-item><def-item><term>LYPLAL1</term><def><p>Lysophospholipase&#x02010;like 1</p></def></def-item><def-item><term>MARCH8</term><def><p>Membrane&#x02010;associated RING&#x02010;CH&#x02010;type finger 8</p></def></def-item><def-item><term>MDSCs</term><def><p>Myeloid&#x02010;derived suppressor cells</p></def></def-item><def-item><term>METTL3</term><def><p>Methyltransferase&#x02010;like 3</p></def></def-item><def-item><term>MiT&#x02010;TFE</term><def><p>Microphthalmia/transcription factor E</p></def></def-item><def-item><term>MLKL</term><def><p>Mixed lineage kinase domain&#x02010;like protein</p></def></def-item><def-item><term>mtDNA</term><def><p>Mitochondrial DNA</p></def></def-item><def-item><term>m6A</term><def><p>N6&#x02010;methyladenosine</p></def></def-item><def-item><term>NCOA4</term><def><p>Nuclear receptor coactivator 4</p></def></def-item><def-item><term>NF&#x02010;&#x003ba;B</term><def><p>Nuclear transcription factor&#x02010;kappa B</p></def></def-item><def-item><term>NK cells</term><def><p>Natural killer cells</p></def></def-item><def-item><term>NLRP3</term><def><p>Nucleotide&#x02010;binding oligomerization domain, leucine&#x02010;rich repeat&#x02010;, and pyrin domain&#x02010;containing protein 3</p></def></def-item><def-item><term>NPC1</term><def><p>Niemann&#x02010;Pick disease type C1 protein</p></def></def-item><def-item><term>OMVs</term><def><p>Outer membrane vesicles</p></def></def-item><def-item><term>ORF9/2p</term><def><p>Open reading frame 9/ 2 protein</p></def></def-item><def-item><term>PARP1</term><def><p>Poly (ADP&#x02010;ribose) polymerase 1</p></def></def-item><def-item><term>PD&#x02010;(L)1</term><def><p>Programmed death&#x02010;ligand 1</p></def></def-item><def-item><term>PERK</term><def><p>Protein kinase RNA&#x02010;like endoplasmic reticulum kinase</p></def></def-item><def-item><term>PI3P</term><def><p>Phosphatidylinositol 3&#x02010;phosphate</p></def></def-item><def-item><term>PP1</term><def><p>Type 1 phosphatase</p></def></def-item><def-item><term>PRRs</term><def><p>Pattern&#x02010;recognition receptors</p></def></def-item><def-item><term>PTMs</term><def><p>Post&#x02010;translational modifications</p></def></def-item><def-item><term>PUMA</term><def><p>p53 upregulated modulator of apoptosis</p></def></def-item><def-item><term>P2X7R</term><def><p>P2X7 receptor</p></def></def-item><def-item><term>RIPK1/RIPK3</term><def><p>Receptor&#x02010;interacting protein kinase 1/3</p></def></def-item><def-item><term>SASPs</term><def><p>Senescence&#x02010;associated secretory phenotypes</p></def></def-item><def-item><term>SECs</term><def><p>SEC homolog, COPII coat complex component</p></def></def-item><def-item><term>SENP2</term><def><p>SUMO&#x02010;specific protease 2</p></def></def-item><def-item><term>SLC19A1</term><def><p>Solute carrier family 19 member 1</p></def></def-item><def-item><term>SLC7A11</term><def><p>Solute carrier family 7 member 11</p></def></def-item><def-item><term>SMPDL3A</term><def><p>Sphingomyelin phosphodiesterase acid&#x02010;like 3A</p></def></def-item><def-item><term>STEEP</term><def><p>STING ER exit protein</p></def></def-item><def-item><term>STIM1</term><def><p>Stromal interaction molecule 1</p></def></def-item><def-item><term>STING</term><def><p>Stimulator of interferon gene</p></def></def-item><def-item><term>SUV39H1</term><def><p>Suppressor of variegation 3&#x02010;9 homolog 1</p></def></def-item><def-item><term>Surf4</term><def><p>Surfeit locus protein 4</p></def></def-item><def-item><term>TAMs</term><def><p>Tumor&#x02010;associated macrophages</p></def></def-item><def-item><term>TBK1</term><def><p>TANK&#x02010;binding kinase 1</p></def></def-item><def-item><term>Th1/9</term><def><p>T helper 1/9 cells</p></def></def-item><def-item><term>TLR2</term><def><p>Toll&#x02010;like receptor 2</p></def></def-item><def-item><term>TME</term><def><p>Tumor microenvironment</p></def></def-item><def-item><term>TNF</term><def><p>Tumor necrosis factor</p></def></def-item><def-item><term>TOLLIP</term><def><p>Toll&#x02010;interacting protein</p></def></def-item><def-item><term>TRAP&#x003b2;</term><def><p>Translocon&#x02010;associated protein beta</p></def></def-item><def-item><term>TREXs</term><def><p>Three&#x02010;prime repair exonucleases</p></def></def-item><def-item><term>TRIMs</term><def><p>Tripartite motif&#x02010;containing proteins</p></def></def-item><def-item><term>Tregs</term><def><p>Regulatory T cells</p></def></def-item><def-item><term>TXNRD1</term><def><p>Thioredoxin reductase 1</p></def></def-item><def-item><term>UBE3C</term><def><p>Ubiquitin protein ligase E3C</p></def></def-item><def-item><term>ULK1</term><def><p>UNC&#x02010;51&#x02010;like kinase 1</p></def></def-item><def-item><term>USPs</term><def><p>Ubiquitin&#x02010;specific proteases</p></def></def-item><def-item><term>WIPI2</term><def><p>WD repeat domain, phosphoinositide&#x02010;interacting protein 2</p></def></def-item><def-item><term>YAP/TAZ</term><def><p>Yes&#x02010;associated protein/Transcriptional coactivator with PDZ&#x02010;binding motif</p></def></def-item><def-item><term>ZBP1</term><def><p>Z&#x02010;DNA binding protein 1</p></def></def-item><def-item><term>ZDHHC</term><def><p>Zinc&#x02010;finger and DHHC motif&#x02010;containing (palmitoyltransferases)</p></def></def-item></def-list><sec id="cac270067-sec-0010"><label>1</label><title>INTRODUCTION</title><p>In 1989, immunologist Charles A. Janeway Jr. proposed that the immune system discriminated between &#x02018;self&#x02019; and &#x02018;non&#x02010;self&#x02019; molecules through pattern&#x02010;recognition receptors (PRRs), enabling specific and appropriate immune responses against pathogen&#x02010;associated molecular patterns [<xref rid="cac270067-bib-0001" ref-type="bibr">1</xref>]. In 2008, the endoplasmic reticulum (ER)&#x02010;resident stimulator of interferon genes (STING) was identified as a critical mediator of type I interferon (IFN&#x02010;&#x003b1;/&#x003b2;) responses, activating IFN regulatory factor 3 (IRF3) and nuclear transcription factor&#x02010;kappa B (NF&#x02010;&#x003ba;B) transcription pathways to orchestrate antiviral immunity [<xref rid="cac270067-bib-0002" ref-type="bibr">2</xref>]. Yet, the primary PRR responsible for detecting pathogenic DNA remained elusive until 2013, when Zhijian Chen et&#x000a0;al. discovered cyclic GMP&#x02010;AMP synthase (cGAS) as the crucial sensor that recognizes microbial and endogenous DNA [<xref rid="cac270067-bib-0003" ref-type="bibr">3</xref>, <xref rid="cac270067-bib-0004" ref-type="bibr">4</xref>]. Upon DNA binding, cGAS synthesizes the second messenger, 2&#x02019;3&#x02019;&#x02010;cyclic GMP&#x02010;AMP (cGAMP), which binds and activates STING, triggering rapid and potent IFN&#x02010;mediated immune responses [<xref rid="cac270067-bib-0005" ref-type="bibr">5</xref>].</p><p>Over the past decade, research on the cGAS&#x02010;STING pathway has revealed its activation mechanisms, regulatory networks, and diverse cellular functions, marking landmark advancements in innate immunity (Figure&#x000a0;<xref rid="cac270067-fig-0001" ref-type="fig">1</xref>). Beyond its canonical role in antimicrobial defense, cGAS&#x02010;STING also regulates cellular senescence, autophagy, lysosomal biogenesis, cell death, and antitumor immunity [<xref rid="cac270067-bib-0006" ref-type="bibr">6</xref>, <xref rid="cac270067-bib-0007" ref-type="bibr">7</xref>, <xref rid="cac270067-bib-0008" ref-type="bibr">8</xref>, <xref rid="cac270067-bib-0009" ref-type="bibr">9</xref>, <xref rid="cac270067-bib-0010" ref-type="bibr">10</xref>, <xref rid="cac270067-bib-0011" ref-type="bibr">11</xref>]. Abnormal cGAS activation by self&#x02010;DNA drives aberrant immune responses and contributes to the pathogenesis of a wide range of autoimmune and inflammatory diseases [<xref rid="cac270067-bib-0012" ref-type="bibr">12</xref>, <xref rid="cac270067-bib-0013" ref-type="bibr">13</xref>, <xref rid="cac270067-bib-0014" ref-type="bibr">14</xref>, <xref rid="cac270067-bib-0015" ref-type="bibr">15</xref>]. STING is considered a promising target for antitumor immunotherapy because of its essential role in stimulating antitumor immunity [<xref rid="cac270067-bib-0016" ref-type="bibr">16</xref>]. Intriguingly, chronic STING activation in chromosomally unstable tumors promotes tumorigenesis and metastasis through downstream signal reprogramming and immunosuppressive mechanisms [<xref rid="cac270067-bib-0017" ref-type="bibr">17</xref>, <xref rid="cac270067-bib-0018" ref-type="bibr">18</xref>, <xref rid="cac270067-bib-0019" ref-type="bibr">19</xref>, <xref rid="cac270067-bib-0020" ref-type="bibr">20</xref>]. Moreover, the clinical outcomes of STING agonists are disappointing, which may partially be due to poor membrane permeability [<xref rid="cac270067-bib-0021" ref-type="bibr">21</xref>], systemic toxicity [<xref rid="cac270067-bib-0016" ref-type="bibr">16</xref>], and resistance mechanisms [<xref rid="cac270067-bib-0019" ref-type="bibr">19</xref>, <xref rid="cac270067-bib-0022" ref-type="bibr">22</xref>]. To overcome these barriers, recent years have witnessed rapid progress in cGAS&#x02010;STING&#x02010;targeted therapies such as nanomaterials, antibody&#x02010;drug conjugates (ADCs), engineered bacteria, alternative strategies, and combination strategies, which offer promising avenues for cancer treatment.</p><fig position="float" fig-type="FIGURE" id="cac270067-fig-0001"><label>FIGURE 1</label><caption><p>A historical perspective and key milestones in cGAS&#x02010;STING signaling. CDN, cyclic dinucleotide; cGAS, cyclic GMP&#x02010;AMP synthase; CIN, chromosomal instability; dMMR, deficient mismatch repair; STING, stimulator of interferon gene.</p></caption><graphic xlink:href="CAC2-45-1513-g002" position="anchor" id="jats-graphic-1"/></fig><p>This review systematically summarized recent regulatory and functional advances in cGAS&#x02010;STING as a cornerstone of innate immunity. By discussing the dual roles of the cGAS&#x02010;STING pathway in cancer immunity, we hope to provide new insights for next&#x02010;generation cGAS&#x02010;STING&#x02010;targeted therapies.</p></sec><sec id="cac270067-sec-0020"><label>2</label><title>STRUCTURAL AND FUNCTIONAL INSIGHTS INTO cGAS&#x02010;STING ACTIVATION</title><p>Initially characterized as a cytosolic DNA sensor, cGAS binds to microbial double&#x02010;stranded DNA (dsDNA) (such as from viruses and bacteria), extracellular self&#x02010;DNA from dead or tumor cells, and self&#x02010;DNA released from damaged mitochondria or nuclei (Figure&#x000a0;<xref rid="cac270067-fig-0002" ref-type="fig">2A</xref>) [<xref rid="cac270067-bib-0023" ref-type="bibr">23</xref>]. However, cGAS is primarily sequestered by nucleosomes under physiological conditions, preventing aberrant activation and maintaining immune homeostasis [<xref rid="cac270067-bib-0024" ref-type="bibr">24</xref>, <xref rid="cac270067-bib-0025" ref-type="bibr">25</xref>]. cGAS is structured as a cGAS/DncV&#x02010;like nucleotidyltransferase domain composed of a C&#x02010;terminal domain containing three DNA&#x02010;binding sites (A, B, and C) and an unstructured N&#x02010;terminal domain [<xref rid="cac270067-bib-0026" ref-type="bibr">26</xref>] (Figure&#x000a0;<xref rid="cac270067-fig-0002" ref-type="fig">2B</xref>). Upon encountering cytosolic dsDNA, cGAS engages the DNA at sites A and B to form a 2:2 cGAS&#x02010;dsDNA complex. This interaction induces conformational rearrangements that structure the catalytic site, enabling the conversion of ATP and GTP to cGAMP, a cyclic dinucleotide (CDN) featuring 2&#x02019;&#x02010;5&#x02019; and 3&#x02019;&#x02010;5&#x02019; bonds between AMP and GMP (Figure&#x000a0;<xref rid="cac270067-fig-0002" ref-type="fig">2A</xref>
<bold>and</bold>
<xref rid="cac270067-fig-0002" ref-type="fig">C</xref>) [<xref rid="cac270067-bib-0027" ref-type="bibr">27</xref>, <xref rid="cac270067-bib-0028" ref-type="bibr">28</xref>].</p><fig position="float" fig-type="FIGURE" id="cac270067-fig-0002"><label>FIGURE 2</label><caption><p>Activation mechanisms and structure basis of the cGAS&#x02010;STING signaling pathway. (A) Upon stimulation by dsDNA from pathogens, dead cells, tumor cells, endogenous micronuclei, or mitochondria, cGAS catalyzes the formation of 2&#x02019;3&#x02019;&#x02010;cGAMP, which acts as a second messenger to induce STING activation. Then STING translocates from the ER to the ERGIC and the Golgi apparatus, thereafter, activating IRF3 and NF&#x02010;&#x003ba;B transcription activity through TBK1 and IKK&#x003b5;. The downstream cascade ultimately promotes the expression of IFNs and ISGs, thus triggering inflammatory responses; (B) cGAS (PDB ID code 4LEY) has three DNA&#x02010;binding sites: site A, B, and C; (C) cGAMP (PDB ID code 4KSY) contains 2&#x02032;&#x02212;5&#x02032; and 3&#x02032;&#x02212;5&#x02032;&#x02010;bonds between AMP and GMP; (D) STING (PDB ID code 6NT5) is a transmembrane protein featured by the LBD (cGAMP binding domain) and the TMD. cGAMP, 2&#x02019;3&#x02019;&#x02010;cyclic GMP&#x02010;AMP; cGAS, cyclic GMP&#x02010;AMP synthase; dsDNA, double&#x02010;stranded DNA; ER, endoplasmic reticulum; ERGIC, ER&#x02010;Golgi intermediate compartment; IFNs, interferons; IKK&#x003b5;, IkappaB kinase epsilon; IRF3, interferon regulatory factor 3; ISGs, interferon&#x02010;stimulated genes; LBD, ligand binding domain; mtDNA, mitochondrial DNA; NF&#x02010;&#x003ba;B, nuclear transcription factor&#x02010;kappa B; p, phosphorylation; STING, stimulator of interferon gene; TBK1, TANK&#x02010;binding kinase 1; TMD, transmembrane domain.</p></caption><graphic xlink:href="CAC2-45-1513-g008" position="anchor" id="jats-graphic-3"/></fig><p>Functioning as an endogenous second messenger, cGAMP triggers the ER&#x02010;resident adaptor, STING, a transmembrane protein featuring four helical domains and a cytosolic region responsible for ligand binding and signal transduction [<xref rid="cac270067-bib-0005" ref-type="bibr">5</xref>, <xref rid="cac270067-bib-0029" ref-type="bibr">29</xref>] (Figure&#x000a0;<xref rid="cac270067-fig-0002" ref-type="fig">2D</xref>). cGAMP binding induces structural rearrangements in STING, facilitating oligomerization from dimers to tetramers/higher&#x02010;order oligomers and triggering downstream cascades (Figure&#x000a0;<xref rid="cac270067-fig-0002" ref-type="fig">2A</xref>) [<xref rid="cac270067-bib-0005" ref-type="bibr">5</xref>]. Following activation, STING undergoes coat protein complex (COP)II&#x02010;mediated vesicular trafficking, relocating sequentially from the ER to the ER&#x02010;Golgi intermediate compartment (ERGIC) and the Golgi apparatus [<xref rid="cac270067-bib-0008" ref-type="bibr">8</xref>]. In the Golgi, TANK&#x02010;binding kinase 1 (TBK1) is recruited to the C&#x02010;terminal domain of STING. Subsequent TBK1 autophosphorylation and STING phosphorylation at serine (S) 366 (human) or S365 (mouse) in the C&#x02010;terminal tail (CTT) enables IRF3 activation and nuclear translocation, initiating the transcription of type I interferons (IFNs) and interferon&#x02010;stimulated genes (ISGs) [<xref rid="cac270067-bib-0030" ref-type="bibr">30</xref>, <xref rid="cac270067-bib-0031" ref-type="bibr">31</xref>]. Simultaneously, STING activates the NF&#x02010;&#x003ba;B pathway, upregulating proinflammatory cytokines including IFN&#x02010;&#x003b2;, tumor necrosis factor&#x02010;&#x003b1; (TNF&#x02010;&#x003b1;), interleukin (IL)&#x02010;1&#x003b2;, and IL&#x02010;6 [<xref rid="cac270067-bib-0032" ref-type="bibr">32</xref>, <xref rid="cac270067-bib-0033" ref-type="bibr">33</xref>, <xref rid="cac270067-bib-0034" ref-type="bibr">34</xref>]. However, the mechanism of STING&#x02010;mediated NF&#x02010;&#x003ba;B activation remains poorly understood, including whether this process requires TBK1 or its homolog I&#x003ba;B kinase &#x003b5; (IKK&#x003b5;), and whether NF&#x02010;&#x003ba;B interacts directly with the STING signalosome or indirectly [<xref rid="cac270067-bib-0035" ref-type="bibr">35</xref>, <xref rid="cac270067-bib-0036" ref-type="bibr">36</xref>].</p></sec><sec id="cac270067-sec-0030"><label>3</label><title>REGULATIONS OF cGAS&#x02010;STING PATHWAY</title><sec id="cac270067-sec-0040"><label>3.1</label><title>Post&#x02010;translational modifications of cGAS and STING</title><p>Post&#x02010;translational modifications (PTMs) play a pivotal role in regulating both cGAS and STING activity through diverse mechanisms, including ubiquitination, SUMOylation, ISGylation, phosphorylation, palmitoylation, and acetylation (Tables <xref rid="cac270067-tbl-0001" ref-type="table">1</xref> and <xref rid="cac270067-tbl-0002" ref-type="table">2</xref>).</p><table-wrap position="float" id="cac270067-tbl-0001" content-type="TABLE"><label>TABLE 1</label><caption><p>Post&#x02010;translational modifications of cGAS.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">Mode of PTM</th><th align="left" rowspan="1" colspan="1">Regulators</th><th align="left" rowspan="1" colspan="1">Sites</th><th align="left" rowspan="1" colspan="1">Modification outcomes</th><th align="left" rowspan="1" colspan="1">Refs.</th></tr></thead><tbody><tr><td rowspan="4" align="left" colspan="1">Ubiquitination</td><td align="left" rowspan="1" colspan="1">TRIM27</td><td align="left" rowspan="1" colspan="1">K63</td><td align="left" rowspan="1" colspan="1">Promote cGAS degradation</td><td align="left" rowspan="1" colspan="1">[<xref rid="cac270067-bib-0037" ref-type="bibr">37</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">UBE3C</td><td align="left" rowspan="1" colspan="1">K27</td><td align="left" rowspan="1" colspan="1">Promote cGAS degradation</td><td align="left" rowspan="1" colspan="1">[<xref rid="cac270067-bib-0038" ref-type="bibr">38</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">TRIM56</td><td align="left" rowspan="1" colspan="1">K335R</td><td align="left" rowspan="1" colspan="1">Promote cGAS dimerization and DNA&#x02010;binding activity</td><td align="left" rowspan="1" colspan="1">[<xref rid="cac270067-bib-0039" ref-type="bibr">39</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">TRIM41</td><td align="left" rowspan="1" colspan="1">NA</td><td align="left" rowspan="1" colspan="1">Promote cGAS enzymatic activity</td><td align="left" rowspan="1" colspan="1">[<xref rid="cac270067-bib-0040" ref-type="bibr">40</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Deubiquitination</td><td align="left" rowspan="1" colspan="1">USP29 and USP27X</td><td align="left" rowspan="1" colspan="1">K48</td><td align="left" rowspan="1" colspan="1">Promote cGAS stabilization</td><td align="left" rowspan="1" colspan="1">[<xref rid="cac270067-bib-0041" ref-type="bibr">41</xref>, <xref rid="cac270067-bib-0042" ref-type="bibr">42</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">SUMOylation</td><td align="left" rowspan="1" colspan="1">TRIM38</td><td align="left" rowspan="1" colspan="1">K217 and K464</td><td align="left" rowspan="1" colspan="1">Promote cGAS activity</td><td align="left" rowspan="1" colspan="1">[<xref rid="cac270067-bib-0043" ref-type="bibr">43</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">DeSUMOylation</td><td align="left" rowspan="1" colspan="1">SENP2</td><td align="left" rowspan="1" colspan="1">NA</td><td align="left" rowspan="1" colspan="1">Promote cGAS degradation</td><td align="left" rowspan="1" colspan="1">[<xref rid="cac270067-bib-0043" ref-type="bibr">43</xref>]</td></tr><tr><td rowspan="2" align="left" colspan="1">ISGylation</td><td align="left" rowspan="1" colspan="1">ARIH1</td><td align="left" rowspan="1" colspan="1">K187</td><td align="left" rowspan="1" colspan="1">Promote cGAS activation</td><td align="left" rowspan="1" colspan="1">[<xref rid="cac270067-bib-0044" ref-type="bibr">44</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">HERC5</td><td align="left" rowspan="1" colspan="1">K21, K187, K219, and K458</td><td align="left" rowspan="1" colspan="1">Promote cGAS activation and enzymatic activity</td><td align="left" rowspan="1" colspan="1">[<xref rid="cac270067-bib-0045" ref-type="bibr">45</xref>]</td></tr><tr><td rowspan="2" align="left" colspan="1">Phosphorylation</td><td align="left" rowspan="1" colspan="1">CDK1&#x02010;cyclin B complex</td><td align="left" rowspan="1" colspan="1">S305 (human)/S291 (mouse)</td><td align="left" rowspan="1" colspan="1">Inhibit cGAS enzymatic activity</td><td align="left" rowspan="1" colspan="1">[<xref rid="cac270067-bib-0046" ref-type="bibr">46</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">AKT</td><td align="left" rowspan="1" colspan="1">S305 (human)/ S291 (mouse)</td><td align="left" rowspan="1" colspan="1">Inhibit cGAS enzymatic activity</td><td align="left" rowspan="1" colspan="1">[<xref rid="cac270067-bib-0047" ref-type="bibr">47</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Dephosphorylation</td><td align="left" rowspan="1" colspan="1">PP1</td><td align="left" rowspan="1" colspan="1">S305 (human)/ S291 (mouse)</td><td align="left" rowspan="1" colspan="1">Promote cGAS DNA sensing ability</td><td align="left" rowspan="1" colspan="1">[<xref rid="cac270067-bib-0046" ref-type="bibr">46</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Palmitoylation</td><td align="left" rowspan="1" colspan="1">ZDHHC9</td><td align="left" rowspan="1" colspan="1">C404/405</td><td align="left" rowspan="1" colspan="1">Promote cGAS dimerization and activation</td><td align="left" rowspan="1" colspan="1">[<xref rid="cac270067-bib-0049" ref-type="bibr">49</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Depalmitoylation</td><td align="left" rowspan="1" colspan="1">LYPLAL1</td><td align="left" rowspan="1" colspan="1">NA</td><td align="left" rowspan="1" colspan="1">Inhibit cGAS activity</td><td align="left" rowspan="1" colspan="1">[<xref rid="cac270067-bib-0049" ref-type="bibr">49</xref>]</td></tr><tr><td rowspan="2" align="left" colspan="1">Acetylation</td><td align="left" rowspan="1" colspan="1">Aspirin</td><td align="left" rowspan="1" colspan="1">K384, K394, and K414</td><td align="left" rowspan="1" colspan="1">Inhibit cGAS activity</td><td align="left" rowspan="1" colspan="1">[<xref rid="cac270067-bib-0051" ref-type="bibr">51</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">KAT5</td><td align="left" rowspan="1" colspan="1">K47, K56, K62, and K83</td><td align="left" rowspan="1" colspan="1">Promote cGAS activity</td><td align="left" rowspan="1" colspan="1">[<xref rid="cac270067-bib-0053" ref-type="bibr">53</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Lactylation</td><td align="left" rowspan="1" colspan="1">AARS1 and AARS2&#x000a0;</td><td align="left" rowspan="1" colspan="1">K131</td><td align="left" rowspan="1" colspan="1">Inhibit cGAS liquid&#x02010;like phase separation and DNA sensing ability</td><td align="left" rowspan="1" colspan="1">[<xref rid="cac270067-bib-0055" ref-type="bibr">55</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">PARylation</td><td align="left" rowspan="1" colspan="1">PARP1</td><td align="left" rowspan="1" colspan="1">D191</td><td align="left" rowspan="1" colspan="1">Inhibit the DNA&#x02010;binding ability of cGAS</td><td align="left" rowspan="1" colspan="1">[<xref rid="cac270067-bib-0056" ref-type="bibr">56</xref>]</td></tr></tbody></table><table-wrap-foot><fn id="cac270067-tbl1-note-0001"><p>Abbreviations: AARSs, alanyl&#x02010;tRNA synthetases; AKT, protein kinase B; ARIH1, ariadne RBR E3 ubiquitin protein ligase 1; C, cysteine; CDK1, cyclin&#x02010;dependent kinase 1; cGAS, cyclic GMP&#x02010;AMP synthase; D, aspartic acid; HERC5, HECT domain&#x02010; and RCC1&#x02010;like domain&#x02010;containing proteins; K, Lysine; KAT5, lysine acetyltransferase 5; LYPLAL1, lysophospholipase&#x02010;like 1; NA, not analyzed; PARP1, poly(ADP&#x02010;ribose) polymerase 1; PP1, serine/threonine&#x02010;protein phosphatase 1; PTM, post&#x02010;translational modification; Refs, references; S, Serine; SENPs, SUMO&#x02010;specific proteases; TRIMs, tripartite motif proteins; UBE3C, ubiquitin protein ligase E3C; USPs, ubiquitin&#x02010;specific proteases; ZDHHC9, zinc finger DHHC&#x02010;type containing palmitoyltransferase 9.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap><table-wrap position="float" id="cac270067-tbl-0002" content-type="TABLE"><label>TABLE 2</label><caption><p>Post&#x02010;translational modifications of STING.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">Mode of PTM</th><th align="left" rowspan="1" colspan="1">Regulators</th><th align="left" rowspan="1" colspan="1">Sites</th><th align="left" rowspan="1" colspan="1">Modification outcomes</th><th align="left" rowspan="1" colspan="1">Refs.</th></tr></thead><tbody><tr><td rowspan="4" align="left" colspan="1">Ubiquitination</td><td align="left" rowspan="1" colspan="1">TRIM29</td><td align="left" rowspan="1" colspan="1">K48, K338, K347, and K370</td><td align="left" rowspan="1" colspan="1">Promote STING degradation</td><td align="left" rowspan="1" colspan="1">[<xref rid="cac270067-bib-0114" ref-type="bibr">114</xref>, <xref rid="cac270067-bib-0115" ref-type="bibr">115</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">TRIM13</td><td align="left" rowspan="1" colspan="1">K6</td><td align="left" rowspan="1" colspan="1">Promote STING degradation</td><td align="left" rowspan="1" colspan="1">[<xref rid="cac270067-bib-0116" ref-type="bibr">116</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">TRIM56 and TRIM32</td><td align="left" rowspan="1" colspan="1">K63</td><td align="left" rowspan="1" colspan="1">Promote STING activation and TBK1 recruitment.</td><td align="left" rowspan="1" colspan="1">[<xref rid="cac270067-bib-0327" ref-type="bibr">327</xref>, <xref rid="cac270067-bib-0328" ref-type="bibr">328</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">TRIM10</td><td align="left" rowspan="1" colspan="1">K27 and K29</td><td align="left" rowspan="1" colspan="1">Promote STING trafficking, aggregation, and TBK1 recruitment</td><td align="left" rowspan="1" colspan="1">[<xref rid="cac270067-bib-0329" ref-type="bibr">329</xref>]</td></tr><tr><td rowspan="3" align="left" colspan="1">Deubiquitination</td><td align="left" rowspan="1" colspan="1">CYLD, OTUD5, USP20, USP44, and OTUD6a</td><td align="left" rowspan="1" colspan="1">K48</td><td align="left" rowspan="1" colspan="1">Stabilize STING</td><td align="left" rowspan="1" colspan="1">[<xref rid="cac270067-bib-0110" ref-type="bibr">110</xref>, <xref rid="cac270067-bib-0330" ref-type="bibr">330</xref>, <xref rid="cac270067-bib-0331" ref-type="bibr">331</xref>, <xref rid="cac270067-bib-0332" ref-type="bibr">332</xref>, <xref rid="cac270067-bib-0333" ref-type="bibr">333</xref>, <xref rid="cac270067-bib-0334" ref-type="bibr">334</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">USP35</td><td align="left" rowspan="1" colspan="1">K6, K11, K27, K29, and K63</td><td align="left" rowspan="1" colspan="1">Inhibit STING activity</td><td align="left" rowspan="1" colspan="1">[<xref rid="cac270067-bib-0335" ref-type="bibr">335</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">USP13</td><td align="left" rowspan="1" colspan="1">K27</td><td align="left" rowspan="1" colspan="1">Inhibit assembly of STING&#x02010;TBK1</td><td align="left" rowspan="1" colspan="1">[<xref rid="cac270067-bib-0336" ref-type="bibr">336</xref>, <xref rid="cac270067-bib-0337" ref-type="bibr">337</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">SUMOylation</td><td align="left" rowspan="1" colspan="1">TRIM38</td><td align="left" rowspan="1" colspan="1">K337</td><td align="left" rowspan="1" colspan="1">Promoting STING activation and stability</td><td align="left" rowspan="1" colspan="1">[<xref rid="cac270067-bib-0043" ref-type="bibr">43</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">DeSUMOylation</td><td align="left" rowspan="1" colspan="1">SENP2</td><td align="left" rowspan="1" colspan="1">NA</td><td align="left" rowspan="1" colspan="1">Promote STING degradation</td><td align="left" rowspan="1" colspan="1">[<xref rid="cac270067-bib-0043" ref-type="bibr">43</xref>]</td></tr><tr><td rowspan="2" align="left" colspan="1">Phosphorylation</td><td align="left" rowspan="1" colspan="1">TBK1</td><td align="left" rowspan="1" colspan="1">S366 (human)/S365 (mouse)</td><td align="left" rowspan="1" colspan="1">Promote IRF3 recruitment and STING activation</td><td align="left" rowspan="1" colspan="1">[<xref rid="cac270067-bib-0031" ref-type="bibr">31</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">ULK1</td><td align="left" rowspan="1" colspan="1">S366</td><td align="left" rowspan="1" colspan="1">Inhibit STING activity</td><td align="left" rowspan="1" colspan="1">[<xref rid="cac270067-bib-0048" ref-type="bibr">48</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Palmitoylation</td><td align="left" rowspan="1" colspan="1">ZDHHC3, ZDHHC7, and ZDHHC15</td><td align="left" rowspan="1" colspan="1">C88 and C91</td><td align="left" rowspan="1" colspan="1">Promote STING activity</td><td align="left" rowspan="1" colspan="1">[<xref rid="cac270067-bib-0050" ref-type="bibr">50</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Acetylation</td><td align="left" rowspan="1" colspan="1">Beclin&#x02010;1</td><td align="left" rowspan="1" colspan="1">K338</td><td align="left" rowspan="1" colspan="1">Promote&#x000a0;STING degradation</td><td align="left" rowspan="1" colspan="1">[<xref rid="cac270067-bib-0054" ref-type="bibr">54</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Alkylation</td><td align="left" rowspan="1" colspan="1">4&#x02010;OI</td><td align="left" rowspan="1" colspan="1">C65, C71, C88, and C147</td><td align="left" rowspan="1" colspan="1">Inhibit STING phosphorylation</td><td align="left" rowspan="1" colspan="1">[<xref rid="cac270067-bib-0057" ref-type="bibr">57</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Carbonylation</td><td align="left" rowspan="1" colspan="1">GPX4</td><td align="left" rowspan="1" colspan="1">C88</td><td align="left" rowspan="1" colspan="1">Inhibit STING trafficking</td><td align="left" rowspan="1" colspan="1">[<xref rid="cac270067-bib-0210" ref-type="bibr">210</xref>]</td></tr></tbody></table><table-wrap-foot><fn id="cac270067-tbl2-note-0001"><p>Abbreviations: C, cysteine; CYLD, CYLD lysine 63 deubiquitinase; GPX4, glutathione peroxidase 4; K, Lysine; NA, not analyzed; OTUDs, OTU deubiquitinases; PTM, post&#x02010;translational modification; Refs, references; S, Serine; SENP2, SUMO&#x02010;specific protease 2; STING, stimulator of interferon gene; TBK1, TANK&#x02010;binding kinase 1; TRIMs, tripartite motif proteins; ULK1, UNC&#x02010;51&#x02010;like kinase 1; USPs, ubiquitin&#x02010;specific proteases; ZDHHCs, zinc finger DHHC&#x02010;type containing palmitoyltransferases.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap><sec id="cac270067-sec-0050"><label>3.1.1</label><title>Ubiquitination, SUMOylation, and ISGylation</title><p>Ubiquitination plays an essential role in regulating the activation and stabilization of both cGAS and STING. Lysine (K) 48&#x02010;, K62&#x02010;, and K27&#x02010;linked polyubiquitinations, by E3 ubiquitin ligases, such as tripartite motif&#x02010;containing protein 7 (TRIM27) [<xref rid="cac270067-bib-0037" ref-type="bibr">37</xref>] and ubiquitin&#x02010;protein ligase E3C (UBE3C) [<xref rid="cac270067-bib-0038" ref-type="bibr">38</xref>], inhibit cGAS activity by impairing its DNA&#x02010;binding capacity and promoting proteasomal degradation. In contrast, monoubiquitination mediated by TRIM56 and TRIM41 enhances cGAS dimerization, DNA&#x02010;binding ability, and cGAMP synthesis [<xref rid="cac270067-bib-0039" ref-type="bibr">39</xref>, <xref rid="cac270067-bib-0040" ref-type="bibr">40</xref>]. The dynamic balance of these modifications is further regulated by deubiquitinating enzymes, such as ubiquitin&#x02010;specific proteases, which promote cGAS stabilization and activation by removing inhibitory ubiquitin chains [<xref rid="cac270067-bib-0041" ref-type="bibr">41</xref>, <xref rid="cac270067-bib-0042" ref-type="bibr">42</xref>]. Similarly, STING activity is precisely controlled by ubiquitination and deubiquitination that influence oligomerization, intracellular trafficking, protein stability, and interactions with TBK1 (Table <xref rid="cac270067-tbl-0002" ref-type="table">2</xref>).</p><p>Likewise, SUMOylation and ISGylation critically regulate cGAS&#x02010;STING activity via E3 ligases. For example, TRIM38&#x02010;mediated SUMOylation of both cGAS and STING enhances their stability and promotes early phase antiviral interferon responses, whereas SUMO&#x02010;specific protease 2 (SENP2)&#x02010;mediated deSUMOylation facilitates their degradation during the later stages of infection to prevent excessive inflammation [<xref rid="cac270067-bib-0043" ref-type="bibr">43</xref>]. Additionally, the E3 ubiquitin ligases, ariadne RBR E3 ubiquitin protein ligase 1 (ARIH1) [<xref rid="cac270067-bib-0044" ref-type="bibr">44</xref>] and HECT and RLD domain containing E3 ubiquitin protein ligase 5 (HERC5) [<xref rid="cac270067-bib-0045" ref-type="bibr">45</xref>], catalyze the ISGylation of cGAS, further potentiating its antiviral activity.</p></sec><sec id="cac270067-sec-0060"><label>3.1.2</label><title>Phosphorylation</title><p>Phosphorylation, one of the most fundamental and extensively studied PTMs, regulates both cGAS enzymatic activity and STING signaling function (Tables <xref rid="cac270067-tbl-0001" ref-type="table">1</xref> and <xref rid="cac270067-tbl-0002" ref-type="table">2</xref>). For instance, mitotic kinase cyclin&#x02010;dependent kinase 1 (CDK1)&#x02010;cyclin B complex phosphorylates human cGAS at S305 (S291 in mice) during mitosis to prevent cGAS&#x02010;mediated aberrant self&#x02010;DNA sensing during cell division, and protein kinase B (AKT)&#x02010;mediated phosphorylation at the same residue negatively modulates antiviral immune responses following viral DNA stimulation [<xref rid="cac270067-bib-0046" ref-type="bibr">46</xref>, <xref rid="cac270067-bib-0047" ref-type="bibr">47</xref>]. In contrast, type 1 phosphatase (PP1) counteracts these inhibitory effects by dephosphorylating cGAS and restoring its catalytic capacity for cGAMP synthesis [<xref rid="cac270067-bib-0046" ref-type="bibr">46</xref>]. Similarly, phosphorylation exerts multifaceted regulatory effects on STING oligomerization, translocation, and downstream activation. TBK1 phosphorylates STING&#x000a0;at S366 (human) or S365 (mouse) in the&#x000a0;CTT and promotes IRF3 recruitment and downstream signaling [<xref rid="cac270067-bib-0030" ref-type="bibr">30</xref>, <xref rid="cac270067-bib-0031" ref-type="bibr">31</xref>], whereas UNC&#x02010;51&#x02010;like kinase (ULK1)&#x02010;mediated phosphorylation at the same residue paradoxically suppresses IRF3 activation, demonstrating the complex, context&#x02010;dependent nature of the phosphorylation&#x02010;mediated regulation of STING [<xref rid="cac270067-bib-0048" ref-type="bibr">48</xref>].</p></sec><sec id="cac270067-sec-0070"><label>3.1.3</label><title>Palmitoylation</title><p>Palmitoylation, a dynamic lipid modification catalyzed by zinc finger and DHHC motif&#x02010;containing (ZDHHC) palmitoyltransferases, is a critical regulatory mechanism for both cGAS and STING activity (Tables <xref rid="cac270067-tbl-0001" ref-type="table">1</xref> and <xref rid="cac270067-tbl-0002" ref-type="table">2</xref>). Palmitoylation of cGAS at the cysteine residues (C404/405) enhances its dimerization and potentiates downstream immune responses [<xref rid="cac270067-bib-0049" ref-type="bibr">49</xref>]. In contrast, the lysophospholipase&#x02010;like 1 (LYPLAL1)&#x02010;induced de&#x02010;palmitoylation of cGAS attenuates cGAS activity, and the inhibition of LYPLAL1 promotes an inflammatory response and enhances the efficacy of programmed death&#x02010;1 (PD&#x02010;1) blockade therapy [<xref rid="cac270067-bib-0049" ref-type="bibr">49</xref>]. Similarly, palmitoylation plays an indispensable role in STING activation, as evidenced by impaired antiviral responses observed in STING variants with C88 and C91 mutations that prevent proper palmitoylation [<xref rid="cac270067-bib-0050" ref-type="bibr">50</xref>].</p></sec><sec id="cac270067-sec-0080"><label>3.1.4</label><title>Acetylation</title><p>Aspirin was discovered to directly acetylate cGAS at specific lysine residues (K384, K394, and K414), resulting in the suppression of cGAS&#x02010;mediated immune responses in autoimmune diseases [<xref rid="cac270067-bib-0051" ref-type="bibr">51</xref>]. Subsequent mass spectrometry analyses revealed the complex site&#x02010;specific effects of cGAS acetylation, showing that acetyl&#x02010;mimetic mutations at K384 and K414 inhibited cGAS activity, whereas K198 acetylation enhanced antiviral responses [<xref rid="cac270067-bib-0052" ref-type="bibr">52</xref>]. Further studies identified lysine acetyltransferase 5 (KAT5) as a positive regulator that promotes cGAS activation through N&#x02010;terminal acetylation (K47, K56, K62, and K83) [<xref rid="cac270067-bib-0053" ref-type="bibr">53</xref>]. The acetylation regulatory network extends to STING: Beclin&#x02010;1 binds to the C&#x02010;terminal domain of STING and induces K338 acetylation, triggering autophagy&#x02010;mediated degradation [<xref rid="cac270067-bib-0054" ref-type="bibr">54</xref>] (Tables <xref rid="cac270067-tbl-0001" ref-type="table">1</xref> and <xref rid="cac270067-tbl-0002" ref-type="table">2</xref>).</p></sec><sec id="cac270067-sec-0090"><label>3.1.5</label><title>Other PTMs</title><p>Recent studies have revealed several novel regulatory mechanisms of how PTMs regulate the cGAS&#x02010;STING pathway (Tables <xref rid="cac270067-tbl-0001" ref-type="table">1</xref> and <xref rid="cac270067-tbl-0002" ref-type="table">2</xref>). Among these, alanyl&#x02010;tRNA synthetase 1 (AARS1) and AARS2 mediate cGAS lactylation, thereby modulating its phase separation properties and impairing its DNA&#x02010;sensing capacity in response to metabolic changes [<xref rid="cac270067-bib-0055" ref-type="bibr">55</xref>]. Another recently discovered modification involves the poly(ADP&#x02010;ribose) polymerase 1 (PARP1)&#x02010;mediated PARylation of cGAS at aspartic acid 191 (D191), which occurs following viral&#x02010;induced genomic instability and subsequent PARP1 translocation to the cytoplasm, effectively suppressing antiviral responses by interfering with cGAS&#x02010;DNA interactions [<xref rid="cac270067-bib-0056" ref-type="bibr">56</xref>]. Additionally, alkylation of STING at specific cysteine residues (C65, C71, C88, and C147) inhibits STING&#x02010;mediated secretion of inflammatory factors [<xref rid="cac270067-bib-0057" ref-type="bibr">57</xref>]. Collectively, these multilayered PTM networks enable the precise spatiotemporal control of cGAS&#x02010;STING signaling.</p></sec></sec><sec id="cac270067-sec-0100"><label>3.2</label><title>Epigenetic modifications of cGAS&#x02010;STING signaling</title><p>Epigenetic modifications exert multilayered control over the cGAS&#x02010;STING pathway activity. At the transcriptional level, promoter hypermethylation of <italic toggle="yes">cGAS</italic> and <italic toggle="yes">STING</italic> genes leads to transcriptional silencing, promoting an immunosuppressive microenvironment and facilitating tumor progression [<xref rid="cac270067-bib-0058" ref-type="bibr">58</xref>, <xref rid="cac270067-bib-0059" ref-type="bibr">59</xref>, <xref rid="cac270067-bib-0060" ref-type="bibr">60</xref>, <xref rid="cac270067-bib-0061" ref-type="bibr">61</xref>, <xref rid="cac270067-bib-0062" ref-type="bibr">62</xref>]. Notably, cancer&#x02010;associated mutations in isocitrate dehydrogenase 1 (IDH1) drive epigenetic silencing of <italic toggle="yes">cGAS</italic> by inducing its hypermethylation [<xref rid="cac270067-bib-0063" ref-type="bibr">63</xref>]. N<sup>6</sup>&#x02010;methyladenosine (m<sup>6</sup>A) RNA methylation mediated by methyltransferase&#x02010;like 3 (METTL3) exerts opposite effects by stabilizing cGAS and STING mRNAs, thereby potentiating inflammatory responses under sterile conditions, such as fibrosis [<xref rid="cac270067-bib-0064" ref-type="bibr">64</xref>]. At the post&#x02010;translational level, epigenetic modifications regulate cGAS activity via protein methylation. The methyltransferase, SUV39H1, catalyzes cGAS methylation and promotes its chromatin sequestration, thus impairing cGAS&#x02010;mediated antitumor immunity in colorectal cancer [<xref rid="cac270067-bib-0065" ref-type="bibr">65</xref>]. Suppression of cGAS can be reversed by methionine deprivation, which has therapeutic potential for colorectal cancer treatment [<xref rid="cac270067-bib-0065" ref-type="bibr">65</xref>]. Similarly, protein arginine N&#x02010;methyltransferase (PRMP5)&#x000a0;induces cGAS methylation at the conserved arginine 124 residue (R124), thereby inhibiting its DNA&#x02010;binding ability and suppressing the antiviral response [<xref rid="cac270067-bib-0066" ref-type="bibr">66</xref>]. In summary, epigenetic modifications of the cGAS&#x02010;STING pathway often result in loss of gene function and promotion of tumor progression.</p></sec><sec id="cac270067-sec-0110"><label>3.3</label><title>Mechanisms to avoid abnormal self&#x02010;DNA recognition</title><p>The activation of cGAS is strictly dependent on its interaction with dsDNA, structure [<xref rid="cac270067-bib-0027" ref-type="bibr">27</xref>], form [<xref rid="cac270067-bib-0028" ref-type="bibr">28</xref>], and length [<xref rid="cac270067-bib-0067" ref-type="bibr">67</xref>], which determine the efficiency of DNA sensing and binding. However, cGAS lacks pathogen specificity during the recognition of dsDNA. Therefore, additional regulatory mechanisms are required to prevent erroneous inflammation caused by the recognition of self&#x02010;DNA by cGAS.</p><sec id="cac270067-sec-0120"><label>3.3.1</label><title>Deoxyribonucleases (DNases)</title><p>DNases maintain cellular DNA homeostasis by constitutively degrading potentially immunostimulatory cytosolic DNA. Three repair exonucleases&#x000a0;(TREXs) and DNase II have emerged as the primary physiological suppressors of aberrant cGAS activation. The abnormal expression of ISGs triggered by TREX1 deficiency can be abrogated by the suppression of cGAS [<xref rid="cac270067-bib-0068" ref-type="bibr">68</xref>], unequivocally establishing the cGAS&#x02010;STING pathway as the dominant mediator of this autoimmune response. TREX1 exhibits critical immuno&#x02010;oncological functions, and its DNA&#x02010;degrading activity facilitates tumor immune evasion, a discovery that has spurred significant interest in developing TREX1 inhibitors as novel immunotherapeutic agents [<xref rid="cac270067-bib-0069" ref-type="bibr">69</xref>, <xref rid="cac270067-bib-0070" ref-type="bibr">70</xref>]. Furthermore, the related exonuclease, TREX2, is another key negative regulator of the cGAS&#x02010;STING pathway, and its DNA&#x02010;scavenging activity similarly suppresses antitumor immunity [<xref rid="cac270067-bib-0071" ref-type="bibr">71</xref>, <xref rid="cac270067-bib-0072" ref-type="bibr">72</xref>, <xref rid="cac270067-bib-0073" ref-type="bibr">73</xref>]. These findings collectively position DNases as central players in maintaining immune tolerance and that their dysfunction leads to either autoimmune pathology or cancer progression.</p></sec><sec id="cac270067-sec-0130"><label>3.3.2</label><title>Cellular compartmentalization</title><p>Under physiological conditions, dsDNA is strictly compartmentalized within the nucleus and mitochondria to prevent the inadvertent activation of the cGAS&#x02010;STING pathway. However, various pathological processes can disrupt this spatial regulation through three principal mechanisms: (1) Micronuclei formation: genome instability arising from mitotic errors, chronic inflammation, DNA damage, or malignant transformation, which leads to the generation of micronuclei. These nuclear envelope&#x02010;encapsulated DNA aggregates serve as potent platforms for cGAS activation, with their frequency correlating with disease severity in cancer and autoinflammatory disorders [<xref rid="cac270067-bib-0074" ref-type="bibr">74</xref>, <xref rid="cac270067-bib-0075" ref-type="bibr">75</xref>, <xref rid="cac270067-bib-0076" ref-type="bibr">76</xref>]; (2) Cytosolic accumulation of chromatin fragments: Cellular senescence and oncogenic transformation cause nuclear envelope integrity loss, releasing chromatin fragments into the cytosol [<xref rid="cac270067-bib-0010" ref-type="bibr">10</xref>, <xref rid="cac270067-bib-0077" ref-type="bibr">77</xref>]. Moreover, metastatic tumor cells exhibit particularly pronounced nuclear envelope ruptures during extracellular matrix traversal, exposing nuclear dsDNA to cGAS [<xref rid="cac270067-bib-0078" ref-type="bibr">78</xref>, <xref rid="cac270067-bib-0079" ref-type="bibr">79</xref>]; (3) Mitochondrial DNA (mtDNA) release: Oxidative stress or permeability transition pore opening disrupts mitochondrial membrane integrity, causing packaging and subsequent cytosolic release of defective mtDNA and activation of cGAS&#x02010;STING signaling [<xref rid="cac270067-bib-0080" ref-type="bibr">80</xref>, <xref rid="cac270067-bib-0081" ref-type="bibr">81</xref>].</p><p>Sophisticated mechanisms govern cGAS nuclear sequestration and its controlled release into the cytoplasm, which are critical for maintaining immune homeostasis [<xref rid="cac270067-bib-0024" ref-type="bibr">24</xref>, <xref rid="cac270067-bib-0025" ref-type="bibr">25</xref>]. Structural studies reveal that cGAS is constitutively anchored to nucleosomes through specific interactions between its DNA&#x02010;binding domain and the nucleosome acidic patch, mediated by evolutionarily conserved residues (R236, R255, R353, and K354); their mutations liberate cGAS from nucleosome sequestration and make it accessible to self&#x02010;DNA [<xref rid="cac270067-bib-0024" ref-type="bibr">24</xref>, <xref rid="cac270067-bib-0025" ref-type="bibr">25</xref>, <xref rid="cac270067-bib-0082" ref-type="bibr">82</xref>, <xref rid="cac270067-bib-0083" ref-type="bibr">83</xref>, <xref rid="cac270067-bib-0084" ref-type="bibr">84</xref>]. Notably, the expressions of nuclear localization and export sequences regulate cGAS cellular distribution and catalytic activity [<xref rid="cac270067-bib-0085" ref-type="bibr">85</xref>, <xref rid="cac270067-bib-0086" ref-type="bibr">86</xref>, <xref rid="cac270067-bib-0087" ref-type="bibr">87</xref>, <xref rid="cac270067-bib-0088" ref-type="bibr">88</xref>].</p></sec></sec><sec id="cac270067-sec-0140"><label>3.4</label><title>Regulation of cGAMP transmission and degradation</title><p>cGAMP serves not only as an intracellular second messenger that activates STING [<xref rid="cac270067-bib-0004" ref-type="bibr">4</xref>], but also as an immunotransmitter between cells (Figure&#x000a0;<xref rid="cac270067-fig-0003" ref-type="fig">3</xref>) [<xref rid="cac270067-bib-0089" ref-type="bibr">89</xref>, <xref rid="cac270067-bib-0090" ref-type="bibr">90</xref>]. cGAMP was initially reported to transfer through gap junctions to bystander cells, amplifying antiviral immunity [<xref rid="cac270067-bib-0089" ref-type="bibr">89</xref>]. Later, cGAMP was found to be incorporated into viral particles [<xref rid="cac270067-bib-0091" ref-type="bibr">91</xref>, <xref rid="cac270067-bib-0092" ref-type="bibr">92</xref>] or secreted in a soluble form [<xref rid="cac270067-bib-0093" ref-type="bibr">93</xref>] to deliver immune signals to non&#x02010;adjacent cells. Nonetheless, it remains unclear how anionic hydrophilic cGAMP or CDNs permeate the cellular phospholipid bilayer. In recent years, several exporters and importers have been shown to mediate cGAMP transport across cell membranes. For example, cGAMP is recognized and forms a ligand&#x02010;bound structure with ATP&#x02010;binding cassette subfamily C member 1 (ABCC1), which mediates cGAMP export and restricts the cell&#x02010;intrinsic interferon response [<xref rid="cac270067-bib-0094" ref-type="bibr">94</xref>, <xref rid="cac270067-bib-0095" ref-type="bibr">95</xref>]. Additionally, leucine&#x02010;rich repeat&#x02010;containing 8A (LRRC8A) heteromeric channels are widely expressed cGAMP transporters that mediate both the import and export of cGAMP [<xref rid="cac270067-bib-0096" ref-type="bibr">96</xref>, <xref rid="cac270067-bib-0097" ref-type="bibr">97</xref>]. Human cathelicidin antimicrobial peptide LL&#x02010;37 also acts as a cGAMP transporter by binding to cGAMP and delivering it to target cells [<xref rid="cac270067-bib-0098" ref-type="bibr">98</xref>]. Also of note, the reduced folate carrier solute carrier family 19 member 1 (SLC19A1) was identified as a major importer of CDNs into target cells [<xref rid="cac270067-bib-0099" ref-type="bibr">99</xref>, <xref rid="cac270067-bib-0100" ref-type="bibr">100</xref>]. Other importers, including P2X7 receptor (P2X7R) [<xref rid="cac270067-bib-0101" ref-type="bibr">101</xref>] and LRRC8A [<xref rid="cac270067-bib-0096" ref-type="bibr">96</xref>, <xref rid="cac270067-bib-0097" ref-type="bibr">97</xref>], have also been identified. However, the expression profiles, structural features, and substrate specificities of the cGAMP transporters require further investigation.</p><fig position="float" fig-type="FIGURE" id="cac270067-fig-0003"><label>FIGURE 3</label><caption><p>Regulation of cGAMP transport. cGAMP is transported between cells to amplify immune responses through gap junctions, viral particles, and other transporters, including ABCC1, LRRC8A, LL&#x02010;37, SLC19A1, and P2X7R. In addition, ENPP1, ENPP3, and SMPDL3A degrade cGAMP and negatively regulate its cellular transport. ABCC1, ATP&#x02010;binding cassette subfamily C member 1; cGAMP, 2&#x02019;3&#x02019;&#x02010;cyclic GMP&#x02010;AMP; cGAS, cyclic GMP&#x02010;AMP synthase; ENPP1/3, ecto&#x02010;nucleotide pyrophosphatase phosphodiesterase 1/3; ER, endoplasmic reticulum; IFNs, interferons; IRF3, interferon regulatory factor 3; ISGS, interferon&#x02010;stimulated genes; LL&#x02010;37, human cathelicidin antimicrobial peptide; LRRC8A, leucine&#x02010;rich repeat&#x02010;containing 8A; NF&#x02010;&#x003ba;B, nuclear transcription factor&#x02010;kappa B; P2X7R, P2X7 receptor; SLC19A1, solute carrier family 19 member 1; SMPDL3A, sphingomyelin phosphodiesterase acid&#x02010;like 3A; STING, stimulator of interferon gene; TBK1, TANK&#x02010;binding kinase 1.</p></caption><graphic xlink:href="CAC2-45-1513-g003" position="anchor" id="jats-graphic-5"/></fig><p>Several negative regulators modulate the cleavage of cGAMP and its interactions with cGAMP transporters. Ecto&#x02010;nucleotide pyrophosphatase phosphodiesterase 1 (ENPP1) is an extensively studied cGAMP hydrolase, which is expressed on cancer cells to eliminate extracellular 2&#x02019;3&#x02019;&#x02010;cGAMP in the tumor microenvironment (TME) and inhibit STING&#x02010;mediated antitumor immune response [<xref rid="cac270067-bib-0093" ref-type="bibr">93</xref>, <xref rid="cac270067-bib-0102" ref-type="bibr">102</xref>, <xref rid="cac270067-bib-0103" ref-type="bibr">103</xref>, <xref rid="cac270067-bib-0104" ref-type="bibr">104</xref>]. ENPP1 is also carried by tumor&#x02010;derived exosomes to hinder the infiltration of CD8<sup>+</sup> and CD4<sup>+</sup> T cells into the TME and block the interaction of cGAMP with the importer LL&#x02010;37 [<xref rid="cac270067-bib-0105" ref-type="bibr">105</xref>]. Recently, other cGAMP hydrolases have also been characterized, like sphingomyelin phosphodiesterase acid&#x02010;like 3A (SMPDL3A) [<xref rid="cac270067-bib-0106" ref-type="bibr">106</xref>] and ENPP3 [<xref rid="cac270067-bib-0107" ref-type="bibr">107</xref>]. It remains unknown whether there are hydrolases that cleave intracellular cGAS, or whether the enzymatic activity of cGAMP hydrolases can be stimulated under other distinct conditions.</p></sec><sec id="cac270067-sec-0150"><label>3.5</label><title>Regulation of STING transport and trafficking</title><p>The transport, trafficking, and degradation of STING are tightly orchestrated to maintain immune homeostasis (Figure&#x000a0;<xref rid="cac270067-fig-0004" ref-type="fig">4</xref>). STING translocation from the ER to the ERGIC is the rate&#x02010;limiting step for STING activation, which relies on the assembly of the ARF GTPases&#x02010;COPII complex&#x02010;STING transport complex [<xref rid="cac270067-bib-0008" ref-type="bibr">8</xref>, <xref rid="cac270067-bib-0108" ref-type="bibr">108</xref>]. Several positive and negative regulators are involved in this process. For example, STING ER exit protein (STEEP) facilitates STING trafficking by stimulating phosphatidylinositol 3&#x02010;phosphate (PI3P) production and inducing ER membrane curvature [<xref rid="cac270067-bib-0109" ref-type="bibr">109</xref>]. Moreover, translocon&#x02010;associated protein beta (TRAP&#x003b2;) serves as an essential positive regulator mediating STING translocation across the ER membrane [<xref rid="cac270067-bib-0002" ref-type="bibr">2</xref>, <xref rid="cac270067-bib-0110" ref-type="bibr">110</xref>]. The COPII vesicle outer layer consists of SEC24 homolog, COPII coat complex component (SEC13) and SEC31, whereas SEC24, SEC23, and secretion&#x02010;associated Ras&#x02010;related GTPase 1 (SAR1) form the inner layer [<xref rid="cac270067-bib-0008" ref-type="bibr">8</xref>, <xref rid="cac270067-bib-0111" ref-type="bibr">111</xref>, <xref rid="cac270067-bib-0112" ref-type="bibr">112</xref>]. Notably, the Ca<sup>2+</sup> sensor stromal interaction molecule 1 (STIM1) is a negative regulator of STING, retaining it in the ER and subsequently attenuating the IFN response [<xref rid="cac270067-bib-0113" ref-type="bibr">113</xref>]. The precise regulatory mechanisms of these cofactors in modulating STING trafficking warrant further investigation.</p><fig position="float" fig-type="FIGURE" id="cac270067-fig-0004"><label>FIGURE 4</label><caption><p>The regulation of STING transport and trafficking. In the ER, TRAP&#x003b2; promotes STING trafficking and STIM1 anchors STING to inhibit its trafficking. STING trafficking to the Golgi apparatus is promoted by STEEP&#x02010;stimulated PI3P production and relies on the assembly of ARF GTPases&#x02010;COPII complex (outer layer: SEC13 and SEC31; inner layer: SEC24, SEC23, and SAR1). In the basal state, STING is terminated through SEL1L&#x02010;HRD1&#x02010;induced ubiquitination and proteasomal degradation. TOLLIP stabilizes STING through direct interaction. The post&#x02010;Golgi termination of STING is triggered through ARF1/Surf4/COPI&#x02010;induced retrograde transport and lysosomal degradation (regulated by AP1, ESCRT, and NPC1). AP1, activator protein 1; ARF1, ADP&#x02010;ribosylation factor 1; cGAMP, 2&#x02019;3&#x02019;&#x02010;cyclic GMP&#x02010;AMP; cGAS, cyclic GMP&#x02010;AMP synthase; COPI /II, coat protein complex I/II; ER, endoplasmic reticulum; ESCRT, endosomal sorting complex required for transport; NPC1, Niemann&#x02010;Pick disease type C1 protein; PI3P, phosphatidylinositol 3&#x02010;phosphate; SAR1, secretion&#x02010;associated Ras&#x02010;related GTPase 1; SECs, SEC homolog, COPII coat complex components; SEL1L&#x02010;HRD1, suppressor of lin&#x02010;12&#x02010;like&#x02010;HMG&#x02010;CoA reductase degradation 1; STEEP, STING ER exit protein; STIM1, stromal interaction molecule 1; STING, stimulator of interferon gene; Surf4, surfeit locus protein 4; TBK1, TANK&#x02010;binding kinase 1; TOLLIP, toll interacting protein; TRAP&#x003b2;, translocation&#x02010;associated protein complex &#x003b2;.</p></caption><graphic xlink:href="CAC2-45-1513-g005" position="anchor" id="jats-graphic-7"/></fig><p>STING termination is mediated by the ubiquitin&#x02010;proteasome system, retrograde transport, and the autophagic endolysosomal system (Figure&#x000a0;<xref rid="cac270067-fig-0004" ref-type="fig">4</xref>). STING can be recognized by E3 ubiquitin ligases, such as TRIM29 [<xref rid="cac270067-bib-0114" ref-type="bibr">114</xref>, <xref rid="cac270067-bib-0115" ref-type="bibr">115</xref>] and TRIM13[<xref rid="cac270067-bib-0116" ref-type="bibr">116</xref>], and subsequently tagged with ubiquitin molecules, thereby facilitating its recognition by the proteasome and degradation into short peptide fragments. In the basal state, the SEL1L&#x02010;HRD1 protein complex, the most conserved branch of ER&#x02010;associated degradation, ubiquitinates and recruits nascent STING for proteasomal degradation [<xref rid="cac270067-bib-0117" ref-type="bibr">117</xref>]. In contrast, TOLLIP stabilizes STING and prevents its degradation through direct interaction [<xref rid="cac270067-bib-0118" ref-type="bibr">118</xref>]. Upon translocation to the Golgi apparatus and the activation of downstream molecules, STING signaling is terminated through recycling and lysosomal degradation. The retrograde transport of STING from the Golgi to the ER, which requires COPI and the adapter molecule surfeit locus protein 4 (Surf4) to form the STING/Surf4/COPI complex, is essential for the tightly control of IFN signaling [<xref rid="cac270067-bib-0119" ref-type="bibr">119</xref>, <xref rid="cac270067-bib-0120" ref-type="bibr">120</xref>, <xref rid="cac270067-bib-0121" ref-type="bibr">121</xref>, <xref rid="cac270067-bib-0122" ref-type="bibr">122</xref>]. The GTPase ADP&#x02010;ribosylation factor 1 (ARF1) was also confirmed to facilitate COPI vesicle&#x02010;mediated the Golgi&#x02010;to&#x02010;ER retrieval of STING [<xref rid="cac270067-bib-0123" ref-type="bibr">123</xref>]. Lysosomal degradation refers to the process by which STING is translocated into lysosomes via the endosomal sorting complex required for transport (ESCRT)&#x02010;mediated autophagy [<xref rid="cac270067-bib-0124" ref-type="bibr">124</xref>]. In this process, the ESCRT machinery recognizes ubiquitinated STING, encapsulates it into intraluminal vesicles, and facilitates its direct engulfment and degradation by the lysosomal membrane, thereby terminating immune signal transduction. In addition, some cofactors control the lysosomal degradation of STING. For instance, the C&#x02010;terminal domain of phosphorylated STING interacts with adaptor protein complex 1 (AP&#x02010;1), facilitating its incorporation into clathrin&#x02010;coated vesicles for lysosomal degradation [<xref rid="cac270067-bib-0125" ref-type="bibr">125</xref>]. This termination process requires additional components, including GCC2, RAB GTPases (e.g., RAB14), and the lysosomal protein Niemann&#x02010;Pick disease type C1 protein (NPC1) [<xref rid="cac270067-bib-0124" ref-type="bibr">124</xref>, <xref rid="cac270067-bib-0126" ref-type="bibr">126</xref>, <xref rid="cac270067-bib-0127" ref-type="bibr">127</xref>]. The spatiotemporal dynamics and intensity of STING signaling are regulated by complex mechanisms, with dysregulated activation being pathogenically linked to tumorigenesis and autoimmune diseases.</p></sec></sec><sec id="cac270067-sec-0160"><label>4</label><title>CELLULAR FUNCTIONS OF cGAS&#x02010;STING PATHWAY</title><sec id="cac270067-sec-0170"><label>4.1</label><title>Antimicrobial defense</title><p>Since its discovery, cGAS has been shown to indiscriminately recognize virus&#x02010;derived dsDNA and trigger interferon&#x02010;dependent antiviral immunity [<xref rid="cac270067-bib-0003" ref-type="bibr">3</xref>]. As research progresses, the antiviral spectrum of cGAS is not only limited to DNA viruses, but also to RNA viruses [<xref rid="cac270067-bib-0128" ref-type="bibr">128</xref>, <xref rid="cac270067-bib-0129" ref-type="bibr">129</xref>] and fungal pathogens [<xref rid="cac270067-bib-0130" ref-type="bibr">130</xref>]. In addition, although STING&#x02010;IFN&#x02010;mediated antiviral immunity is initiated through S365 phosphorylation in the CTT of STING, mice harboring an S365A mutation in STING are still protected against herpes simplex virus&#x02010;1 (HSV&#x02010;1) infection, indicating the IFN&#x02010;independent activity of STING [<xref rid="cac270067-bib-0131" ref-type="bibr">131</xref>, <xref rid="cac270067-bib-0132" ref-type="bibr">132</xref>]. Transcriptomic analysis revealed widespread IFN&#x02010;independent STING activity in macrophages, particularly T cells, which contribute to antiviral immunity [<xref rid="cac270067-bib-0131" ref-type="bibr">131</xref>]. However, the IFN&#x02010;independent mechanism of STING&#x02010;induced resistance to HSV&#x02010;1 remains unresolved, and it has been proposed that autophagy or an autophagy&#x02010;like process might be involved [<xref rid="cac270067-bib-0132" ref-type="bibr">132</xref>]. In addition, pathogens have developed various mechanisms to antagonize cGAS or STING activity. For example, the essential varicella zoster virus tegument protein, open reading frame 9 (ORF9), antagonizes cGAS activity to produce cGAMP [<xref rid="cac270067-bib-0133" ref-type="bibr">133</xref>]. A recent study illustrated that the immune evasion mechanism is highly conserved between animal and bacterial viruses, as animal poxvirus proteins that suppress cGAS&#x02010;STING activity exhibit structural homology with bacteriophage Acb1 proteins, providing an evolutionary basis for the immune evasion of viruses [<xref rid="cac270067-bib-0134" ref-type="bibr">134</xref>].</p></sec><sec id="cac270067-sec-0180"><label>4.2</label><title>Autophagy and lysosome biogenesis</title><p>It has been widely acknowledged that the cGAS&#x02010;STING pathway induces IFN&#x02010;I production in a TBK1&#x02010;/IKK&#x02010;dependent manner to defend against foreign pathogens, while a growing body of evidence demonstrates that cGAS&#x02010;STING can also trigger noncanonical autophagy and promote lysosome biogenesis, thereby facilitating the clearance of cytoplasmic DNA and intracellular pathogens [<xref rid="cac270067-bib-0008" ref-type="bibr">8</xref>, <xref rid="cac270067-bib-0009" ref-type="bibr">9</xref>]. These functions are regarded as ancestral roles of the cGAS&#x02010;STING pathway, which likely evolved prior to the emergence of IFN&#x02010;I signaling (Figure&#x000a0;<xref rid="cac270067-fig-0005" ref-type="fig">5</xref>) [<xref rid="cac270067-bib-0008" ref-type="bibr">8</xref>, <xref rid="cac270067-bib-0009" ref-type="bibr">9</xref>]. Upon activation by cGAMP, STING interacts with light chain 3 (LC3)&#x000a0;and induces LC3 lipidation, a canonical step in autophagy [<xref rid="cac270067-bib-0008" ref-type="bibr">8</xref>, <xref rid="cac270067-bib-0135" ref-type="bibr">135</xref>, <xref rid="cac270067-bib-0136" ref-type="bibr">136</xref>, <xref rid="cac270067-bib-0137" ref-type="bibr">137</xref>, <xref rid="cac270067-bib-0138" ref-type="bibr">138</xref>]. Autophagy regulators, including WD repeat domain, phosphoinositide&#x02010;interacting protein 2 (WIPI2), autophagy related 5 (ATG5), vacuolar ATPase (V&#x02010;ATPase), and ATG16L1, are indispensable for STING&#x02010;induced LC3 lipidation and autophagosome formation [<xref rid="cac270067-bib-0008" ref-type="bibr">8</xref>, <xref rid="cac270067-bib-0136" ref-type="bibr">136</xref>, <xref rid="cac270067-bib-0137" ref-type="bibr">137</xref>, <xref rid="cac270067-bib-0138" ref-type="bibr">138</xref>]. Mechanistically, STING competes with PI3P for binding to the FRRG motif of WIPI2, which recruits ATG16L1 and ATG5 to single&#x02010;membrane perinuclear vesicles and induces V&#x02010;ATPase&#x02010;dependent LC3 lipidation. STING&#x02010;induced autophagy is essential for the clearance of cytosolic DNA and viruses and the termination of IFN&#x02010;induced inflammatory responses [<xref rid="cac270067-bib-0008" ref-type="bibr">8</xref>, <xref rid="cac270067-bib-0137" ref-type="bibr">137</xref>].</p><fig position="float" fig-type="FIGURE" id="cac270067-fig-0005"><label>FIGURE 5</label><caption><p>STING&#x02010;induced noncanonical autophagy and lysosome biogenesis. The cGAS&#x02010;STING&#x02010;mediated noncanonical autophagy involves regulators, including WIPI2, ATG5, V&#x02010;ATPase, and ATG16L1, which induce LC3 lipidation. STING also inhibits canonical autophagy through competing with PI3P for binding to WIPI2. STING has recently been shown to function as a proton channel. The increased proton flux and pH in the Golgi apparatus and acidic vesicles, followed by STING activation, are essential for LC3 lipidation. Also, the lipidation of the GABARAPs abrogates the inhibition of mTORC2 on the transcriptional activity of TFEB, TFE3, and MITF, thus promoting lysosomal biogenesis. The non&#x02010;canonical autophagy and lysosome biogenesis are essential for cell survival and host defense and considered the primordial function of the cGAS&#x02010;STING pathway, prior to the emergence of STING&#x02010;NF&#x02010;&#x003ba;B/IRF3&#x02010;IFN&#x02010;dependent functions in antimicrobial defense and immune surveillance (recently adapted functions). ATG16L1, autophagy&#x02010;related protein 16&#x02010;like 1; ATG5, autophagy related 5; cGAMP, 2&#x02019;3&#x02019;&#x02010;cyclic GMP&#x02010;AMP; cGAS, cyclic GMP&#x02010;AMP synthase; GABARAP, gamma&#x02010;aminobutyric acid receptor&#x02010;associated protein; IFNs, interferons; IRF3, interferon regulatory factor 3; LC3, light chain 3; MITF, microphthalmia&#x02010;associated transcription factor; mTORC2, mechanistic target of rapamycin complex 2; NF&#x02010;&#x003ba;B, nuclear transcription factor&#x02010;kappa B; PI3P, phosphatidylinositol 3&#x02010;phosphate; STING, stimulator of interferon gene; TBK1, TANK&#x02010;binding kinase 1; TFEB, transcription factor EB; WIPI2, WD repeat domain, phosphoinositide&#x02010;interacting protein 2.</p></caption><graphic xlink:href="CAC2-45-1513-g006" position="anchor" id="jats-graphic-9"/></fig><p>Recently, emerging evidence has revealed the critical role of STING as a proton channel [<xref rid="cac270067-bib-0139" ref-type="bibr">139</xref>, <xref rid="cac270067-bib-0140" ref-type="bibr">140</xref>, <xref rid="cac270067-bib-0141" ref-type="bibr">141</xref>, <xref rid="cac270067-bib-0142" ref-type="bibr">142</xref>, <xref rid="cac270067-bib-0143" ref-type="bibr">143</xref>, <xref rid="cac270067-bib-0144" ref-type="bibr">144</xref>]. Increased proton flux and pH in the Golgi apparatus and liposomes following STING activation are essential for LC3 lipidation and inflammasome activation, triggering non&#x02010;canonical autophagy [<xref rid="cac270067-bib-0139" ref-type="bibr">139</xref>, <xref rid="cac270067-bib-0140" ref-type="bibr">140</xref>]. Furthermore, proton channel activity is essential for STING&#x02010;induced lipidation of ATG8 proteins, especially gamma&#x02010;aminobutyric acid receptor&#x02010;associated proteins (GABARAPs), which abrogate the phosphorylation and inhibition of microphthalmia/transcription factor E (MiT/TFE) transcription factors (TFEB, TFE3, and MITF) by rapamycin complex 1 (mTORC1), thereby stimulating lysosome biogenesis [<xref rid="cac270067-bib-0142" ref-type="bibr">142</xref>, <xref rid="cac270067-bib-0143" ref-type="bibr">143</xref>, <xref rid="cac270067-bib-0144" ref-type="bibr">144</xref>]. In mammalian cells, TFEB and its paralogs serve as master regulators of lysosomal biogenesis, with their activity being tightly controlled by mTORC1 [<xref rid="cac270067-bib-0009" ref-type="bibr">9</xref>, <xref rid="cac270067-bib-0145" ref-type="bibr">145</xref>, <xref rid="cac270067-bib-0146" ref-type="bibr">146</xref>, <xref rid="cac270067-bib-0147" ref-type="bibr">147</xref>, <xref rid="cac270067-bib-0148" ref-type="bibr">148</xref>]. Under nutrient&#x02010;rich conditions, activated mTORC1 phosphorylates TFEB at the lysosomal surface and causes cytoplasmic retention of TFEB, whereas upon nutrient deprivation, mTORC1 inactivation leads to TFEB dephosphorylation and nuclear translocation [<xref rid="cac270067-bib-0145" ref-type="bibr">145</xref>, <xref rid="cac270067-bib-0146" ref-type="bibr">146</xref>, <xref rid="cac270067-bib-0147" ref-type="bibr">147</xref>]. Within the nucleus, TFEB drives lysosomal biogenesis by upregulating the expression of lysosome&#x02010;related genes [<xref rid="cac270067-bib-0009" ref-type="bibr">9</xref>, <xref rid="cac270067-bib-0148" ref-type="bibr">148</xref>]. Functionally, enhanced lysosomal biogenesis promotes the clearance of cytoplasmic DNA and invading pathogens and plays an essential role in cellular antibacterial and antiviral innate immune defenses [<xref rid="cac270067-bib-0143" ref-type="bibr">143</xref>].</p></sec><sec id="cac270067-sec-0190"><label>4.3</label><title>Cellular senescence</title><p>Cellular senescence is characterized by stable and irreversible cell cycle arrest and secretion of senescence&#x02010;associated secretory phenotypes (SASPs), which are essential for senescence&#x02010;induced growth arrest, tissue repair, and immune surveillance [<xref rid="cac270067-bib-0149" ref-type="bibr">149</xref>, <xref rid="cac270067-bib-0150" ref-type="bibr">150</xref>, <xref rid="cac270067-bib-0151" ref-type="bibr">151</xref>, <xref rid="cac270067-bib-0152" ref-type="bibr">152</xref>]. The cGAS&#x02010;STING signaling pathway has been considered a critical participant and regulator of cellular senescence (Figure&#x000a0;<xref rid="cac270067-fig-0006" ref-type="fig">6</xref>) [<xref rid="cac270067-bib-0010" ref-type="bibr">10</xref>, <xref rid="cac270067-bib-0077" ref-type="bibr">77</xref>, <xref rid="cac270067-bib-0153" ref-type="bibr">153</xref>, <xref rid="cac270067-bib-0154" ref-type="bibr">154</xref>]. It was discovered that chromatin fragments released from intact nuclei in primary cells during senescence can be recognized by cGAS and trigger proinflammatory SASPs [<xref rid="cac270067-bib-0010" ref-type="bibr">10</xref>, <xref rid="cac270067-bib-0077" ref-type="bibr">77</xref>, <xref rid="cac270067-bib-0153" ref-type="bibr">153</xref>]. DNA damage [<xref rid="cac270067-bib-0155" ref-type="bibr">155</xref>], oxidative stress [<xref rid="cac270067-bib-0156" ref-type="bibr">156</xref>], replicative stress [<xref rid="cac270067-bib-0157" ref-type="bibr">157</xref>], oncogenic signals [<xref rid="cac270067-bib-0158" ref-type="bibr">158</xref>], and mitochondrial dysfunction [<xref rid="cac270067-bib-0020" ref-type="bibr">20</xref>, <xref rid="cac270067-bib-0159" ref-type="bibr">159</xref>, <xref rid="cac270067-bib-0160" ref-type="bibr">160</xref>] also drive the abnormal activation of cGAS&#x02010;STING and trigger cellular senescence. Retrotransposable elements (e.g., long interspersed nuclear element&#x02010;1, LINE&#x02010;1) [<xref rid="cac270067-bib-0161" ref-type="bibr">161</xref>, <xref rid="cac270067-bib-0162" ref-type="bibr">162</xref>, <xref rid="cac270067-bib-0163" ref-type="bibr">163</xref>] and endogenous retroviruses (e.g., human endogenous retrovirus K) [<xref rid="cac270067-bib-0164" ref-type="bibr">164</xref>] can become transcriptionally unlocked to transcribe RNA intermediates and are subsequently reverse transcribed to generate cDNAs, eliciting cGAS&#x02010;STING&#x02010;mediated SASPs in senescent cells. In DNA damage&#x02010;induced senescent cells, nuclear cGAS promotes tripartite motif&#x02010;containing protein 41 (TRIM41)&#x02010;mediated ubiquitination and degradation of open reading frame 2 protein (ORF2p), thereby inducing senescence&#x02010;associated repression of LINE&#x02010;1 retrotransposition to maintain genome stability [<xref rid="cac270067-bib-0165" ref-type="bibr">165</xref>]. Additionally, several protective mechanisms exist to sustain the cGAS sensing of cytoplasmic DNA and preserve the proinflammatory output of SASPs. Thioredoxin reductase 1 (TXNRD1), a cytoplasmic chromatin fragment&#x02010;localized protein, interacts with cGAS to positively regulate its enzymatic activity, thus driving SASP and inflammation [<xref rid="cac270067-bib-0166" ref-type="bibr">166</xref>]. In senescent cells, the expressions of DNases (both DNase II and TREX1) are significantly downregulated, and DNA fragments accumulate in the cytosol, thereby stimulating cGAS&#x02010;STING activation [<xref rid="cac270067-bib-0167" ref-type="bibr">167</xref>]. The activity of the transcriptional coactivators, Yes&#x02010;associated protein (YAP) and transcriptional co&#x02010;activator with PDZ&#x02010;binding motif (TAZ), is significantly suppressed during physiological aging in stromal cells because YAP/TAZ directly regulates lamin B1 and actin&#x02010;related protein 2 (ACTR2) transcription, thus maintaining nuclear envelope integrity and preventing the release of nuclear DNA fragments to be sensed by cGAS [<xref rid="cac270067-bib-0168" ref-type="bibr">168</xref>].</p><fig position="float" fig-type="FIGURE" id="cac270067-fig-0006"><label>FIGURE 6</label><caption><p>Activation and regulation mechanisms of STING&#x02010;induced cellular senescence. Chromatin fragments, oxidative stress, mitochondrial dysfunction (leading to mtDNA release), and retroviruses can trigger cGAS&#x02010;STING&#x02010;mediated cellular senescence and SASPs. Several regulators are involved in the regulation of STING&#x02010;induced senescence. Nuclear cGAS promotes TRIM41&#x02010;mediated ubiquitination and degradation of ORF2p, thus inhibiting LINE1 retrotransposition to maintain genome stability. TXNRD1 is a cytoplasmic chromatin fragment&#x02010;localized protein that promotes cGAS activity. YAP/TAZ directly regulates lamin B1 and ACTR2 transcription to prevent the release of nuclear DNA fragments. Non&#x02010;canonical pathways are involved in the cGAS&#x02010;STING&#x02010;mediated induction of SASPs. IRF3 interacts with RB to block RB hyperphosphorylation and E2F transcription, thus promoting senescence. In addition, STING/PERK/eIF2&#x003b1; signaling and STING/PERK/NF&#x02010;&#x003ba;B signaling also participate in STING&#x02010;induced cellular senescence. ACTR2, actin&#x02010;related protein 2; cGAS, cyclic GMP&#x02010;AMP synthase; E2F, early 2 factor; eIF2&#x003b1;, eukaryotic initiation factor 2 alpha; IRF3, IFN regulatory factor 3; LINE1, long interspersed nuclear element&#x02010;1; mtDNA, mitochondrial DNA; NF&#x02010;&#x003ba;B, nuclear transcription factor&#x02010;kappa B; ORF2p, open reading frame 2 protein; PERK, protein kinase RNA&#x02010;like endoplasmic reticulum kinase; RB, retinoblastoma protein; SASPs, senescence&#x02010;associated secretory phenotypes; STING, stimulator of interferon gene; TRIM41, tripartite motif&#x02010;containing protein 41; TXNRD1, thioredoxin reductase 1; Ub, ubiquitination; YAP/TAZ, Yes&#x02010;associated protein/Transcriptional coactivator with PDZ&#x02010;binding motif.</p></caption><graphic xlink:href="CAC2-45-1513-g001" position="anchor" id="jats-graphic-11"/></fig><p>Some non&#x02010;canonical pathways are involved in the cGAS&#x02010;STING&#x02010;mediated induction of SASPs (Figure&#x000a0;<xref rid="cac270067-fig-0006" ref-type="fig">6</xref>). For example, upon STING&#x02010;mediated activation during innate DNA sensing, IRF3 interacts with retinoblastoma (RB) in the nucleus to block CDK4/6&#x02010;mediated RB hyperphosphorylation and the activation of downstream early 2 factor (E2F) transcription factors, thus promoting hepatic stellate cells toward senescence [<xref rid="cac270067-bib-0169" ref-type="bibr">169</xref>, <xref rid="cac270067-bib-0170" ref-type="bibr">170</xref>]. Also intriguingly, after receiving proinflammatory signals from cGAMP, STING activates protein kinase RNA&#x02010;like endoplasmic reticulum kinase (PERK), which then mediates the phosphorylation of eukaryotic initiation factor 2&#x003b1; (eIF2&#x003b1;) to establish an inflammatory&#x02010; and survival&#x02010;preferred translation program that is essential for cellular senescence and organ fibrosis [<xref rid="cac270067-bib-0171" ref-type="bibr">171</xref>]. Furthermore, a recent study has also demonstrated that mtDNA released by senescent cells was transferred by extracellular vesicles to myeloid&#x02010;derived suppressor cells (PMN&#x02010;MDSCs), the immunosuppressive activity of which was subsequently enhanced via cGAS/STING/NF&#x02010;&#x003ba;B or cGAS/STING/PERK/NF&#x02010;&#x003ba;B signaling pathway [<xref rid="cac270067-bib-0020" ref-type="bibr">20</xref>]. This study highlights the crosstalk between cGAS&#x02010;STING&#x02010;driven cellular senescence and immune surveillance. Moreover, the distinct DNA sources and signaling pathways involved in cGAS&#x02010;STING&#x02010;mediated aging and senescence require further characterization.</p></sec><sec id="cac270067-sec-0200"><label>4.4</label><title>Cell death</title><p>cGAS&#x02010;STING signaling orchestrates cell death, including apoptosis, necroptosis, pyroptosis, ferroptosis, and autophagy, through IFN&#x02010;dependent or &#x02010;independent mechanisms, dynamically shaping cell fate during infection and injury.</p><sec id="cac270067-sec-0210"><label>4.4.1</label><title>Apoptosis</title><p>STING activation drives apoptosis in cancerous T cells and B cells [<xref rid="cac270067-bib-0172" ref-type="bibr">172</xref>, <xref rid="cac270067-bib-0173" ref-type="bibr">173</xref>]. The direct interaction and co&#x02010;translocation of IRF3 and Bax to the mitochondria trigger the mitochondrial apoptotic pathway [<xref rid="cac270067-bib-0174" ref-type="bibr">174</xref>]. In contrast, cGAS&#x02010;STING activation is also a consequence of apoptosis, during which the mitochondria undergo outer membrane permeabilization, and BAK/BAX macropores allow the release of mtDNA, thus stimulating cGAS&#x02010;STING&#x02010;mediated innate immune signaling [<xref rid="cac270067-bib-0175" ref-type="bibr">175</xref>, <xref rid="cac270067-bib-0176" ref-type="bibr">176</xref>] and SASP [<xref rid="cac270067-bib-0159" ref-type="bibr">159</xref>]. Apoptotic caspases, including caspase&#x02010;3 (human) and caspase&#x02010;7 (mouse), play negative roles in mtDNA&#x02010;triggered immune responses by mediating the cleavage of cGAS, STING, and IRF3 [<xref rid="cac270067-bib-0175" ref-type="bibr">175</xref>, <xref rid="cac270067-bib-0177" ref-type="bibr">177</xref>].</p></sec><sec id="cac270067-sec-0220"><label>4.4.2</label><title>Necroptosis</title><p>Necroptosis is initiated by the receptor&#x02010;interacting protein kinase 1 (RIPK1)&#x02010;RIPK3 mixed lineage kinase domain&#x02010;like protein (MLKL) axis to induce inflammatory cell death [<xref rid="cac270067-bib-0178" ref-type="bibr">178</xref>, <xref rid="cac270067-bib-0179" ref-type="bibr">179</xref>]. cGAS&#x02010;STING&#x02010;mediated IFN and TNF drive cell necroptosis by promoting MLKL expression and oligomerization [<xref rid="cac270067-bib-0180" ref-type="bibr">180</xref>, <xref rid="cac270067-bib-0181" ref-type="bibr">181</xref>, <xref rid="cac270067-bib-0182" ref-type="bibr">182</xref>, <xref rid="cac270067-bib-0183" ref-type="bibr">183</xref>]. cGAS activation suppresses oncogenic proliferation by inducing Z&#x02010;DNA binding protein 1 (ZBP1)/RIPK3/MLKL&#x02010;mediated necroptosis [<xref rid="cac270067-bib-0184" ref-type="bibr">184</xref>]. PERK/STING/RIPK3 axis induces necroptosis and cognitive dysfunction [<xref rid="cac270067-bib-0185" ref-type="bibr">185</xref>]. Conversely, RIP3/MLKL&#x02010;induced necroptosis promotes the transcription of the proapoptotic factor PUMA, which stimulates the release of mtDNA and triggers activation of the cGAS&#x02010;STING pathway [<xref rid="cac270067-bib-0186" ref-type="bibr">186</xref>]. This evidence supports a positive feedback loop between cGAS&#x02010;STING signaling and necroptosis.</p></sec><sec id="cac270067-sec-0230"><label>4.4.3</label><title>Pyroptosis</title><p>There is also a feedback loop between the cGAS&#x02010;STING pathway and pyroptosis [<xref rid="cac270067-bib-0187" ref-type="bibr">187</xref>]. On one hand, cGAS&#x02010;STING activates nucleotide&#x02010;binding oligomerization domain, leucine&#x02010;rich repeat&#x02010;, and pyrin domain&#x02010;containing protein 3 (NLRP3) inflammasome [<xref rid="cac270067-bib-0188" ref-type="bibr">188</xref>, <xref rid="cac270067-bib-0189" ref-type="bibr">189</xref>, <xref rid="cac270067-bib-0190" ref-type="bibr">190</xref>, <xref rid="cac270067-bib-0191" ref-type="bibr">191</xref>, <xref rid="cac270067-bib-0192" ref-type="bibr">192</xref>] and absent in melanoma 2 (AIM2) inflammasome [<xref rid="cac270067-bib-0193" ref-type="bibr">193</xref>, <xref rid="cac270067-bib-0194" ref-type="bibr">194</xref>, <xref rid="cac270067-bib-0195" ref-type="bibr">195</xref>, <xref rid="cac270067-bib-0196" ref-type="bibr">196</xref>] in response to viral infection and mitochondrial oxidative stress, resulting in robust interferon response and immune activation [<xref rid="cac270067-bib-0192" ref-type="bibr">192</xref>]. In contrast, the key components of pyroptosis are the positive or negative regulators that influence the activity of the cGAS&#x02010;STING pathway. For example, gasdermin&#x02010;D (GSDMD) and GSDME both facilitate the release of mtDNA and trigger cGAS&#x02010;STING activation [<xref rid="cac270067-bib-0197" ref-type="bibr">197</xref>, <xref rid="cac270067-bib-0198" ref-type="bibr">198</xref>]. Deficiency of NLRP3 [<xref rid="cac270067-bib-0199" ref-type="bibr">199</xref>, <xref rid="cac270067-bib-0200" ref-type="bibr">200</xref>] or AIM2 [<xref rid="cac270067-bib-0201" ref-type="bibr">201</xref>, <xref rid="cac270067-bib-0202" ref-type="bibr">202</xref>] activates the STING&#x02010;type I IFN signaling pathway, indicating the negative role of these inflammasomes in regulating cGAS&#x02010;STING activity.</p></sec><sec id="cac270067-sec-0240"><label>4.4.4</label><title>Ferroptosis</title><p>Ferroptosis is a distinct form of cell death characterized by iron reliance and lipid peroxidation [<xref rid="cac270067-bib-0203" ref-type="bibr">203</xref>, <xref rid="cac270067-bib-0204" ref-type="bibr">204</xref>, <xref rid="cac270067-bib-0205" ref-type="bibr">205</xref>]. The activation of STING signaling directly or indirectly promotes ferroptosis by regulating ferroptosis&#x02010;related factors, including glutathione peroxidase 4 (GPX4), nuclear receptor coactivator 4 (NCOA4), and solute carrier family 7 member 11 (SLC7A11), ultimately resulting in aggravated tissue damage [<xref rid="cac270067-bib-0206" ref-type="bibr">206</xref>, <xref rid="cac270067-bib-0207" ref-type="bibr">207</xref>, <xref rid="cac270067-bib-0208" ref-type="bibr">208</xref>]. In addition, chemotherapy&#x02010;induced mitochondrial stress activates the STING&#x02010;mediated DNA sensing pathway, subsequently promoting lipid peroxidation and ferroptotic cell death by bypassing the interferon response [<xref rid="cac270067-bib-0209" ref-type="bibr">209</xref>]. Intriguingly, deficiency of GPX4, a critical enzyme that antagonizes lipid peroxidation and sustains redox homeostasis, inhibits cGAS&#x02010;STING activation by promoting STING carbonylation at C88 [<xref rid="cac270067-bib-0210" ref-type="bibr">210</xref>].</p></sec></sec></sec><sec id="cac270067-sec-0250"><label>5</label><title>THE DUAL ROLES OF cGAS&#x02010;STING SIGNALING IN CANCER</title><p>During the malignant transformation of cells, errors in chromosome segregation [<xref rid="cac270067-bib-0211" ref-type="bibr">211</xref>] and alterations in the DNA damage response, such as defective mismatch repair [<xref rid="cac270067-bib-0074" ref-type="bibr">74</xref>, <xref rid="cac270067-bib-0212" ref-type="bibr">212</xref>, <xref rid="cac270067-bib-0213" ref-type="bibr">213</xref>, <xref rid="cac270067-bib-0214" ref-type="bibr">214</xref>], activate cGAS&#x02010;STING in the TME. The role of cGAS&#x02010;STING signaling in tumorigenesis and progression is extremely complicated and is partially discussed below.</p><sec id="cac270067-sec-0260"><label>5.1</label><title>The antitumor role of cGAS&#x02010;STING signaling in the TME</title><p>The cGAS&#x02010;STING pathway regulates immune cell differentiation, infiltration, and function while also influencing cancer cell death and metabolism (Figure&#x000a0;<xref rid="cac270067-fig-0007" ref-type="fig">7</xref>).</p><fig position="float" fig-type="FIGURE" id="cac270067-fig-0007"><label>FIGURE 7</label><caption><p>The role of the cGAS&#x02010;STING signaling in the TME. DCs are activated through IFN responses triggered by cancer cells and by uptake of tumor&#x02010;derived exosomes, thereby enhancing antigen presentation via MHC&#x02010;I/TCR interactions and promoting CD8&#x0207a; T cell responses. IFNs promote NK cell activation through direct interactions or induction of IL&#x02010;15/IL&#x02010;15R&#x003b1; on DCs. The STING&#x02010;dependent induction of IL&#x02010;18 and IL&#x02010;1&#x003b2; in TAMs promoted the antitumor effect of NK cells through the upregulation of costimulatory signals 4&#x02010;1BBL/4&#x02010;1BB. Conversely, the STING/IRF3/IL&#x02010;35 axis in B cells significantly suppresses NK cell proliferation. STING activation also promotes antitumor CD4+ T cell responses: in Th1 cells, IRF3 signaling drives IFN&#x02010;&#x003b3; production, while in Th9 cells, mTOR signaling induces IL&#x02010;9 secretion, both contributing to T cell differentiation and antitumor activity. Additionally, CDN treatment enhances IL&#x02010;12 secretion from MDSCs, thereby promoting T cell responses, while also inhibiting tumor angiogenesis. Also of note, IFN signaling activation in tumor cells drives SLC14A1+ CAF differentiation, and tumor&#x02010;derived exosomes induce the IFN&#x003b2;1&#x02010;secretory phenotype in CAFs. 4&#x02010;1BBL/4&#x02010;1BB, 4&#x02010;1BB ligand/4&#x02010;1BB; CAFs, cancer&#x02010;associated fibroblasts; CDNs, cyclic dinucleotides; cGAS, cyclic GMP&#x02010;AMP synthase; DCs, dendritic cell; IFNs, interferons; IL&#x02010;15R&#x003b1;/&#x003b2;&#x003b3;, interleukin&#x02010;15 receptor &#x003b1;/&#x003b2;&#x003b3; subunit; IRF3, IFN regulatory factor 3; MDSCs, myeloid&#x02010;derived suppressor cells; MHC&#x02010;I/TCR, major histocompatibility complex I/ T cell receptor; mTOR, rapamycin; NK cells, natural killer cell; STING, stimulator of interferon gene; TAMs, tumor&#x02010;associated macrophages; Th1/9, T helper 1/9; TME, tumor microenvironment.</p></caption><graphic xlink:href="CAC2-45-1513-g007" position="anchor" id="jats-graphic-13"/></fig><sec id="cac270067-sec-0270"><label>5.1.1</label><title>Myeloid cells</title><p>STING in myeloid cells predominantly drives IFN&#x02010;dependent signaling, which has been extensively studied. As the most potent antigen&#x02010;presenting cells (APCs) in tumor immunotherapy, dendritic cells (DCs) contribute to the capture, processing, and presentation of tumor antigens to activate CD8<sup>+</sup> T&#x02010;cell responses [<xref rid="cac270067-bib-0215" ref-type="bibr">215</xref>]. The recruitment and functionality of DCs depend on both cell&#x02010;autonomous and microenvironmental cGAS&#x02010;STING signaling following the engulfment of DNA&#x02010;damaged cells [<xref rid="cac270067-bib-0216" ref-type="bibr">216</xref>, <xref rid="cac270067-bib-0217" ref-type="bibr">217</xref>, <xref rid="cac270067-bib-0218" ref-type="bibr">218</xref>]. On one hand, the accumulation of cytosolic dsDNA in cancer cells leads to the activation of the cGAS&#x02010;STING inflammatory cascade, which is responsible for the intratumoral infiltration and antigen presentation of DCs [<xref rid="cac270067-bib-0219" ref-type="bibr">219</xref>]. On the other hand, dsDNA from cancer cells is transferred to the cytoplasm of basic leucine zipper ATF&#x02010;like transcription factor 3 (BATF3)&#x02010;dependent DCs through tumor&#x02010;derived exosomes, which then activate STING&#x02010;dependent IFN production and upregulate costimulatory molecules in DCs, ultimately stimulating CD8<sup>+</sup> T cell responses [<xref rid="cac270067-bib-0220" ref-type="bibr">220</xref>, <xref rid="cac270067-bib-0221" ref-type="bibr">221</xref>, <xref rid="cac270067-bib-0222" ref-type="bibr">222</xref>]. In regressing tumors, the activation state of CD11b<sup>+</sup> conventional DCs with the expression of ISGs and presentation of MHC class I complexes has been observed [<xref rid="cac270067-bib-0223" ref-type="bibr">223</xref>].</p><p>Tumor&#x02010;associated macrophages (TAMs) are categorized into two subsets: proinflammatory M1 and anti&#x02010;inflammatory M2 TAMs [<xref rid="cac270067-bib-0224" ref-type="bibr">224</xref>, <xref rid="cac270067-bib-0225" ref-type="bibr">225</xref>]. STING activation in the TME was confirmed to promote TAM polarization&#x000a0;into M1&#x02010;like proinflammatory macrophages as well as to optimize phagocytic activity and apoptosis&#x02010;inducing effects [<xref rid="cac270067-bib-0226" ref-type="bibr">226</xref>, <xref rid="cac270067-bib-0227" ref-type="bibr">227</xref>, <xref rid="cac270067-bib-0228" ref-type="bibr">228</xref>, <xref rid="cac270067-bib-0229" ref-type="bibr">229</xref>]. In addition, activation of the cGAS&#x02010;STING pathway can drive the conversion of M2 to M1 TAMs [<xref rid="cac270067-bib-0230" ref-type="bibr">230</xref>, <xref rid="cac270067-bib-0231" ref-type="bibr">231</xref>] and inhibit M2 TAM polarization [<xref rid="cac270067-bib-0228" ref-type="bibr">228</xref>]. Also of note, the STING&#x02010;dependent induction of IL&#x02010;18 and IL&#x02010;1&#x003b2;&#x000a0;in macrophages also promoted the antitumor effect of NK cells through the upregulation of costimulatory signals 4&#x02010;1BB ligand/4&#x02010;1BB [<xref rid="cac270067-bib-0232" ref-type="bibr">232</xref>].</p><p>Studies indicate that neutrophils exhibit negligible STING expression, which may serve as a protective mechanism against excessive immune activation [<xref rid="cac270067-bib-0233" ref-type="bibr">233</xref>]. Using a mouse model with neutrophil&#x02010;specific expression of the STING gain&#x02010;of&#x02010;function mutant N153S, researchers have demonstrated that STING overexpression triggers IFN&#x02010;independent systemic inflammation, marked by significantly elevated serum levels of inflammatory factors, including granulocyte colony&#x02010;stimulating factor (G&#x02010;CSF), chemokine C&#x02010;C motif ligands 4 (CCL4), and CCL5 (RANTES) [<xref rid="cac270067-bib-0233" ref-type="bibr">233</xref>]. Notably, interferon&#x02010;induced Ly6E&#x02010;high neutrophils have emerged as a circulating biomarker for anti&#x02010;PD&#x02010;1 therapy response in mice. These neutrophils are induced by activation of the tumor&#x02010;intrinsic STING pathway and possess the capacity to sensitize therapy&#x02010;resistant tumors to anti&#x02010;PD&#x02010;1 treatment [<xref rid="cac270067-bib-0234" ref-type="bibr">234</xref>].</p><p>As distinct immune cells that exert immunosuppressive effects, myeloid&#x02010;derived suppressor cells (MDSCs) play an essential role in tumor progression and metastasis [<xref rid="cac270067-bib-0235" ref-type="bibr">235</xref>, <xref rid="cac270067-bib-0236" ref-type="bibr">236</xref>]. STING signaling has been identified as a negative regulator of MDSC differentiation via the suppressors of cytokine signaling 1 (SOCS1)&#x02010;mediated inhibition of granulocyte&#x02010;macrophage colony&#x02010;stimulating factor (GM&#x02010;CSF)/IL&#x02010;6 production [<xref rid="cac270067-bib-0237" ref-type="bibr">237</xref>]. Treatment with low doses of c&#x02010;di&#x02010;GMP increases MDSC secretion of IL&#x02010;12, which significantly improves T cell responses to cancer vaccines [<xref rid="cac270067-bib-0238" ref-type="bibr">238</xref>]. STING deletion in CD11b<sup>+</sup> brain&#x02010;infiltrating leukocytes significantly promoted the induction of MDSCs while decreasing IFN&#x02010;&#x003b3;&#x02010;producing CD8<sup>+</sup> T cells, thus decreasing the survival rate of glioma&#x02010;bearing <italic toggle="yes">Sting<sup>Gt/Gt</sup>
</italic> mice [<xref rid="cac270067-bib-0239" ref-type="bibr">239</xref>].</p></sec><sec id="cac270067-sec-0280"><label>5.1.2</label><title>Lymphocytes</title><p>Spontaneous T cell responses are crucial for tumor regression, and intrinsic cGAS&#x02010;STING activation in T cells is essential for their functionality [<xref rid="cac270067-bib-0240" ref-type="bibr">240</xref>, <xref rid="cac270067-bib-0241" ref-type="bibr">241</xref>]. Reportedly, STING agonism augmented stem cell&#x02010;like CD8<sup>+</sup> T cell differentiation, as well as enhanced the differentiation and antitumor role of T helper 1 (Th1) and Th9 cells by stimulating the secretion of IFN&#x02010;&#x003b3; (via STING/IRF3 signaling) and IL&#x02010;9 (via STING/ rapamycin signaling), respectively [<xref rid="cac270067-bib-0242" ref-type="bibr">242</xref>, <xref rid="cac270067-bib-0243" ref-type="bibr">243</xref>]. Loss of intrinsic STING signaling in CD8&#x0207a; T cells inhibits their functional capacity and memory differentiation by inducing excessive hexokinase 2 (HK2)&#x02010;mediated glycolysis, causing lactate accumulation that suppresses IFN&#x02010;&#x003b3; production and impairs immunotherapy efficacy [<xref rid="cac270067-bib-0244" ref-type="bibr">244</xref>]. Tumor&#x02010;intrinsic STING expression is closely associated with T cell exhaustion [<xref rid="cac270067-bib-0233" ref-type="bibr">233</xref>]. Notably, this phenomenon is clinically relevant in patients with colorectal cancer; STING expression is downregulated in tumor&#x02010;infiltrating CD8<sup>+</sup> T cells, and the STING&#x02010;low population exhibits significant upregulation of exhaustion markers, including PD&#x02010;1, T cell immunoglobulin and mucin domain containing&#x02010;3, lymphocyte activation gene 3, and thymocyte selection&#x02010;associated high mobility group box [<xref rid="cac270067-bib-0233" ref-type="bibr">233</xref>]. Nevertheless, the intrinsic STING of CD8<sup>+</sup> T cells is reportedly correlated with proapoptotic and antiproliferative gene signatures, and cancer cell&#x02010;derived cGAMP limits the proliferation, survival, and function of STING&#x02010;expressing CD8<sup>+</sup> T cells [<xref rid="cac270067-bib-0245" ref-type="bibr">245</xref>]. However, the physiological function of STING in T cells remains poorly understood.</p><p>To address the problem that tumor cells may evade CD8<sup>+</sup> T cell recognition owing to the deficiency of MHC molecules or neoantigens, NK cells can mediate tumor rejection in CD8<sup>+</sup> T cell&#x02010;resistant cancers [<xref rid="cac270067-bib-0246" ref-type="bibr">246</xref>]. CDN treatment&#x02010;induced IFN production activates NK cells and promotes their cytotoxic activity through direct interactions or induction of IL&#x02010;15 receptors on DCs [<xref rid="cac270067-bib-0246" ref-type="bibr">246</xref>]. Tumor&#x02010;derived cGAMP, which is transferred to non&#x02010;tumor cells, is essential for NK cell&#x02010;mediated killing of tumor cells [<xref rid="cac270067-bib-0247" ref-type="bibr">247</xref>]. Additionally, intrinsic STING signaling, which is partially triggered by&#x000a0;tumor mtDNA recognition, maintains a reservoir of TCF&#x02010;1<sup>+</sup>NK cells [<xref rid="cac270067-bib-0248" ref-type="bibr">248</xref>].</p><p>cGAS&#x02010;STING signaling is also involved in regulatory T cells (Tregs)&#x02010;cell&#x02010;mediated immunosuppression. In lung cancer, Tregs establish an immunosuppressive microenvironment by inhibiting STING signaling, leading to reduced CD4<sup>+</sup> T&#x02010;cell infiltration and enhanced metastatic progression. STING inhibition promotes GATA binding protein 3/ nitric oxide synthase 2&#x02010;mediated immunosuppression and contributes to CD8<sup>+</sup> T cell exhaustion [<xref rid="cac270067-bib-0249" ref-type="bibr">249</xref>]. Similarly, in multiple myeloma, Treg&#x02010;derived TGF&#x02010;&#x003b2;1 directly suppresses the cGAS&#x02010;STING pathway in tumor cells, which results in downregulation of MHC class I molecules and upregulation of programmed death&#x02010;ligand 1 (PD&#x02010;L1), ultimately facilitating immune evasion [<xref rid="cac270067-bib-0250" ref-type="bibr">250</xref>]. These findings highlighted the central role of STING in regulating the immunosuppressive function of Tregs.</p></sec><sec id="cac270067-sec-0290"><label>5.1.3</label><title>Tumor cells</title><p>During abnormal mitosis and proliferation of tumor cells, cytoplasmic fragments, and micronuclei trigger cGAS&#x02010;STING&#x02010;mediated cellular senescence and tumor regression [<xref rid="cac270067-bib-0010" ref-type="bibr">10</xref>, <xref rid="cac270067-bib-0074" ref-type="bibr">74</xref>, <xref rid="cac270067-bib-0251" ref-type="bibr">251</xref>]. The DNA double&#x02010;strand break sensor, meiotic recombination 11 protein, rescues nuclear cGAS from sequestered chromatin, and activated cGAS promotes ZBP1/RIPK3/MLKL&#x02010;mediated necroptosis of tumor cells and subsequently inhibits oncogenic proliferation [<xref rid="cac270067-bib-0184" ref-type="bibr">184</xref>]. The above evidence suggests that the regulation of cell death pathways is involved in the suppressive effect of cGAS&#x02010;STING in cancer cells. Independent of the IRF3/IFN&#x02010;triggered innate immune function, STING directly targets and inhibits HK2 activity to restrict tumor aerobic glycolysis, thereby functioning as a cell&#x02010;intrinsic metabolic checkpoint to promote antitumor immunity [<xref rid="cac270067-bib-0252" ref-type="bibr">252</xref>]. These results established an important link between the intrinsic tumor&#x02010;suppressive activity of STING and cellular metabolism.</p></sec><sec id="cac270067-sec-0300"><label>5.1.4</label><title>Tumor angiogenesis</title><p>Tumor angiogenesis is indispensable for tumor growth and progression [<xref rid="cac270067-bib-0253" ref-type="bibr">253</xref>]. TET&#x02010;2 mediates the epigenetic upregulation of cGAS in tumor cells and produces cGAMP, which activates STING signaling in endothelial cells, promotes vascular normalization, and enhances the transendothelial migration of lymphocytes [<xref rid="cac270067-bib-0254" ref-type="bibr">254</xref>]. Reportedly, intraperitoneal administration of the STING agonist ADU&#x02010;S100 significantly suppressed aberrant angiogenesis and normalized tumor vessels, which recovered effector T cell function in a&#x000a0;type&#x02010;I interferon&#x02010;dependent manner [<xref rid="cac270067-bib-0255" ref-type="bibr">255</xref>]. Evidence indicates that the cGAS&#x02010;STING pathway suppresses tumor angiogenesis while activating immune responses.</p></sec></sec><sec id="cac270067-sec-0310"><label>5.2</label><title>Pro&#x02010;tumorigenic and pro&#x02010;metastatic role of cGAS&#x02010;STING signaling</title><p>The influence of chromosomal instability (CIN)&#x02010;induced cGAS&#x02010;STING signaling on tumorigenesis and progression is highly correlated with the signal intensity, TME context, and complex regulatory mechanisms of this pathway. Acute interferon signaling exerts antitumor effects by promoting the activation of T and NK cells by APCs (Figure&#x000a0;<xref rid="cac270067-fig-0008" ref-type="fig">8A</xref>) [<xref rid="cac270067-bib-0256" ref-type="bibr">256</xref>, <xref rid="cac270067-bib-0257" ref-type="bibr">257</xref>, <xref rid="cac270067-bib-0258" ref-type="bibr">258</xref>, <xref rid="cac270067-bib-0259" ref-type="bibr">259</xref>]. Conversely, chronic cGAS&#x02010;STING activation mediates downstream signal reprogramming, induces the expression of immunosuppressive factors, and initiates a series of adaptive immune evasion mechanisms, ultimately promoting tumor immunosuppression, survival, invasion, and metastasis (Figure&#x000a0;<xref rid="cac270067-fig-0008" ref-type="fig">8B</xref>) [<xref rid="cac270067-bib-0018" ref-type="bibr">18</xref>, <xref rid="cac270067-bib-0260" ref-type="bibr">260</xref>].</p><fig position="float" fig-type="FIGURE" id="cac270067-fig-0008"><label>FIGURE 8</label><caption><p>CIN&#x02010;induced acute and chronic STING stimulation dynamically regulate tumor progression. (A) Acute drug&#x02010;induced CIN promotes the antitumor activity of APCs, T cells, and NK cells through STING&#x02010;induced IRF3 and NF&#x02010;&#x003ba;B transcription via TBK1 and IKK&#x003b5; recruitment, thus promoting the expression of IFNs and ISGs; (B) However, cancer&#x02010;inherited chronic CIN triggers downstream rewiring of STING and upregulation of immunosuppressive factors. Non&#x02010;canonical NF&#x02010;&#x003ba;B signaling promotes cancer cell survival through IL&#x02010;6/STAT3 signaling and facilitates metastasis. Chronic CIN also triggers ER stress response (including PERK, IRE1, and ATF6 signaling pathway), promoting metastasis and leading to an immunosuppressive TME (enriched with M2&#x02010;like macrophages, dysfunctional CD8+ T cells, and MDSCs), which is also induced by the upregulation of immunosuppressive PD&#x02010;L1, IDO, and adenosine by chronic IFN response. APCs, antigen&#x02010;presenting cells; ATF6, activating transcription factor 6; CIN, chromosomal instability; ER, endoplasmic reticulum; IDO, indoleamine 2,3&#x02019;&#x02010;dioxygenase; IFNs, interferons; IKK&#x003b5;, IkappaB kinase epsilon; IL&#x02010;6, interleukin&#x02010;6; IRE1, inositol&#x02010;requiring enzyme 1; IRF3, IFN regulatory factor 3; ISGs, interferon&#x02010;stimulated genes; MDSCs, myeloid&#x02010;derived suppressor cells; NF&#x02010;&#x003ba;B, nuclear transcription factor&#x02010;kappa B; NK cells, natural killer cells; PD&#x02010;L1, programmed death&#x02010;ligand 1; PERK, protein kinase RNA&#x02010;like endoplasmic reticulum kinase; STAT3, signal transducer and activator of transcription 3; STING, stimulator of interferon gene; TBK1, TANK&#x02010;binding kinase 1.</p></caption><graphic xlink:href="CAC2-45-1513-g004" position="anchor" id="jats-graphic-15"/></fig><sec id="cac270067-sec-0320"><label>5.2.1</label><title>Rewiring of downstream signaling</title><p>The dualistic effects of STING on tumorigenesis may stem from its differential signaling patterns. Evidence suggested that the TBK1&#x02010;independent non&#x02010;canonical NF&#x02010;&#x003ba;B pathway is an essential mediator of tumorigenesis and metastasis. In CIN&#x02010;positive malignancies, disruption of cGAS&#x02010;STING signaling preferentially compromises tumor cell viability [<xref rid="cac270067-bib-0260" ref-type="bibr">260</xref>]. Mechanistically, CIN augments IL&#x02010;6/STAT3 pro&#x02010;survival signaling via non&#x02010;canonical NF&#x02010;&#x003ba;B activation [<xref rid="cac270067-bib-0260" ref-type="bibr">260</xref>]. Continuous chromosome segregation errors activate the cGAS&#x02010;STING pathway and downstream TBK1&#x02010;independent non&#x02010;canonical NF&#x02010;&#x003ba;B signaling, which drives tumor metastasis [<xref rid="cac270067-bib-0211" ref-type="bibr">211</xref>]. Additionally, chronic STING stimulation induces a transition from proinflammatory interferon signaling to the ER stress pathway [<xref rid="cac270067-bib-0017" ref-type="bibr">17</xref>, <xref rid="cac270067-bib-0018" ref-type="bibr">18</xref>]. Reportedly, chronic STING stimulation via STING agonists significantly weakened interferon response (called &#x0201c;interferon tachyphylaxis&#x0201d;), while the ER stress signals were activated, leading to an immunosuppressive TME (enriched with M2 TAMs, dysfunctional T cells, and MDSCs) and promoting cancer cell invasion and metastasis [<xref rid="cac270067-bib-0018" ref-type="bibr">18</xref>]. The depletion of ER stress sensors, including inositol&#x02010;requiring enzyme 1 (IRE1), PERK, or activating transcription factor 6 (ATF6), significantly inhibited tumor metastasis in chromosomally unstable tumors [<xref rid="cac270067-bib-0018" ref-type="bibr">18</xref>].</p></sec><sec id="cac270067-sec-0330"><label>5.2.2</label><title>Induction of immunosuppression</title><p>Low levels of chronic type I interferon can lead to the upregulation of immunosuppressive factors, such as immune checkpoints and indoleamine 2,3&#x02019;&#x02010;dioxygenase (IDO; catabolizes tryptophan to kynurenine), which dampens immune responses and promotes cancer cell immune escape [<xref rid="cac270067-bib-0261" ref-type="bibr">261</xref>, <xref rid="cac270067-bib-0262" ref-type="bibr">262</xref>]. After STING activation, cell&#x02010;intrinsic PD&#x02010;L1 expression is significantly upregulated within tumor monocytes, which acts as a major barrier to treatment resistance to STING agonists [<xref rid="cac270067-bib-0019" ref-type="bibr">19</xref>]. Pretreatment with toll&#x02010;like receptor 2 (TLR2) promotes the interaction between TNF receptor associated factor 6 and STING, inhibits IFN&#x02010;I signaling, and reduces PD&#x02010;L1 expression [<xref rid="cac270067-bib-0019" ref-type="bibr">19</xref>]. Notably, chromosomally unstable tumors also develop resistance mechanisms via upregulating ENPP1 expression, which catalyzes cGAMP to GMP and AMP [<xref rid="cac270067-bib-0093" ref-type="bibr">93</xref>, <xref rid="cac270067-bib-0263" ref-type="bibr">263</xref>]. Furthermore, AMP can be hydrolyzed by NT5E (also known as CD73) into the immunosuppressive metabolite adenosine, which promotes tumor progression [<xref rid="cac270067-bib-0263" ref-type="bibr">263</xref>].</p><p>Notably, the cGAS&#x02010;STING pathway is involved in immune evasion in TME. It was recently uncovered that mtDNA released from senescent cells via extracellular vesicles was selectively sensed by polymorphonuclear MDSCs in the TME, thus stimulating its immunosuppressive activity through cGAS/STING/NF&#x02010;&#x003ba;B signaling and promoting tumor progression [<xref rid="cac270067-bib-0020" ref-type="bibr">20</xref>]. Cancer&#x02010;associated fibroblasts (CAFs) also act as immunosuppressive cells that influence the antitumor treatment response of patients with cancer [<xref rid="cac270067-bib-0264" ref-type="bibr">264</xref>, <xref rid="cac270067-bib-0265" ref-type="bibr">265</xref>, <xref rid="cac270067-bib-0266" ref-type="bibr">266</xref>]. Activation of cGAS/STING/IFN signaling in tumor cells drives SLC14A1<sup>+</sup> CAF differentiation [<xref rid="cac270067-bib-0267" ref-type="bibr">267</xref>]. In addition, cisplatin promotes DNA transfer from tumor cells to CAFs, inducing the IFN&#x003b2;1&#x02010;secretory phenotype in CAFs, which modulates resistance to chemotherapy [<xref rid="cac270067-bib-0268" ref-type="bibr">268</xref>]. Additionally, the STING/IRF3/IL&#x02010;35 axis in regulatory B cells significantly suppresses NK cell proliferation and induces resistance to SING agonist monotherapy [<xref rid="cac270067-bib-0022" ref-type="bibr">22</xref>]. Moreover, in breast cancer susceptibility gene 1 (<italic toggle="yes">BRCA1</italic>)&#x02010;mutated ovarian cancer, BRCA1 deficiency causes the transcriptional reprogramming of STING and IFN, which mediates the upregulation of vascular endothelial growth factor A, thereby mediating immune resistance and tumor progression [<xref rid="cac270067-bib-0269" ref-type="bibr">269</xref>].</p></sec></sec></sec><sec id="cac270067-sec-0340"><label>6</label><title>FiRST&#x02010;GENERATION OF STING agonists and challenges</title><sec id="cac270067-sec-0350"><label>6.1</label><title>CDNs</title><p>Natural CDNs produced by malignant cells or bacteria, such as cGAMP, c&#x02010;diGMP, and c&#x02010;diAMP, can traverse the cell membrane through the reduced folate carrier, SLC19A1, and activate STING in the absence of cGAS [<xref rid="cac270067-bib-0099" ref-type="bibr">99</xref>]. Nevertheless, the poor metabolic stability and low delivery efficacy of natural CDNs limit their application and have promoted the development of CDN&#x02010;based STING synthetic agonists (Table <xref rid="cac270067-tbl-0003" ref-type="table">3</xref>) [<xref rid="cac270067-bib-0270" ref-type="bibr">270</xref>, <xref rid="cac270067-bib-0271" ref-type="bibr">271</xref>]. ADU&#x02010;S100 (MIW815) was the first CDN STING agonist to enter clinical trials with higher STING binding affinity and stronger IFN&#x02010;I&#x02010;inducing effect [<xref rid="cac270067-bib-0272" ref-type="bibr">272</xref>]. However, the clinical outcome of ADU&#x02010;S100 has been disappointing and its clinical development was terminated [<xref rid="cac270067-bib-0021" ref-type="bibr">21</xref>, <xref rid="cac270067-bib-0273" ref-type="bibr">273</xref>]. According to a phase I dose&#x02010;escalation trial of ADU&#x02010;S100, only one out of 47 patients with advanced/metastatic cancer treated with monotherapy achieved a confirmed partial response [<xref rid="cac270067-bib-0021" ref-type="bibr">21</xref>]. The limited efficacy may be attributed to several factors highlighted in that study. First, due to their poor membrane permeability, ADU&#x02010;S100 as well as other CDNs (such as IMSA&#x02010;101, MK&#x02010;1454, MK&#x02010;2118, BI&#x02010;1387446, and E7766) require intratumoral (IT) administration for effective delivery. However, plasma pharmacokinetic analyses demonstrated that IT&#x02010;administered ADU&#x02010;S100 was rapidly absorbed from the injection site into systemic circulation and exhibited a short half&#x02010;life. In addition, factors such as intratumoral pressure and injection technique may lead to uneven drug distribution, potentially compromising the therapeutic effects. Furthermore, due to the multiple target lesions and heterogeneity of patients, the systemic immune response may be limited [<xref rid="cac270067-bib-0021" ref-type="bibr">21</xref>].</p><table-wrap position="float" id="cac270067-tbl-0003" content-type="TABLE"><label>TABLE 3</label><caption><p>Clinical trials involving cyclic dinucleotides.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="char" char="." span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">Drug</th><th align="left" rowspan="1" colspan="1">Delivery method</th><th align="left" rowspan="1" colspan="1">Co&#x02010;therapy</th><th align="left" rowspan="1" colspan="1">Cancer types</th><th align="left" rowspan="1" colspan="1">Phase</th><th align="left" rowspan="1" colspan="1">Status</th><th align="left" rowspan="1" colspan="1">Enrollment</th><th align="left" rowspan="1" colspan="1">Termination reasons/Results</th><th align="left" rowspan="1" colspan="1">ID</th></tr></thead><tbody><tr><td rowspan="3" align="left" colspan="1">ADU&#x02010;S100</td><td align="left" rowspan="1" colspan="1">IT</td><td align="left" rowspan="1" colspan="1">Pembrolizumab</td><td align="left" rowspan="1" colspan="1">Metastatic/recurrent head and neck cancer</td><td align="left" rowspan="1" colspan="1">II</td><td align="left" rowspan="1" colspan="1">Terminated</td><td align="char" rowspan="1" colspan="1">16</td><td align="left" rowspan="1" colspan="1">No substantial antitumor activity was observed</td><td align="left" rowspan="1" colspan="1">NCT03937141</td></tr><tr><td align="left" rowspan="1" colspan="1">IT</td><td align="left" rowspan="1" colspan="1">Ipilimumab</td><td align="left" rowspan="1" colspan="1">Advanced/&#x0200b;metastatic solid tumors or lymphomas</td><td align="left" rowspan="1" colspan="1">I</td><td align="left" rowspan="1" colspan="1">Terminated</td><td align="char" rowspan="1" colspan="1">47</td><td align="left" rowspan="1" colspan="1">No substantial antitumor activity was observed</td><td align="left" rowspan="1" colspan="1">NCT02675439</td></tr><tr><td align="left" rowspan="1" colspan="1">IT</td><td align="left" rowspan="1" colspan="1">Spartalizumab</td><td align="left" rowspan="1" colspan="1">Solid tumors or lymphomas</td><td align="left" rowspan="1" colspan="1">IB</td><td align="left" rowspan="1" colspan="1">Terminated</td><td align="char" rowspan="1" colspan="1">106</td><td align="left" rowspan="1" colspan="1">Sponsor's decision</td><td align="left" rowspan="1" colspan="1">NCT03172936</td></tr><tr><td rowspan="3" align="left" colspan="1">IMSA&#x02010;101</td><td align="left" rowspan="1" colspan="1">IT</td><td align="left" rowspan="1" colspan="1">ICI</td><td align="left" rowspan="1" colspan="1">Adult solid tumors</td><td align="left" rowspan="1" colspan="1">I/IIA&#x000a0;</td><td align="left" rowspan="1" colspan="1">Completed</td><td align="char" rowspan="1" colspan="1">40</td><td align="left" rowspan="1" colspan="1">DLT: 16.7%; Low ORR in the monotherapy and combination group</td><td align="left" rowspan="1" colspan="1">NCT04020185</td></tr><tr><td align="left" rowspan="1" colspan="1">IT</td><td align="left" rowspan="1" colspan="1">PULSAR&#x02010;ICI</td><td align="left" rowspan="1" colspan="1">Oligoprogressive diseases</td><td align="left" rowspan="1" colspan="1">II</td><td align="left" rowspan="1" colspan="1">Terminated</td><td align="char" rowspan="1" colspan="1">16</td><td align="left" rowspan="1" colspan="1">Change in ImmuneSensor corporate strategy</td><td align="left" rowspan="1" colspan="1">NCT05846659</td></tr><tr><td align="left" rowspan="1" colspan="1">IT</td><td align="left" rowspan="1" colspan="1">PULSAR&#x02010;ICI</td><td align="left" rowspan="1" colspan="1">Oligometastatic diseases</td><td align="left" rowspan="1" colspan="1">II</td><td align="left" rowspan="1" colspan="1">Terminated</td><td align="char" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">Change in ImmuneSensor corporate strategy</td><td align="left" rowspan="1" colspan="1">NCT05846646</td></tr><tr><td rowspan="2" align="left" colspan="1">MK&#x02010;1454</td><td align="left" rowspan="1" colspan="1">IT</td><td align="left" rowspan="1" colspan="1">Pembrolizumab</td><td align="left" rowspan="1" colspan="1">Squamous&#x02010;cell carcinoma of the head and neck</td><td align="left" rowspan="1" colspan="1">II</td><td align="left" rowspan="1" colspan="1">Completed</td><td align="char" rowspan="1" colspan="1">18</td><td align="left" rowspan="1" colspan="1">ORR: 50.0% (95% CI: 15.7 to 84.3) in the combination group; SAEs: 62.50% in the combination group</td><td align="left" rowspan="1" colspan="1">NCT04220866</td></tr><tr><td align="left" rowspan="1" colspan="1">IT</td><td align="left" rowspan="1" colspan="1">Pembrolizumab</td><td align="left" rowspan="1" colspan="1">Lymphomas and solid tumors</td><td align="left" rowspan="1" colspan="1">I</td><td align="left" rowspan="1" colspan="1">Completed</td><td align="char" rowspan="1" colspan="1">156</td><td align="left" rowspan="1" colspan="1">DLT: 15.1% in the monotherapy group, 10.4% (cut/subcut lesions) and 0% (visceral lesions) in the combination group; Adverse events: 100% in all groups</td><td align="left" rowspan="1" colspan="1">NCT03010176</td></tr><tr><td align="left" rowspan="1" colspan="1">MK&#x02010;2118</td><td align="left" rowspan="1" colspan="1">IT</td><td align="left" rowspan="1" colspan="1">Pembrolizumab</td><td align="left" rowspan="1" colspan="1">Advanced/&#x0200b;metastatic solid tumors or lymphomas</td><td align="left" rowspan="1" colspan="1">I</td><td align="left" rowspan="1" colspan="1">Terminated</td><td align="char" rowspan="1" colspan="1">140</td><td align="left" rowspan="1" colspan="1">Business reasons</td><td align="left" rowspan="1" colspan="1">NCT03249792</td></tr><tr><td align="left" rowspan="1" colspan="1">BI&#x02010;1387446</td><td align="left" rowspan="1" colspan="1">IT</td><td align="left" rowspan="1" colspan="1">Ezabenlimab</td><td align="left" rowspan="1" colspan="1">Neoplasms</td><td align="left" rowspan="1" colspan="1">I</td><td align="left" rowspan="1" colspan="1">Completed</td><td align="char" rowspan="1" colspan="1">39</td><td align="left" rowspan="1" colspan="1">No results posted</td><td align="left" rowspan="1" colspan="1">NCT04147234</td></tr><tr><td rowspan="2" align="left" colspan="1">TAK&#x02010;676</td><td align="left" rowspan="1" colspan="1">IV</td><td align="left" rowspan="1" colspan="1">Pembrolizumab and radiotherapy</td><td align="left" rowspan="1" colspan="1">Non&#x02010;small&#x02010;cell lung cancer, triple&#x02010;negative breast cancer, and squamous&#x02010;cell carcinoma of the head and neck</td><td align="left" rowspan="1" colspan="1">I</td><td align="left" rowspan="1" colspan="1">Completed</td><td align="char" rowspan="1" colspan="1">34</td><td align="left" rowspan="1" colspan="1">No results posted</td><td align="left" rowspan="1" colspan="1">NCT04879849</td></tr><tr><td align="left" rowspan="1" colspan="1">IV</td><td align="left" rowspan="1" colspan="1">Pembrolizumab</td><td align="left" rowspan="1" colspan="1">Solid neoplasms</td><td align="left" rowspan="1" colspan="1">I/II</td><td align="left" rowspan="1" colspan="1">Active, not recruiting</td><td align="char" rowspan="1" colspan="1">248</td><td align="left" rowspan="1" colspan="1">No results posted</td><td align="left" rowspan="1" colspan="1">NCT04420884</td></tr><tr><td align="left" rowspan="1" colspan="1">E7766</td><td align="left" rowspan="1" colspan="1">IT</td><td align="left" rowspan="1" colspan="1">NA</td><td align="left" rowspan="1" colspan="1">Advanced solid tumors and lymphomas</td><td align="left" rowspan="1" colspan="1">I</td><td align="left" rowspan="1" colspan="1">Terminated</td><td align="char" rowspan="1" colspan="1">24</td><td align="left" rowspan="1" colspan="1">Business decision and no clinical activity data</td><td align="left" rowspan="1" colspan="1">NCT04144140</td></tr><tr><td align="left" rowspan="1" colspan="1">BMS&#x02010;986301</td><td align="left" rowspan="1" colspan="1">IM/IT/IV</td><td align="left" rowspan="1" colspan="1">Nivolumab and Ipilimumab</td><td align="left" rowspan="1" colspan="1">Advanced solid cancers</td><td align="left" rowspan="1" colspan="1">I</td><td align="left" rowspan="1" colspan="1">Completed</td><td align="char" rowspan="1" colspan="1">54</td><td align="left" rowspan="1" colspan="1">No results posted</td><td align="left" rowspan="1" colspan="1">NCT03956680</td></tr><tr><td align="left" rowspan="1" colspan="1">SB 11285</td><td align="left" rowspan="1" colspan="1">IV</td><td align="left" rowspan="1" colspan="1">Atezolizumab</td><td align="left" rowspan="1" colspan="1">Squamous&#x02010;cell carcinoma of the head and neck, melanoma, and solid tumors</td><td align="left" rowspan="1" colspan="1">I</td><td align="left" rowspan="1" colspan="1">Completed</td><td align="char" rowspan="1" colspan="1">61</td><td align="left" rowspan="1" colspan="1">No results posted</td><td align="left" rowspan="1" colspan="1">NCT04096638</td></tr></tbody></table><table-wrap-foot><fn id="cac270067-tbl3-note-0002"><p>Abbreviations: 95% CI, 95% confidence intervals; DLT, dose&#x02010;limiting toxicity; ICI, immune checkpoint inhibitor; ID, ClinicalTrials.gov identifiers; IM, intramuscular; IT, intratumoral; IV, intravenous; NA, not applicable; ORR, overall response rate; PULSAR, personalized ultra&#x02010;fractionated stereotactic adaptive radiotherapy; SAEs, serious adverse events.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap></sec><sec id="cac270067-sec-0360"><label>6.2</label><title>Non&#x02010;CDN small agonists</title><p>Various non&#x02010;CDN small agonists have been designed to overcome the poor membrane permeability of CDNs. An amidobenzimidazole&#x02010;based compound (diABZI) was the first non&#x02010;CDN small agonist of STING proposed in 2018 [<xref rid="cac270067-bib-0274" ref-type="bibr">274</xref>]. Synthetic small&#x02010;molecule STING agonists such as MSA&#x02010;2 [<xref rid="cac270067-bib-0275" ref-type="bibr">275</xref>] and SR&#x02010;717 [<xref rid="cac270067-bib-0276" ref-type="bibr">276</xref>] also show promising antitumor effects in preclinical models. However, poor oral bioavailability, latent off&#x02010;target distribution, systemic toxicity, and suboptimal delivery to immune&#x02010;rich sites such as lymph nodes restrict their clinical application [<xref rid="cac270067-bib-0016" ref-type="bibr">16</xref>]. Other novel small&#x02010;molecule STING agonists, including SNX281, GSK3745417, ONO&#x02010;7914, HG&#x02010;381, and KL340399, have also been reported; however, their efficacy has yet to be studied in clinical trials (Table <xref rid="cac270067-tbl-0004" ref-type="table">4</xref>).</p><table-wrap position="float" id="cac270067-tbl-0004" content-type="TABLE"><label>TABLE 4</label><caption><p>Clinical trials of other cGAS&#x02010;STING modulators.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="char" char="." span="1"/><col align="left" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">Type</th><th align="left" rowspan="1" colspan="1">Drug</th><th align="left" rowspan="1" colspan="1">Delivery method</th><th align="left" rowspan="1" colspan="1">Co&#x02010;therapy</th><th align="left" rowspan="1" colspan="1">Conditions</th><th align="left" rowspan="1" colspan="1">Phase</th><th align="left" rowspan="1" colspan="1">Status</th><th align="left" rowspan="1" colspan="1">Enrollment</th><th align="left" rowspan="1" colspan="1">ID</th></tr></thead><tbody><tr><td rowspan="6" align="left" colspan="1">Small molecules</td><td align="left" rowspan="1" colspan="1">SNX281</td><td align="left" rowspan="1" colspan="1">IV</td><td align="left" rowspan="1" colspan="1">Pembrolizumab</td><td align="left" rowspan="1" colspan="1">Advanced solid tumors and advanced lymphomas</td><td align="left" rowspan="1" colspan="1">I</td><td align="left" rowspan="1" colspan="1">
<p>Terminated</p>
<p>(sponsor decision not due to safety concerns)</p>
</td><td align="char" rowspan="1" colspan="1">27</td><td align="left" rowspan="1" colspan="1">NCT04609579</td></tr><tr><td rowspan="2" align="left" colspan="1">GSK3745417</td><td align="left" rowspan="1" colspan="1">IV</td><td align="left" rowspan="1" colspan="1">Dostarlimab</td><td align="left" rowspan="1" colspan="1">Neoplasms</td><td align="left" rowspan="1" colspan="1">I</td><td align="left" rowspan="1" colspan="1">Active, not recruiting</td><td align="char" rowspan="1" colspan="1">97</td><td align="left" rowspan="1" colspan="1">NCT03843359</td></tr><tr><td align="left" rowspan="1" colspan="1">IV</td><td align="left" rowspan="1" colspan="1">NA</td><td align="left" rowspan="1" colspan="1">Acute myeloid leukemia</td><td align="left" rowspan="1" colspan="1">I</td><td align="left" rowspan="1" colspan="1">Terminated (a reprioritization of organizational allocation of resources for clinical research programs)</td><td align="char" rowspan="1" colspan="1">18</td><td align="left" rowspan="1" colspan="1">NCT05424380</td></tr><tr><td align="left" rowspan="1" colspan="1">ONO&#x02010;7914</td><td align="left" rowspan="1" colspan="1">IV</td><td align="left" rowspan="1" colspan="1">
<p>ONO&#x02010;4538</p>
</td><td align="left" rowspan="1" colspan="1">Solid tumors</td><td align="left" rowspan="1" colspan="1">I</td><td align="left" rowspan="1" colspan="1">Terminated (due to strategic reasons)</td><td align="char" rowspan="1" colspan="1">
<p>25</p>
</td><td align="left" rowspan="1" colspan="1">NCT06535009</td></tr><tr><td align="left" rowspan="1" colspan="1">HG&#x02010;381</td><td align="left" rowspan="1" colspan="1">IV</td><td align="left" rowspan="1" colspan="1">NA</td><td align="left" rowspan="1" colspan="1">Advanced solid tumors</td><td align="left" rowspan="1" colspan="1">I</td><td align="left" rowspan="1" colspan="1">Recruiting</td><td align="char" rowspan="1" colspan="1">
<p>57<xref rid="cac270067-tbl4-note-0001" ref-type="table-fn">
<sup>*</sup>
</xref>
</p>
</td><td align="left" rowspan="1" colspan="1">NCT04998422</td></tr><tr><td align="left" rowspan="1" colspan="1">KL340399</td><td align="left" rowspan="1" colspan="1">IT</td><td align="left" rowspan="1" colspan="1">NA</td><td align="left" rowspan="1" colspan="1">Advanced solid tumors</td><td align="left" rowspan="1" colspan="1">I</td><td align="left" rowspan="1" colspan="1">Recruiting</td><td align="char" rowspan="1" colspan="1">
<p>30<xref rid="cac270067-tbl4-note-0001" ref-type="table-fn">
<sup>*</sup>
</xref>
</p>
</td><td align="left" rowspan="1" colspan="1">
<p>NCT05387928,</p>
<p>NCT05549804</p>
</td></tr><tr><td rowspan="2" align="left" colspan="1">Nanomaterials</td><td align="left" rowspan="1" colspan="1">
<p>CDK&#x02010;002/</p>
<p>ExoSTING</p>
</td><td align="left" rowspan="1" colspan="1">IT</td><td align="left" rowspan="1" colspan="1">NA</td><td align="left" rowspan="1" colspan="1">Advanced solid tumors</td><td align="left" rowspan="1" colspan="1">I/II</td><td align="left" rowspan="1" colspan="1">
<p>Completed</p>
<p>(no results posted)</p>
</td><td align="char" rowspan="1" colspan="1">
<p>27</p>
</td><td align="left" rowspan="1" colspan="1">NCT04592484</td></tr><tr><td align="left" rowspan="1" colspan="1">ONM&#x02010;501</td><td align="left" rowspan="1" colspan="1">IT</td><td align="left" rowspan="1" colspan="1">Cemiplimab</td><td align="left" rowspan="1" colspan="1">Advanced solid tumors and lymphomas</td><td align="left" rowspan="1" colspan="1">I</td><td align="left" rowspan="1" colspan="1">Recruiting</td><td align="char" rowspan="1" colspan="1">
<p>168<xref rid="cac270067-tbl4-note-0001" ref-type="table-fn">
<sup>*</sup>
</xref>
</p>
</td><td align="left" rowspan="1" colspan="1">NCT06022029</td></tr><tr><td rowspan="2" align="left" colspan="1">ADCs</td><td align="left" rowspan="1" colspan="1">TAK&#x02010;500</td><td align="left" rowspan="1" colspan="1">IV</td><td align="left" rowspan="1" colspan="1">Pembrolizumab</td><td align="left" rowspan="1" colspan="1">Locally advanced or metastatic solid tumors</td><td align="left" rowspan="1" colspan="1">I/II</td><td align="left" rowspan="1" colspan="1">Terminated (clinical futility)</td><td align="char" rowspan="1" colspan="1">
<p>61</p>
</td><td align="left" rowspan="1" colspan="1">NCT05070247</td></tr><tr><td align="left" rowspan="1" colspan="1">XMT&#x02010;2056</td><td align="left" rowspan="1" colspan="1">IV</td><td align="left" rowspan="1" colspan="1">NA</td><td align="left" rowspan="1" colspan="1">Advanced/recurrent solid tumors that express HER2</td><td align="left" rowspan="1" colspan="1">I</td><td align="left" rowspan="1" colspan="1">Recruiting</td><td align="char" rowspan="1" colspan="1">
<p>162<xref rid="cac270067-tbl4-note-0001" ref-type="table-fn">
<sup>*</sup>
</xref>
</p>
</td><td align="left" rowspan="1" colspan="1">NCT05514717</td></tr><tr><td align="left" rowspan="1" colspan="1">Engineered bacteria</td><td align="left" rowspan="1" colspan="1">SYNB1891</td><td align="left" rowspan="1" colspan="1">IT</td><td align="left" rowspan="1" colspan="1">Atezolizumab</td><td align="left" rowspan="1" colspan="1">Metastatic solid neoplasms and lymphomas</td><td align="left" rowspan="1" colspan="1">I</td><td align="left" rowspan="1" colspan="1">
<p>Terminated</p>
<p>(Business reasons)</p>
</td><td align="char" rowspan="1" colspan="1">32</td><td align="left" rowspan="1" colspan="1">NCT04167137</td></tr><tr><td rowspan="6" align="left" colspan="1">ENPP1 antagonists</td><td align="left" rowspan="1" colspan="1">ISM5939</td><td align="left" rowspan="1" colspan="1">PO</td><td align="left" rowspan="1" colspan="1">NA</td><td align="left" rowspan="1" colspan="1">Advanced and/&#x0200b;or metastatic solid tumors</td><td align="left" rowspan="1" colspan="1">IA/B</td><td align="left" rowspan="1" colspan="1">Not yet recruiting</td><td align="char" rowspan="1" colspan="1">159<xref rid="cac270067-tbl4-note-0001" ref-type="table-fn">
<sup>*</sup>
</xref>
</td><td align="left" rowspan="1" colspan="1">NCT06724042</td></tr><tr><td rowspan="2" align="left" colspan="1">RBS2418</td><td align="left" rowspan="1" colspan="1">PO</td><td align="left" rowspan="1" colspan="1">NA</td><td align="left" rowspan="1" colspan="1">Advanced, metastatic, and progressive colorectal cancer</td><td align="left" rowspan="1" colspan="1">IIA</td><td align="left" rowspan="1" colspan="1">Recruiting</td><td align="char" rowspan="1" colspan="1">150<xref rid="cac270067-tbl4-note-0001" ref-type="table-fn">
<sup>*</sup>
</xref>
</td><td align="left" rowspan="1" colspan="1">NCT06824064</td></tr><tr><td align="left" rowspan="1" colspan="1">PO</td><td align="left" rowspan="1" colspan="1">Pembrolizumab</td><td align="left" rowspan="1" colspan="1">Advanced and metastatic solid tumors</td><td align="left" rowspan="1" colspan="1">IA/B</td><td align="left" rowspan="1" colspan="1">Recruiting</td><td align="char" rowspan="1" colspan="1">164<xref rid="cac270067-tbl4-note-0001" ref-type="table-fn">
<sup>*</sup>
</xref>
</td><td align="left" rowspan="1" colspan="1">NCT05270213</td></tr><tr><td align="left" rowspan="1" colspan="1">TXN10128</td><td align="left" rowspan="1" colspan="1">PO</td><td align="left" rowspan="1" colspan="1">Irinotecan or Paclitaxel</td><td align="left" rowspan="1" colspan="1">Solid tumors</td><td align="left" rowspan="1" colspan="1">I</td><td align="left" rowspan="1" colspan="1">Recruiting</td><td align="char" rowspan="1" colspan="1">96<xref rid="cac270067-tbl4-note-0001" ref-type="table-fn">
<sup>*</sup>
</xref>
</td><td align="left" rowspan="1" colspan="1">NCT05978492</td></tr><tr><td rowspan="2" align="left" colspan="1">SR&#x02010;8541A</td><td align="left" rowspan="1" colspan="1">PO</td><td align="left" rowspan="1" colspan="1">Botensilimab plus balstilimab</td><td align="left" rowspan="1" colspan="1">Refractory metastatic microsatellite stable colorectal cancer</td><td align="left" rowspan="1" colspan="1">II</td><td align="left" rowspan="1" colspan="1">Recruiting</td><td align="char" rowspan="1" colspan="1">70<xref rid="cac270067-tbl4-note-0001" ref-type="table-fn">
<sup>*</sup>
</xref>
</td><td align="left" rowspan="1" colspan="1">NCT06589440</td></tr><tr><td align="left" rowspan="1" colspan="1">PO</td><td align="left" rowspan="1" colspan="1">ICI</td><td align="left" rowspan="1" colspan="1">Advanced/&#x0200b;metastatic solid tumors</td><td align="left" rowspan="1" colspan="1">I</td><td align="left" rowspan="1" colspan="1">Recruiting</td><td align="char" rowspan="1" colspan="1">25<xref rid="cac270067-tbl4-note-0001" ref-type="table-fn">
<sup>*</sup>
</xref>
</td><td align="left" rowspan="1" colspan="1">NCT06063681</td></tr></tbody></table><table-wrap-foot><fn id="cac270067-tbl4-note-0001"><label>*</label><p>Estimated enrollment.</p></fn><fn id="cac270067-tbl4-note-0002"><p>Abbreviations: ADCs, antibody&#x02010;drug conjugates; ICI, immune checkpoint inhibitor; ID, ClinicalTrials.gov identifiers; IT, intratumoral; IV, intravenous; NA, not applicable; PO, per os, oral administration.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap></sec></sec><sec id="cac270067-sec-0370"><label>7</label><title>Next Generation of STING modulators for cancer therapy</title><p>The conventional STING agonists face challenges including rapid systemic clearance, systemic toxicity, restricted administration routes, suboptimal therapeutic efficacy, emerging resistance mechanisms, and tumor heterogeneity, which restrict their clinical application [<xref rid="cac270067-bib-0016" ref-type="bibr">16</xref>, <xref rid="cac270067-bib-0021" ref-type="bibr">21</xref>, <xref rid="cac270067-bib-0022" ref-type="bibr">22</xref>]. Efforts should be made to optimize pharmacokinetics, mitigate toxicity, improve delivery routes, and investigate alternative combinations and biomarker&#x02010;guided therapeutic strategies. Novel STING agonists (such as nanomaterials, ADCs, and engineered bacteria) as well as alternative strategies, are currently under clinical evaluation (Table&#x000a0;<xref rid="cac270067-tbl-0004" ref-type="table">4</xref>).</p><sec id="cac270067-sec-0380"><label>7.1</label><title>Nanomaterials</title><p>In recent years, the emergence of nanomaterials has profoundly revolutionized STING agonists delivery, such as lipid nanoparticles [<xref rid="cac270067-bib-0277" ref-type="bibr">277</xref>, <xref rid="cac270067-bib-0278" ref-type="bibr">278</xref>, <xref rid="cac270067-bib-0279" ref-type="bibr">279</xref>], polymeric nanocarriers [<xref rid="cac270067-bib-0280" ref-type="bibr">280</xref>], metal&#x02010;organic frameworks [<xref rid="cac270067-bib-0281" ref-type="bibr">281</xref>, <xref rid="cac270067-bib-0282" ref-type="bibr">282</xref>, <xref rid="cac270067-bib-0283" ref-type="bibr">283</xref>, <xref rid="cac270067-bib-0284" ref-type="bibr">284</xref>], mesoporous silicon nanoparticles [<xref rid="cac270067-bib-0285" ref-type="bibr">285</xref>, <xref rid="cac270067-bib-0286" ref-type="bibr">286</xref>], exosomes [<xref rid="cac270067-bib-0287" ref-type="bibr">287</xref>], hydrogels [<xref rid="cac270067-bib-0288" ref-type="bibr">288</xref>, <xref rid="cac270067-bib-0289" ref-type="bibr">289</xref>, <xref rid="cac270067-bib-0290" ref-type="bibr">290</xref>], nanogels [<xref rid="cac270067-bib-0291" ref-type="bibr">291</xref>], scaffolds [<xref rid="cac270067-bib-0290" ref-type="bibr">290</xref>, <xref rid="cac270067-bib-0292" ref-type="bibr">292</xref>], and ferritin nanoparticles [<xref rid="cac270067-bib-0293" ref-type="bibr">293</xref>, <xref rid="cac270067-bib-0294" ref-type="bibr">294</xref>]. Modification of STING agonists via precise drug delivery systems and multifunctional platforms significantly improves their water solubility, extends their half&#x02010;life, achieves remarkable region&#x02010;specific biodistribution, and maximizes therapeutic effects while minimizing adverse effects [<xref rid="cac270067-bib-0295" ref-type="bibr">295</xref>]. For example, a novel &#x0201c;shock&#x02010;and&#x02010;lock&#x0201d; polymeric STING&#x02010;activating nanoparticle (PolySTING) encapsulates cGAMP in a micellar matrix composed of the polymer PSC7A, ensuring specific identification by conventional type 1 dendritic cells (cDC1s) over other immune cells to mount a robust antitumor immunity and avoid STING&#x02010;mediated T cell death [<xref rid="cac270067-bib-0296" ref-type="bibr">296</xref>]. In addition, a polymeric nanoplatform with resiquimod (R848) and cGAMP co&#x02010;encapsulation (named M&#x02010;PNP@R@C) promotes the conversion of M2 TAMs to proinflammatory M1 TAMs and enhanced antitumor immunity [<xref rid="cac270067-bib-0297" ref-type="bibr">297</xref>]. The design of STING agonist&#x02010;based nanotechnologies capable of specifically activating the STING signaling pathway in DCs or TAMs effectively mitigated systemic toxicity, providing valuable guidance for future drug development.</p><p>ExoSTING is an engineered extracellular vesicle&#x02010;based STING agonist that integrates CDN into the lumen, facilitating the activation of APCs within the TME and generating systemic antitumor immunity [<xref rid="cac270067-bib-0298" ref-type="bibr">298</xref>]. According to phase I/II data, intratumoral injection of ExoSTING in advanced solid tumors showed tumor contraction in injected tumors as well as in distal non&#x02010;injected tumors, and no adverse reactions of DLT and grade 3 or above were observed (NCT04592484). A related nanoagonist (ONM&#x02010;501) is being evaluated in a phase I clinical trial to determine its safety and therapeutic efficacy alone or in combination with cemiplimab for tumors (NCT06022029).</p></sec><sec id="cac270067-sec-0390"><label>7.2</label><title>Antibody&#x02010;drug conjugates</title><p>STING is ubiquitously expressed in both tumors and normal tissues; therefore, the systemic administration of STING agonists may induce cytokine storms. The development of novel drug delivery systems or ADCs based on STING agonists may prevent corresponding adverse reactions. TAK&#x02010;500 is an ADC that specifically targets STING and CCR2 and facilitates the recruitment and activation of CCR2<sup>+</sup> myeloid cells within the TME [<xref rid="cac270067-bib-0299" ref-type="bibr">299</xref>]. However, a phase I/II clinical trial evaluating the efficacy of TAK&#x02010;500, with or without pembrolizumab, in locally advanced or metastatic solid tumors was terminated due to clinical futility (NCT05070247). Additionally, XMT&#x02010;2056, a HER2&#x02010;directed STING ADC, induced tumor regression in various tumor models and showed combinatorial effects with immune checkpoint inhibitors (ICIs) [<xref rid="cac270067-bib-0300" ref-type="bibr">300</xref>]. XMT&#x02010;2056 is currently in a phase I study that has enrolled patients with advanced or relapsed HER2&#x02010;expressing solid tumors (NCT05514717). ADCs show potential for achieving precision therapy and may represent a key area for the future development of STING agonists.</p></sec><sec id="cac270067-sec-0400"><label>7.3</label><title>Engineered bacteria</title><p>Synthetic biology is an efficient tool in drug design. SYNB1891, developed from non&#x02010;pathogenic <italic toggle="yes">Escherichia coli Nissle</italic> to produce CDNs under hypoxia, promotes STING activation in phagocytic ADCs and elicits robust antitumor immunity in murine models [<xref rid="cac270067-bib-0301" ref-type="bibr">301</xref>]. A phase I clinical trial (NCT04167137) evaluating the safety and efficacy of SYNB1891 alone or in combination with atezolizumab, in patients with metastatic solid tumors or lymphomas, demonstrated that SYNB1891 was well tolerated and showed evidence of STING pathway target engagement [<xref rid="cac270067-bib-0302" ref-type="bibr">302</xref>]. Bacterial outer membrane vesicles (OMVs) have garnered interest as cancer vaccines that potently stimulate immune responses [<xref rid="cac270067-bib-0303" ref-type="bibr">303</xref>]. Anchoring OMVs with ferrous ions loaded with STING agonists elicited promising antitumor responses in a murine model of colon cancer [<xref rid="cac270067-bib-0304" ref-type="bibr">304</xref>]. Nevertheless, concerns of low yield, toxicity, and unclear mechanisms of action of bacterial materials need to be resolved.</p></sec><sec id="cac270067-sec-0410"><label>7.4</label><title>Alternative strategies</title><p>Given the clinical challenges associated with direct STING agonists, alternative strategies that efficiently and safely target the STING pathway may represent promising therapeutic breakthroughs. For instance, ENPP1 antagonists have emerged as a promising next&#x02010;generation STING modulator [<xref rid="cac270067-bib-0305" ref-type="bibr">305</xref>, <xref rid="cac270067-bib-0306" ref-type="bibr">306</xref>]. As an ectoenzyme that degrades extracellular cGAMP, ENPP1 suppresses STING activation in the TME, and its overexpression correlates with a poor response to immunotherapy [<xref rid="cac270067-bib-0093" ref-type="bibr">93</xref>, <xref rid="cac270067-bib-0102" ref-type="bibr">102</xref>, <xref rid="cac270067-bib-0103" ref-type="bibr">103</xref>, <xref rid="cac270067-bib-0104" ref-type="bibr">104</xref>]. Unlike direct STING agonists, ENPP1 inhibitors achieve in situ activation of the STING pathway by elevating extracellular cGAMP concentrations, specifically within the TME [<xref rid="cac270067-bib-0305" ref-type="bibr">305</xref>]. This spatially restricted action minimizes the systemic toxicity and offers a significantly improved safety profile [<xref rid="cac270067-bib-0305" ref-type="bibr">305</xref>]. Mechanistically, ENPP1 inhibition preserves extracellular cGAMP, which is preferentially taken up by APCs, and triggers efficient type I IFN production [<xref rid="cac270067-bib-0305" ref-type="bibr">305</xref>]. Furthermore, as ENPP1 is frequently overexpressed across diverse solid tumors, targeting ENPP1 represents a broader strategy for potentiating antitumor immunity [<xref rid="cac270067-bib-0305" ref-type="bibr">305</xref>]. To date, four candidate oral ENPP1 inhibitors (ISM5939, RBS2418, TXN10128, and SR&#x02010;8541A) have been tested in clinical trials [<xref rid="cac270067-bib-0305" ref-type="bibr">305</xref>]. The development of ENPP1 antagonists has provided new insights into the development of indirect STING modulators, such as ENPP3 and DNase antagonists.</p></sec><sec id="cac270067-sec-0420"><label>7.5</label><title>Optogenetic approaches</title><p>Owing to the systemic toxicity and spatiotemporal control limitations of conventional STING agonists, optogenetic tools offer a promising approach for precise modulation of the cGAS&#x02010;STING signaling pathway [<xref rid="cac270067-bib-0307" ref-type="bibr">307</xref>]. For instance, light&#x02010;inducible SMOC&#x02010;like repeats (LiSmore) are light&#x02010;sensitive optogenetic devices consisting of a tandem STING CTT (amino acids 340&#x02010;379) fused with the photosensitive protein CRY2clust. Upon blue light illumination, CRY2clust forms clusters, driving STING&#x02010;CTT aggregation and subsequently inducing DC maturation, ultimately activating cytotoxic T lymphocytes [<xref rid="cac270067-bib-0308" ref-type="bibr">308</xref>]. Similarly, OptoSTING employs a nanobody&#x02010;CRY2 fusion system, enabling light&#x02010;inducible clustering of STING [<xref rid="cac270067-bib-0309" ref-type="bibr">309</xref>]. Notably, OptoSTING is the first tool capable of precisely controlling STING aggregation. Mechanistically, STING clustering is strictly dependent on ER exit, as only the cytosolic fragment (cyt&#x02010;OptoSTING) can successfully trigger type I interferon responses [<xref rid="cac270067-bib-0309" ref-type="bibr">309</xref>]. Structural investigations have demonstrated that upon binding to its ligand, cGAMP, STING undergoes conformational changes that induce ER membrane curvature, thereby facilitating ER escape and subsequent downstream signaling activation [<xref rid="cac270067-bib-0310" ref-type="bibr">310</xref>]. These structural findings provide novel insights for the rational design of next&#x02010;generation STING agonists.</p></sec><sec id="cac270067-sec-0430"><label>7.6</label><title>Combination strategies</title><p>The limited efficacy of STING agonist monotherapy in clinical trials reflects profound tumor resistance, underscoring the need for rational combination strategies. The combination of STING agonists with ICIs shows encouraging results in preclinical models [<xref rid="cac270067-bib-0311" ref-type="bibr">311</xref>, <xref rid="cac270067-bib-0312" ref-type="bibr">312</xref>]. For example, the combination of an anti&#x02010;TGF&#x02010;&#x003b2;/PD&#x02010;L1 bispecific antibody (YM101) with oral STING agonist MSA&#x02010;2 synergistically amplified immune response in multiple murine tumor models [<xref rid="cac270067-bib-0311" ref-type="bibr">311</xref>]. Nevertheless, the combination of the STING agonist ADU&#x02010;S100 and spartalizumab showed minimal antitumor responses in patients with advanced/metastatic solid tumors or lymphomas, with an overall response rate of 10.4% [<xref rid="cac270067-bib-0273" ref-type="bibr">273</xref>]. Mechanistically, it was recently discovered that STING agonists activate and expand PD&#x02010;L1&#x02010;high monocytes in the TME through the IRF3&#x02010;IFN&#x02010;I signaling axis, thereby suppressing immune responses and compromising the therapeutic efficacy of STING agonists [<xref rid="cac270067-bib-0019" ref-type="bibr">19</xref>]. Intriguingly, the PD&#x02010;L1 blockade failed to counteract this effect, while pretreatment with TLR2 agonist significantly improved the antitumor efficacy of STING agonists, as TLR2 activation reprogrammed STING signaling to enhance NF&#x02010;&#x003ba;B activation and reduce PD&#x02010;L1 expression in monocytes [<xref rid="cac270067-bib-0019" ref-type="bibr">19</xref>]. Additionally, the STING&#x02010;IL&#x02010;35 axis in regulatory B cells was correlated with tumor resistance to STING monotherapy by attenuating the NK&#x02010;mediated antitumor response, and the combination of STING agonists with anti&#x02010;IL&#x02010;35 blockade therapy significantly promoted tumor elimination in preclinical tumor models [<xref rid="cac270067-bib-0022" ref-type="bibr">22</xref>]. Notably, recent studies have increasingly focused on combinatorial approaches that integrate STING agonists with adoptive cell therapies (e.g., CAR&#x02010;transduced cell therapies [<xref rid="cac270067-bib-0313" ref-type="bibr">313</xref>, <xref rid="cac270067-bib-0314" ref-type="bibr">314</xref>, <xref rid="cac270067-bib-0315" ref-type="bibr">315</xref>, <xref rid="cac270067-bib-0316" ref-type="bibr">316</xref>, <xref rid="cac270067-bib-0317" ref-type="bibr">317</xref>]), which prevent the outgrowth of Ag&#x02010;loss tumor variants and elicit superior antitumor immune responses.</p><p>The combination of traditional chemotherapy and radiotherapy with STING agonists also exhibited improved treatment efficacy [<xref rid="cac270067-bib-0318" ref-type="bibr">318</xref>, <xref rid="cac270067-bib-0319" ref-type="bibr">319</xref>, <xref rid="cac270067-bib-0320" ref-type="bibr">320</xref>, <xref rid="cac270067-bib-0321" ref-type="bibr">321</xref>, <xref rid="cac270067-bib-0322" ref-type="bibr">322</xref>]. Chemotherapeutic agents can induce DNA damage&#x02010;mediated accumulation of cytoplasmic DNA, thereby activating the STING&#x02010;IFN response [<xref rid="cac270067-bib-0323" ref-type="bibr">323</xref>, <xref rid="cac270067-bib-0324" ref-type="bibr">324</xref>]. Harnessing STING&#x02010;mediated antitumor immunity to bridge chemotherapy&#x02010;induced DNA damage is a promising strategy for chemosensitization. For instance, the recently identified STING agonist, carvedilol, synergizes with etoposide to promote a STING&#x02010;dependent type I IFN response and remodels the TME by augmenting NK cell infiltration, thereby potentiating chemotherapeutic efficacy [<xref rid="cac270067-bib-0318" ref-type="bibr">318</xref>]. Additionally, the proinflammatory effects of STING demonstrate its therapeutic potential in counteracting the immunosuppressive effects of radiotherapy, monotherapy, and overcoming radioresistance [<xref rid="cac270067-bib-0320" ref-type="bibr">320</xref>, <xref rid="cac270067-bib-0321" ref-type="bibr">321</xref>]. Reportedly, a distinct subset of CAFs characterized by high interferon regulatory factor&#x02010;1 (IRF1) expression, termed inflammatory CAFs (iCAFs), is enriched in various radiotherapy&#x02010;sensitive solid tumors [<xref rid="cac270067-bib-0320" ref-type="bibr">320</xref>]. Activation of the STING&#x02010;IFN&#x02010;&#x003b3; signaling pathway in iCAFs drives its polarization and promotes the secretion of CCL4 and CCL5, thus enhancing radiotherapeutic efficacy [<xref rid="cac270067-bib-0320" ref-type="bibr">320</xref>].</p></sec><sec id="cac270067-sec-0440"><label>7.7</label><title>Patient heterogeneity and precision therapy</title><p>Inherent genetic diversity of the STING pathway may influence the efficacy of STING agonists. Analyzed from single nucleotide polymorphism data, STING exhibits significant population&#x02010;level heterogeneity, with five major variants (R232, HAQ, R232H, AQ, and R293Q) showing distinct geographical distributions and differential responsiveness to STING agonists [<xref rid="cac270067-bib-0325" ref-type="bibr">325</xref>]. The development of pan&#x02010;spectrum STING agonists like c[G(2&#x02032;,5&#x02032;)U(2&#x02032;,5&#x02032;)], which show pan&#x02010;variant activity, offers a promising prospect to overcome this heterogeneity [<xref rid="cac270067-bib-0326" ref-type="bibr">326</xref>].</p><p>Biomarker&#x02010;guided therapy is also an essential approach for improving the responsiveness of patients to immunotherapy, particularly STING&#x02010;targeted therapies. An XCR1<sup>+</sup>STING<sup>+</sup>CXCL9<sup>+</sup> signature in cDC1s, in which STING activation drives transcriptional programs associated with improved survival, suggests that these cells are putative biomarkers for immunotherapy stratification [<xref rid="cac270067-bib-0296" ref-type="bibr">296</xref>]. Future studies should aim to identify additional predictive biomarkers of treatment responses.</p></sec></sec><sec id="cac270067-sec-0450"><label>8</label><title>CONCLUSIONS AND PERSPECTIVES</title><p>The last decade has witnessed great progress in uncovering the regulatory mechanisms, biological functions, and targeted therapies of the cGAS&#x02010;STING signaling pathway. However, there are also other unresolved problems: (1) the complex regulatory mechanisms of cGAS&#x02010;STING require further exploration; (2) since more cellular functions of cGAS&#x02010;STING have been uncovered, including the recently identified role of STING as a proton channel to regulate lysosomal biogenesis, autophagy, and Golgi functions [<xref rid="cac270067-bib-0139" ref-type="bibr">139</xref>, <xref rid="cac270067-bib-0141" ref-type="bibr">141</xref>, <xref rid="cac270067-bib-0144" ref-type="bibr">144</xref>], other uncharacterized roles of cGAS and STING require further clarification; and (3) how to improve the clinical efficiency of cGAS&#x02010;STING modulators. Although STING agonists exhibited promising antitumor effects in preclinical murine models, these drugs failed to elicit effective responses in patients with cancer either as single agents or in combination with PD&#x02010;(L)1 inhibitor, according to clinical studies published to date [<xref rid="cac270067-bib-0021" ref-type="bibr">21</xref>, <xref rid="cac270067-bib-0273" ref-type="bibr">273</xref>]. These disappointing outcomes may be attributed to the short half&#x02010;life, systemic toxicity, restricted administration routes, suboptimal therapeutic efficacy, emerging resistance mechanisms, and tumor heterogeneity [<xref rid="cac270067-bib-0015" ref-type="bibr">15</xref>, <xref rid="cac270067-bib-0020" ref-type="bibr">20</xref>, <xref rid="cac270067-bib-0021" ref-type="bibr">21</xref>]. In the future, nanomaterials, ADCs, engineered bacterial alternatives, alternative strategies (e.g., ENPP1 antagonists), combination strategies, and biomarker&#x02010;guided precision therapies may revolutionize the development of cancer immunotherapy.</p></sec><sec id="cac270067-sec-0460"><title>AUTHOR CONTRIBUTIONS</title><p>Yuheng Yan conducted publication collection, analysis, and drafted the manuscript. Ximin Tan, Bin Song, and Ming Yi participated in the analysis and interpretation of publications. Qian Chu and Kongming Wu designed this review and revised the manuscript. All of the authors reviewed and approved this manuscript.</p></sec><sec sec-type="COI-statement" id="cac270067-sec-0480"><title>CONFLICT OF INTEREST STATEMENT</title><p>The authors declare no competing interests.</p></sec><sec id="cac270067-sec-0510"><title>ETHICS APPROVAL AND CONSENT TO PARTICIPATE</title><p>Not applicable.</p></sec></body><back><ack id="cac270067-sec-0470"><title>ACKNOWLEDGEMENT</title><p>This work was supported by the National Natural Science Foundation of China (Grant numbers: 82272794, 82573178, and 82472969) and grants from the Research and Innovation Team Project for Scientific Breakthroughs at Shanxi Bethune Hospital (Grant number: 2024AOXIANG04).</p></ack><sec sec-type="data-availability" id="cac270067-sec-0500"><title>DATA AVAILABILITY STATEMENT</title><p>Not applicable.</p></sec><ref-list id="cac270067-bibl-0001"><title>REFERENCES</title><ref id="cac270067-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="cac270067-cite-0002">
<string-name>
<surname>Paul</surname>
<given-names>WE</given-names>
</string-name>, <string-name>
<surname>Germain</surname>
<given-names>RN</given-names>
</string-name>. <article-title>Obituary: Charles A. Janeway Jr (1943&#x02010;2003)</article-title>. <source>Nature</source>. <year>2003</year>;<volume>423</volume>(<issue>6937</issue>):<fpage>237</fpage>.<pub-id pub-id-type="pmid">12748629</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="cac270067-cite-0003">
<string-name>
<surname>Ishikawa</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Barber</surname>
<given-names>GN</given-names>
</string-name>. <article-title>STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling</article-title>. <source>Nature</source>. <year>2008</year>;<volume>455</volume>(<issue>7213</issue>):<fpage>674</fpage>&#x02010;<lpage>8</lpage>.<pub-id pub-id-type="pmid">18724357</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="cac270067-cite-0004">
<string-name>
<surname>Sun</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Du</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>ZJ</given-names>
</string-name>. <article-title>Cyclic GMP&#x02010;AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway</article-title>. <source>Science</source>. <year>2013</year>;<volume>339</volume>(<issue>6121</issue>):<fpage>786</fpage>&#x02010;<lpage>91</lpage>.<pub-id pub-id-type="pmid">23258413</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="cac270067-cite-0005">
<string-name>
<surname>Wu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Du</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Shi</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>C</given-names>
</string-name>, et&#x000a0;al. <article-title>Cyclic GMP&#x02010;AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA</article-title>. <source>Science</source>. <year>2013</year>;<volume>339</volume>(<issue>6121</issue>):<fpage>826</fpage>&#x02010;<lpage>30</lpage>.<pub-id pub-id-type="pmid">23258412</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="cac270067-cite-0006">
<string-name>
<surname>Shang</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>ZJ</given-names>
</string-name>, <string-name>
<surname>Bai</surname>
<given-names>XC</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>X</given-names>
</string-name>. <article-title>Cryo&#x02010;EM structures of STING reveal its mechanism of activation by cyclic GMP&#x02010;AMP</article-title>. <source>Nature</source>. <year>2019</year>;<volume>567</volume>(<issue>7748</issue>):<fpage>389</fpage>&#x02010;<lpage>93</lpage>.<pub-id pub-id-type="pmid">30842659</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="cac270067-cite-0007">
<string-name>
<surname>Zhang</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>C</given-names>
</string-name>. <article-title>Regulation of cGAS&#x02010;STING signalling and its diversity of cellular outcomes</article-title>. <source>Nat Rev Immunol</source>. <year>2025</year>;<volume>25</volume>(<issue>6</issue>):<fpage>425</fpage>&#x02010;<lpage>44</lpage>.<pub-id pub-id-type="pmid">39774812</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="cac270067-cite-0008">
<string-name>
<surname>Chen</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>P</given-names>
</string-name>. <article-title>Cellular functions of cGAS&#x02010;STING signaling</article-title>. <source>Trends Cell Biol</source>. <year>2023</year>;<volume>33</volume>(<issue>8</issue>):<fpage>630</fpage>&#x02010;<lpage>48</lpage>.<pub-id pub-id-type="pmid">36437149</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="cac270067-cite-0009">
<string-name>
<surname>Gui</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Tan</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Shi</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>M</given-names>
</string-name>, et&#x000a0;al. <article-title>Autophagy induction via STING trafficking is a primordial function of the cGAS pathway</article-title>. <source>Nature</source>. <year>2019</year>;<volume>567</volume>(<issue>7747</issue>):<fpage>262</fpage>&#x02010;<lpage>6</lpage>.<pub-id pub-id-type="pmid">30842662</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="cac270067-cite-0010">
<string-name>
<surname>Settembre</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Di Malta</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Polito</surname>
<given-names>VA</given-names>
</string-name>, <string-name>
<surname>Garcia Arencibia</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Vetrini</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Erdin</surname>
<given-names>S</given-names>
</string-name>, et&#x000a0;al. <article-title>TFEB links autophagy to lysosomal biogenesis</article-title>. <source>Science</source>. <year>2011</year>;<volume>332</volume>(<issue>6036</issue>):<fpage>1429</fpage>&#x02010;<lpage>33</lpage>.<pub-id pub-id-type="pmid">21617040</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="cac270067-cite-0011">
<string-name>
<surname>Dou</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Ghosh</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Vizioli</surname>
<given-names>MG</given-names>
</string-name>, <string-name>
<surname>Zhu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Sen</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Wangensteen</surname>
<given-names>KJ</given-names>
</string-name>, et&#x000a0;al. <article-title>Cytoplasmic chromatin triggers inflammation in senescence and cancer</article-title>. <source>Nature</source>. <year>2017</year>;<volume>550</volume>(<issue>7676</issue>):<fpage>402</fpage>&#x02010;<lpage>6</lpage>.<pub-id pub-id-type="pmid">28976970</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="cac270067-cite-0012">
<string-name>
<surname>Li</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Yi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Qin</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Song</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Chu</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>K</given-names>
</string-name>. <article-title>Activating cGAS&#x02010;STING pathway for the optimal effect of cancer immunotherapy</article-title>. <source>J Hematol Oncol</source>. <year>2019</year>;<volume>12</volume>(<issue>1</issue>):<fpage>35</fpage>.<pub-id pub-id-type="pmid">30935414</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="cac270067-cite-0013">
<string-name>
<surname>Decout</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Katz</surname>
<given-names>JD</given-names>
</string-name>, <string-name>
<surname>Venkatraman</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Ablasser</surname>
<given-names>A</given-names>
</string-name>. <article-title>The cGAS&#x02010;STING pathway as a therapeutic target in inflammatory diseases</article-title>. <source>Nat Rev Immunol</source>. <year>2021</year>;<volume>21</volume>(<issue>9</issue>):<fpage>548</fpage>&#x02010;<lpage>69</lpage>.<pub-id pub-id-type="pmid">33833439</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="cac270067-cite-0014">
<string-name>
<surname>Goldbach&#x02010;Mansky</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Alehashemi</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>de</surname>
<given-names>Jesus AA</given-names>
</string-name>. <article-title>Emerging concepts and treatments in autoinflammatory interferonopathies and monogenic systemic lupus erythematosus</article-title>. <source>Nat Rev Rheumatol</source>. <year>2025</year>;<volume>21</volume>(<issue>1</issue>):<fpage>22</fpage>&#x02010;<lpage>45</lpage>.<pub-id pub-id-type="pmid">39623155</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="cac270067-cite-0015">
<string-name>
<surname>Wang</surname>
<given-names>MM</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Fan</surname>
<given-names>RR</given-names>
</string-name>, <string-name>
<surname>Tang</surname>
<given-names>YQ</given-names>
</string-name>, <string-name>
<surname>Guo</surname>
<given-names>ZY</given-names>
</string-name>, et&#x000a0;al. <article-title>The role of the cGAS&#x02010;STING signaling pathway in viral infections, inflammatory and autoimmune diseases</article-title>. <source>Acta Pharmacol Sin</source>. <year>2024</year>;<volume>45</volume>(<issue>10</issue>):<fpage>1997</fpage>&#x02010;<lpage>2010</lpage>.<pub-id pub-id-type="pmid">38822084</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="cac270067-cite-0016">
<string-name>
<surname>Zhao</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Yan</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>Y</given-names>
</string-name>, et&#x000a0;al. <article-title>Inflammation and tumor progression: signaling pathways and targeted intervention</article-title>. <source>Signal Transduct Target Ther</source>. <year>2021</year>;<volume>6</volume>(<issue>1</issue>):<fpage>263</fpage>.<pub-id pub-id-type="pmid">34248142</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="cac270067-cite-0017">
<string-name>
<surname>Chen</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Qu</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Pan</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Cheng</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Xue</surname>
<given-names>X</given-names>
</string-name>. <article-title>Manganese&#x02010;coordinated nanoparticle with high drug&#x02010;loading capacity and synergistic photo&#x02010;/immuno&#x02010;therapy for cancer treatments</article-title>. <source>Biomaterials</source>. <year>2025</year>;<volume>312</volume>:<elocation-id>122745</elocation-id>.<pub-id pub-id-type="pmid">39098306</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="cac270067-cite-0018">
<string-name>
<surname>Chen</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Agustinus</surname>
<given-names>AS</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>DiBona</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Bakhoum</surname>
<given-names>SF</given-names>
</string-name>. <article-title>Chromosomal instability as a driver of cancer progression</article-title>. <source>Nat Rev Genet</source>. <year>2025</year>;<volume>26</volume>(<issue>1</issue>):<fpage>31</fpage>&#x02010;<lpage>46</lpage>.<pub-id pub-id-type="pmid">39075192</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="cac270067-cite-0019">
<string-name>
<surname>Li</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Hubisz</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Earlie</surname>
<given-names>EM</given-names>
</string-name>, <string-name>
<surname>Duran</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Hong</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Varela</surname>
<given-names>AA</given-names>
</string-name>, et&#x000a0;al. <article-title>Non&#x02010;cell&#x02010;autonomous cancer progression from chromosomal instability</article-title>. <source>Nature</source>. <year>2023</year>;<volume>620</volume>(<issue>7976</issue>):<fpage>1080</fpage>&#x02010;<lpage>8</lpage>.<pub-id pub-id-type="pmid">37612508</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="cac270067-cite-0020">
<string-name>
<surname>Song</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Pan</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Shen</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Ye</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>G</given-names>
</string-name>, et&#x000a0;al. <article-title>Targeting tumor monocyte&#x02010;intrinsic PD&#x02010;L1 by rewiring STING signaling and enhancing STING agonist therapy</article-title>. <source>Cancer Cell</source>. <year>2025</year>;<volume>43</volume>(<issue>3</issue>):<fpage>503</fpage>&#x02010;<lpage>18</lpage>.e10.<pub-id pub-id-type="pmid">40068600</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="cac270067-cite-0021">
<string-name>
<surname>Lai</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Bancaro</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Troiani</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Cal&#x000ec;</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>Y</given-names>
</string-name>, et&#x000a0;al. <article-title>Mitochondrial DNA released by senescent tumor cells enhances PMN&#x02010;MDSC&#x02010;driven immunosuppression through the cGAS&#x02010;STING pathway</article-title>. <source>Immunity</source>. <year>2025</year>;<volume>58</volume>(<issue>4</issue>):<fpage>811</fpage>&#x02010;<lpage>25</lpage>.e7.<pub-id pub-id-type="pmid">40203808</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="cac270067-cite-0022">
<string-name>
<surname>Meric&#x02010;Bernstam</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Sweis</surname>
<given-names>RF</given-names>
</string-name>, <string-name>
<surname>Hodi</surname>
<given-names>FS</given-names>
</string-name>, <string-name>
<surname>Messersmith</surname>
<given-names>WA</given-names>
</string-name>, <string-name>
<surname>Andtbacka</surname>
<given-names>RHI</given-names>
</string-name>, <string-name>
<surname>Ingham</surname>
<given-names>M</given-names>
</string-name>, et&#x000a0;al. <article-title>Phase I Dose&#x02010;Escalation Trial of MIW815 (ADU&#x02010;S100), an Intratumoral STING Agonist, in Patients with Advanced/Metastatic Solid Tumors or Lymphomas</article-title>. <source>Clin Cancer Res</source>. <year>2022</year>;<volume>28</volume>(<issue>4</issue>):<fpage>677</fpage>&#x02010;<lpage>88</lpage>.<pub-id pub-id-type="pmid">34716197</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="cac270067-cite-0023">
<string-name>
<surname>Li</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Mirlekar</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Johnson</surname>
<given-names>BM</given-names>
</string-name>, <string-name>
<surname>Brickey</surname>
<given-names>WJ</given-names>
</string-name>, <string-name>
<surname>Wrobel</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>N</given-names>
</string-name>, et&#x000a0;al. <article-title>STING&#x02010;induced regulatory B cells compromise NK function in cancer immunity</article-title>. <source>Nature</source>. <year>2022</year>;<volume>610</volume>(<issue>7931</issue>):<fpage>373</fpage>&#x02010;<lpage>80</lpage>.<pub-id pub-id-type="pmid">36198789</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="cac270067-cite-0024">
<string-name>
<surname>Hopfner</surname>
<given-names>KP</given-names>
</string-name>, <string-name>
<surname>Hornung</surname>
<given-names>V</given-names>
</string-name>. <article-title>Molecular mechanisms and cellular functions of cGAS&#x02010;STING signalling</article-title>. <source>Nat Rev Mol Cell Biol</source>. <year>2020</year>;<volume>21</volume>(<issue>9</issue>):<fpage>501</fpage>&#x02010;<lpage>21</lpage>.<pub-id pub-id-type="pmid">32424334</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="cac270067-cite-0025">
<string-name>
<surname>Pathare</surname>
<given-names>GR</given-names>
</string-name>, <string-name>
<surname>Decout</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Gluck</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Cavadini</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Makasheva</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Hovius</surname>
<given-names>R</given-names>
</string-name>, et&#x000a0;al. <article-title>Structural mechanism of cGAS inhibition by the nucleosome</article-title>. <source>Nature</source>. <year>2020</year>;<volume>587</volume>(<issue>7835</issue>):<fpage>668</fpage>&#x02010;<lpage>72</lpage>.<pub-id pub-id-type="pmid">32911482</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="cac270067-cite-0026">
<string-name>
<surname>Zhao</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Rowlett</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Jing</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Shinde</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Lei</surname>
<given-names>Y</given-names>
</string-name>, et&#x000a0;al. <article-title>The molecular basis of tight nuclear tethering and inactivation of cGAS</article-title>. <source>Nature</source>. <year>2020</year>;<volume>587</volume>(<issue>7835</issue>):<fpage>673</fpage>&#x02010;<lpage>7</lpage>.<pub-id pub-id-type="pmid">32911481</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="cac270067-cite-0027">
<string-name>
<surname>Kranzusch</surname>
<given-names>PJ</given-names>
</string-name>. <article-title>cGAS and CD&#x02010;NTase enzymes: structure, mechanism, and evolution</article-title>. <source>Curr Opin Struct Biol</source>. <year>2019</year>;<volume>59</volume>:<fpage>178</fpage>&#x02010;<lpage>87</lpage>.<pub-id pub-id-type="pmid">31593902</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="cac270067-cite-0028">
<string-name>
<surname>Li</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Shu</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Yi</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Chaton</surname>
<given-names>CT</given-names>
</string-name>, <string-name>
<surname>Shelton</surname>
<given-names>CL</given-names>
</string-name>, <string-name>
<surname>Diao</surname>
<given-names>J</given-names>
</string-name>, et&#x000a0;al. <article-title>Cyclic GMP&#x02010;AMP synthase is activated by double&#x02010;stranded DNA&#x02010;induced oligomerization</article-title>. <source>Immunity</source>. <year>2013</year>;<volume>39</volume>(<issue>6</issue>):<fpage>1019</fpage>&#x02010;<lpage>31</lpage>.<pub-id pub-id-type="pmid">24332030</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="cac270067-cite-0029">
<string-name>
<surname>Zhang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Du</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>Z</given-names>
</string-name>, et&#x000a0;al. <article-title>The cytosolic DNA sensor cGAS forms an oligomeric complex with DNA and undergoes switch&#x02010;like conformational changes in the activation loop</article-title>. <source>Cell Rep</source>. <year>2014</year>;<volume>6</volume>(<issue>3</issue>):<fpage>421</fpage>&#x02010;<lpage>30</lpage>.<pub-id pub-id-type="pmid">24462292</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="cac270067-cite-0030">
<string-name>
<surname>Shu</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Yi</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Watts</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Kao</surname>
<given-names>CC</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>P</given-names>
</string-name>. <article-title>Structure of STING bound to cyclic di&#x02010;GMP reveals the mechanism of cyclic dinucleotide recognition by the immune system</article-title>. <source>Nat Struct Mol Biol</source>. <year>2012</year>;<volume>19</volume>(<issue>7</issue>):<fpage>722</fpage>&#x02010;<lpage>4</lpage>.<pub-id pub-id-type="pmid">22728658</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="cac270067-cite-0031">
<string-name>
<surname>Liu</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Cai</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Cong</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>T</given-names>
</string-name>, et&#x000a0;al. <article-title>Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation</article-title>. <source>Science</source>. <year>2015</year>;<volume>347</volume>(<issue>6227</issue>):<elocation-id>aaa2630</elocation-id>.<pub-id pub-id-type="pmid">25636800</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="cac270067-cite-0032">
<string-name>
<surname>Zhang</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Shang</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Gui</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Bai</surname>
<given-names>XC</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>ZJ</given-names>
</string-name>. <article-title>Structural basis of STING binding with and phosphorylation by TBK1</article-title>. <source>Nature</source>. <year>2019</year>;<volume>567</volume>(<issue>7748</issue>):<fpage>394</fpage>&#x02010;<lpage>8</lpage>.<pub-id pub-id-type="pmid">30842653</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="cac270067-cite-0033">
<string-name>
<surname>Abdullah</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Frugier</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Bedoui</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Taylor</surname>
<given-names>JM</given-names>
</string-name>, <article-title>Crack PJ. STING&#x02010;mediated type&#x02010;I interferons contribute to the neuroinflammatory process and detrimental effects following traumatic brain injury</article-title>. <source>J Neuroinflammation</source>. <year>2018</year>;<volume>15</volume>(<issue>1</issue>):<fpage>323</fpage>.<pub-id pub-id-type="pmid">30463579</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="cac270067-cite-0034">
<string-name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Gong</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Peng</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>Z</given-names>
</string-name>, et&#x000a0;al. <article-title>Activation of the STING pathway induces peripheral sensitization via neuroinflammation in a rat model of bone cancer pain</article-title>. <source>Inflamm Res</source>. <year>2023</year>;<volume>72</volume>(<issue>1</issue>):<fpage>117</fpage>&#x02010;<lpage>32</lpage>.<pub-id pub-id-type="pmid">36346430</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="cac270067-cite-0035">
<string-name>
<surname>Blaauboer</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Gabrielle</surname>
<given-names>VD</given-names>
</string-name>, <string-name>
<surname>Jin</surname>
<given-names>L</given-names>
</string-name>. <article-title>MPYS/STING&#x02010;mediated TNF&#x02010;&#x003b1;, not type I IFN, is essential for the mucosal adjuvant activity of (3&#x02032;&#x02010;5&#x02032;)&#x02010;cyclic&#x02010;di&#x02010;guanosine&#x02010;monophosphate in vivo</article-title>. <source>J Immunol</source>. <year>2014</year>;<volume>192</volume>(<issue>1</issue>):<fpage>492</fpage>&#x02010;<lpage>502</lpage>.<pub-id pub-id-type="pmid">24307739</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="cac270067-cite-0036">
<string-name>
<surname>Yum</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Fang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>ZJ</given-names>
</string-name>. <article-title>TBK1 recruitment to STING activates both IRF3 and NF&#x02010;&#x003ba;B that mediate immune defense against tumors and viral infections</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2021</year>;<volume>118</volume>(<issue>14</issue>):<elocation-id>e2100225118</elocation-id>.<pub-id pub-id-type="pmid">33785602</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="cac270067-cite-0037">
<string-name>
<surname>Balka</surname>
<given-names>KR</given-names>
</string-name>, <string-name>
<surname>Louis</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Saunders</surname>
<given-names>TL</given-names>
</string-name>, <string-name>
<surname>Smith</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Calleja</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>D'Silva</surname>
<given-names>DB</given-names>
</string-name>, et&#x000a0;al., <article-title>TBK1 and IKKepsilon Act Redundantly to Mediate STING&#x02010;Induced NF&#x02010;kappaB Responses in Myeloid Cells</article-title>. <source>Cell Rep</source>. <year>2020</year>;<volume>31</volume>(<issue>1</issue>):<elocation-id>107492</elocation-id>.<pub-id pub-id-type="pmid">32268090</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="cac270067-cite-0038">
<string-name>
<surname>Qin</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Cai</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Cao</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Bai</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Yuan</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</string-name>, et&#x000a0;al. <article-title>Listerin promotes cGAS protein degradation through the ESCRT pathway to negatively regulate cGAS&#x02010;mediated immune response</article-title>. <source>Proc Natl Acad Sci U S A.</source>
<year>2023</year>;<volume>120</volume>(<issue>52</issue>):<elocation-id>e2308853120</elocation-id>.<pub-id pub-id-type="pmid">38109536</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0038"><label>38</label><mixed-citation publication-type="journal" id="cac270067-cite-0039">
<string-name>
<surname>Ma</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Bai</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Jiang</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Zhu</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Pan</surname>
<given-names>M</given-names>
</string-name>, et&#x000a0;al. <article-title>Tegument protein UL21 of alpha&#x02010;herpesvirus inhibits the innate immunity by triggering CGAS degradation through TOLLIP&#x02010;mediated selective autophagy</article-title>. <source>Autophagy</source>. <year>2023</year>;<volume>19</volume>(<issue>5</issue>):<fpage>1512</fpage>&#x02010;<lpage>32</lpage>.<pub-id pub-id-type="pmid">36343628</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="cac270067-cite-0040">
<string-name>
<surname>Seo</surname>
<given-names>GJ</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Shin</surname>
<given-names>WJ</given-names>
</string-name>, <string-name>
<surname>Sklan</surname>
<given-names>EH</given-names>
</string-name>, <string-name>
<surname>Eoh</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Jung</surname>
<given-names>JU</given-names>
</string-name>. <article-title>TRIM56&#x02010;mediated monoubiquitination of cGAS for cytosolic DNA sensing</article-title>. <source>Nat Commun</source>. <year>2018</year>;<volume>9</volume>(<issue>1</issue>):<fpage>613</fpage>.<pub-id pub-id-type="pmid">29426904</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0040"><label>40</label><mixed-citation publication-type="journal" id="cac270067-cite-0041">
<string-name>
<surname>Liu</surname>
<given-names>ZS</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>ZY</given-names>
</string-name>, <string-name>
<surname>Cai</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Mao</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Dai</surname>
<given-names>J</given-names>
</string-name>, et&#x000a0;al. <article-title>RINCK&#x02010;mediated monoubiquitination of cGAS promotes antiviral innate immune responses</article-title>. <source>Cell Biosci</source>. <year>2018</year>;<volume>8</volume>:<fpage>35</fpage>.<pub-id pub-id-type="pmid">29760876</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0041"><label>41</label><mixed-citation publication-type="journal" id="cac270067-cite-0042">
<string-name>
<surname>Zhang</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Tang</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>An</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Ye</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Zhong</surname>
<given-names>B</given-names>
</string-name>. <article-title>USP29 maintains the stability of cGAS and promotes cellular antiviral responses and autoimmunity</article-title>. <source>Cell Res</source>. <year>2020</year>;<volume>30</volume>(<issue>10</issue>):<fpage>914</fpage>&#x02010;<lpage>27</lpage>.<pub-id pub-id-type="pmid">32457395</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0042"><label>42</label><mixed-citation publication-type="journal" id="cac270067-cite-0043">
<string-name>
<surname>Guo</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Jiang</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Kong</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>L</given-names>
</string-name>, et&#x000a0;al. <article-title>Cutting Edge: USP27X Deubiquitinates and Stabilizes the DNA Sensor cGAS to Regulate Cytosolic DNA&#x02010;Mediated Signaling</article-title>. <source>J Immunol</source>. <year>2019</year>;<volume>203</volume>(<issue>8</issue>):<fpage>2049</fpage>&#x02010;<lpage>54</lpage>.<pub-id pub-id-type="pmid">31534008</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0043"><label>43</label><mixed-citation publication-type="journal" id="cac270067-cite-0044">
<string-name>
<surname>Hu</surname>
<given-names>MM</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Xie</surname>
<given-names>XQ</given-names>
</string-name>, <string-name>
<surname>Liao</surname>
<given-names>CY</given-names>
</string-name>, <string-name>
<surname>Lin</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>TT</given-names>
</string-name>, et&#x000a0;al. <article-title>Sumoylation Promotes the Stability of the DNA Sensor cGAS and the Adaptor STING to Regulate the Kinetics of Response to DNA Virus</article-title>. <source>Immunity</source>. <year>2016</year>;<volume>45</volume>(<issue>3</issue>):<fpage>555</fpage>&#x02010;<lpage>69</lpage>.<pub-id pub-id-type="pmid">27637147</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0044"><label>44</label><mixed-citation publication-type="journal" id="cac270067-cite-0045">
<string-name>
<surname>Xiong</surname>
<given-names>TC</given-names>
</string-name>, <string-name>
<surname>Wei</surname>
<given-names>MC</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>FX</given-names>
</string-name>, <string-name>
<surname>Shi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Gan</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Tang</surname>
<given-names>Z</given-names>
</string-name>, et&#x000a0;al. <article-title>The E3 ubiquitin ligase ARIH1 promotes antiviral immunity and autoimmunity by inducing mono&#x02010;ISGylation and oligomerization of cGAS</article-title>. <source>Nat Commun</source>. <year>2022</year>;<volume>13</volume>(<issue>1</issue>):<fpage>5973</fpage>.<pub-id pub-id-type="pmid">36217001</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0045"><label>45</label><mixed-citation publication-type="journal" id="cac270067-cite-0046">
<string-name>
<surname>Chu</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Qian</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Duan</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Ding</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>W</given-names>
</string-name>, et&#x000a0;al. <article-title>HERC5&#x02010;catalyzed ISGylation potentiates cGAS&#x02010;mediated innate immunity</article-title>. <source>Cell Rep</source>. <year>2024</year>;<volume>43</volume>(<issue>3</issue>):<elocation-id>113870</elocation-id>.<pub-id pub-id-type="pmid">38421872</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0046"><label>46</label><mixed-citation publication-type="journal" id="cac270067-cite-0047">
<string-name>
<surname>Zhong</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Hu</surname>
<given-names>MM</given-names>
</string-name>, <string-name>
<surname>Bian</surname>
<given-names>LJ</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Shu</surname>
<given-names>HB</given-names>
</string-name>. <article-title>Phosphorylation of cGAS by CDK1 impairs self&#x02010;DNA sensing in mitosis</article-title>. <source>Cell Discov</source>. <year>2020</year>;<volume>6</volume>:<fpage>26</fpage>.<pub-id pub-id-type="pmid">32351706</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0047"><label>47</label><mixed-citation publication-type="journal" id="cac270067-cite-0048">
<string-name>
<surname>Seo</surname>
<given-names>GJ</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Tan</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Liang</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Choi</surname>
<given-names>Y</given-names>
</string-name>, et&#x000a0;al. <article-title>Akt Kinase&#x02010;Mediated Checkpoint of cGAS DNA Sensing Pathway</article-title>. <source>Cell Rep</source>. <year>2015</year>;<volume>13</volume>(<issue>2</issue>):<fpage>440</fpage>&#x02010;<lpage>9</lpage>.<pub-id pub-id-type="pmid">26440888</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0048"><label>48</label><mixed-citation publication-type="journal" id="cac270067-cite-0049">
<string-name>
<surname>Konno</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Konno</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Barber</surname>
<given-names>GN</given-names>
</string-name>. <article-title>Cyclic dinucleotides trigger ULK1 (ATG1) phosphorylation of STING to prevent sustained innate immune signaling</article-title>. <source>Cell</source>. <year>2013</year>;<volume>155</volume>(<issue>3</issue>):<fpage>688</fpage>&#x02010;<lpage>98</lpage>.<pub-id pub-id-type="pmid">24119841</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0049"><label>49</label><mixed-citation publication-type="journal" id="cac270067-cite-0050">
<string-name>
<surname>Fan</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Gao</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Nie</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Hou</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Dan</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>Z</given-names>
</string-name>, et&#x000a0;al. <article-title>Targeting LYPLAL1&#x02010;mediated cGAS depalmitoylation enhances the response to anti&#x02010;tumor immunotherapy</article-title>. <source>Mol Cell</source>. <year>2023</year>;<volume>83</volume>(<issue>19</issue>):<fpage>3520</fpage>&#x02010;<lpage>32</lpage> e7.<pub-id pub-id-type="pmid">37802025</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0050"><label>50</label><mixed-citation publication-type="journal" id="cac270067-cite-0051">
<string-name>
<surname>Mukai</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Konno</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Akiba</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Uemura</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Waguri</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kobayashi</surname>
<given-names>T</given-names>
</string-name>, et&#x000a0;al. <article-title>Activation of STING requires palmitoylation at the Golgi</article-title>. <source>Nat Commun</source>. <year>2016</year>;<volume>7</volume>:<elocation-id>11932</elocation-id>.<pub-id pub-id-type="pmid">27324217</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0051"><label>51</label><mixed-citation publication-type="journal" id="cac270067-cite-0052">
<string-name>
<surname>Dai</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>YJ</given-names>
</string-name>, <string-name>
<surname>He</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>ZS</given-names>
</string-name>, et&#x000a0;al. <article-title>Acetylation Blocks cGAS Activity and Inhibits Self&#x02010;DNA&#x02010;Induced Autoimmunity</article-title>. <source>Cell</source>. <year>2019</year>;<volume>176</volume>(<issue>6</issue>):<fpage>1447</fpage>&#x02010;<lpage>60</lpage> e14.<pub-id pub-id-type="pmid">30799039</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0052"><label>52</label><mixed-citation publication-type="journal" id="cac270067-cite-0053">
<string-name>
<surname>Song</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Greco</surname>
<given-names>TM</given-names>
</string-name>, <string-name>
<surname>Lum</surname>
<given-names>KK</given-names>
</string-name>, <string-name>
<surname>Taber</surname>
<given-names>CE</given-names>
</string-name>, <article-title>Cristea IM. The DNA Sensor cGAS is Decorated by Acetylation and Phosphorylation Modifications in the Context of Immune Signaling</article-title>. <source>Mol Cell Proteomics</source>. <year>2020</year>;<volume>19</volume>(<issue>7</issue>):<fpage>1193</fpage>&#x02010;<lpage>208</lpage>.<pub-id pub-id-type="pmid">32345711</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0053"><label>53</label><mixed-citation publication-type="journal" id="cac270067-cite-0054">
<string-name>
<surname>Song</surname>
<given-names>ZM</given-names>
</string-name>, <string-name>
<surname>Lin</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Yi</surname>
<given-names>XM</given-names>
</string-name>, <string-name>
<surname>Guo</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Hu</surname>
<given-names>MM</given-names>
</string-name>, <string-name>
<surname>Shu</surname>
<given-names>HB</given-names>
</string-name>. <article-title>KAT5 acetylates cGAS to promote innate immune response to DNA virus</article-title>. <source>Proc Natl Acad Sci U S A.</source>
<year>2020</year>;<volume>117</volume>(<issue>35</issue>):<fpage>21568</fpage>&#x02010;<lpage>75</lpage>.<pub-id pub-id-type="pmid">32817552</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0054"><label>54</label><mixed-citation publication-type="journal" id="cac270067-cite-0055">
<string-name>
<surname>Wang</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Pan</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Qiu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Shen</surname>
<given-names>S</given-names>
</string-name>, et&#x000a0;al. <article-title>IL&#x02010;33/ST2 antagonizes STING signal transduction via autophagy in response to acetaminophen&#x02010;mediated toxicological immunity</article-title>. <source>Cell Commun Signal</source>. <year>2023</year>;<volume>21</volume>(<issue>1</issue>):<fpage>80</fpage>.<pub-id pub-id-type="pmid">37081450</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0055"><label>55</label><mixed-citation publication-type="journal" id="cac270067-cite-0056">
<string-name>
<surname>Li</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Ran</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>Q</given-names>
</string-name>, et&#x000a0;al. <article-title>AARS1 and AARS2 sense L&#x02010;lactate to regulate cGAS as global lysine lactyltransferases</article-title>. <source>Nature</source>. <year>2024</year>;<volume>634</volume>(<issue>8036</issue>):<fpage>1229</fpage>&#x02010;<lpage>37</lpage>.<pub-id pub-id-type="pmid">39322678</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0056"><label>56</label><mixed-citation publication-type="journal" id="cac270067-cite-0057">
<string-name>
<surname>Wang</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Chang</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Ma</surname>
<given-names>M</given-names>
</string-name>, et&#x000a0;al. <article-title>Cytoplasmic PARP1 links the genome instability to the inhibition of antiviral immunity through PARylating cGAS</article-title>. <source>Mol Cell</source>. <year>2022</year>;<volume>82</volume>(<issue>11</issue>):<fpage>2032</fpage>&#x02010;<lpage>49</lpage> e7.<pub-id pub-id-type="pmid">35460603</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0057"><label>57</label><mixed-citation publication-type="journal" id="cac270067-cite-0058">
<string-name>
<surname>Li</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Kang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Jiang</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Gong</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>L</given-names>
</string-name>, et&#x000a0;al. <article-title>4&#x02010;octyl itaconate as a metabolite derivative inhibits inflammation via alkylation of STING</article-title>. <source>Cell Rep</source>. <year>2023</year>;<volume>42</volume>(<issue>3</issue>):<elocation-id>112145</elocation-id>.<pub-id pub-id-type="pmid">36862550</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0058"><label>58</label><mixed-citation publication-type="journal" id="cac270067-cite-0059">
<string-name>
<surname>Falahat</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Berglund</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Putney</surname>
<given-names>RM</given-names>
</string-name>, <string-name>
<surname>Perez&#x02010;Villarroel</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Aoyama</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Pilon&#x02010;Thomas</surname>
<given-names>S</given-names>
</string-name>, et&#x000a0;al. <article-title>Epigenetic reprogramming of tumor cell&#x02010;intrinsic STING function sculpts antigenicity and T cell recognition of melanoma</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2021</year>;<volume>118</volume>(<issue>15</issue>):<elocation-id>e2013598118</elocation-id>.<pub-id pub-id-type="pmid">33827917</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0059"><label>59</label><mixed-citation publication-type="journal" id="cac270067-cite-0060">
<string-name>
<surname>Xia</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Konno</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Barber</surname>
<given-names>GN</given-names>
</string-name>. <article-title>Recurrent Loss of STING Signaling in Melanoma Correlates with Susceptibility to Viral Oncolysis</article-title>. <source>Cancer Res</source>. <year>2016</year>;<volume>76</volume>(<issue>22</issue>):<fpage>6747</fpage>&#x02010;<lpage>59</lpage>.<pub-id pub-id-type="pmid">27680683</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0060"><label>60</label><mixed-citation publication-type="journal" id="cac270067-cite-0061">
<string-name>
<surname>de Queiroz</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Xia</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Konno</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Barber</surname>
<given-names>GN</given-names>
</string-name>. <article-title>Ovarian Cancer Cells Commonly Exhibit Defective STING Signaling Which Affects Sensitivity to Viral Oncolysis</article-title>. <source>Mol Cancer Res</source>. <year>2019</year>;<volume>17</volume>(<issue>4</issue>):<fpage>974</fpage>&#x02010;<lpage>86</lpage>.<pub-id pub-id-type="pmid">30587523</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0061"><label>61</label><mixed-citation publication-type="journal" id="cac270067-cite-0062">
<string-name>
<surname>Xia</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Konno</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Ahn</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Barber</surname>
<given-names>GN</given-names>
</string-name>. <article-title>Deregulation of STING Signaling in Colorectal Carcinoma Constrains DNA Damage Responses and Correlates With Tumorigenesis</article-title>. <source>Cell Rep</source>. <year>2016</year>;<volume>14</volume>(<issue>2</issue>):<fpage>282</fpage>&#x02010;<lpage>97</lpage>.<pub-id pub-id-type="pmid">26748708</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0062"><label>62</label><mixed-citation publication-type="journal" id="cac270067-cite-0063">
<string-name>
<surname>Konno</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Yamauchi</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Berglund</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Putney</surname>
<given-names>RM</given-names>
</string-name>, <string-name>
<surname>Mule</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>Barber</surname>
<given-names>GN</given-names>
</string-name>. <article-title>Suppression of STING signaling through epigenetic silencing and missense mutation impedes DNA damage mediated cytokine production</article-title>. <source>Oncogene</source>. <year>2018</year>;<volume>37</volume>(<issue>15</issue>):<fpage>2037</fpage>&#x02010;<lpage>51</lpage>.<pub-id pub-id-type="pmid">29367762</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0063"><label>63</label><mixed-citation publication-type="journal" id="cac270067-cite-0064">
<string-name>
<surname>Wu</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Kondo</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Kammula</surname>
<given-names>AV</given-names>
</string-name>, <string-name>
<surname>Shi</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Xiao</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Dhiab</surname>
<given-names>S</given-names>
</string-name>, et&#x000a0;al. <article-title>Mutant IDH1 inhibition induces dsDNA sensing to activate tumor immunity</article-title>. <source>Science</source>. <year>2024</year>;<volume>385</volume>(<issue>6705</issue>):<elocation-id>eadl6173</elocation-id>.<pub-id pub-id-type="pmid">38991060</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0064"><label>64</label><mixed-citation publication-type="journal" id="cac270067-cite-0065">
<string-name>
<surname>Tsai</surname>
<given-names>YC</given-names>
</string-name>, <string-name>
<surname>Hsieh</surname>
<given-names>TH</given-names>
</string-name>, <string-name>
<surname>Liao</surname>
<given-names>YR</given-names>
</string-name>, <string-name>
<surname>Tsai</surname>
<given-names>MT</given-names>
</string-name>, <string-name>
<surname>Lin</surname>
<given-names>TP</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>DY</given-names>
</string-name>, et&#x000a0;al. <article-title>METTL3&#x02010;Mediated N6&#x02010;methyladenosine mRNA Modification and cGAS&#x02010;STING Pathway Activity in Kidney Fibrosis</article-title>. <source>J Am Soc Nephrol</source>. <year>2024</year>;<volume>35</volume>(<issue>10</issue>):<fpage>1312</fpage>&#x02010;<lpage>29</lpage>.<pub-id pub-id-type="pmid">39352860</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0065"><label>65</label><mixed-citation publication-type="journal" id="cac270067-cite-0066">
<string-name>
<surname>Fang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Hao</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Yu</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Gu</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Peng</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Zhuo</surname>
<given-names>H</given-names>
</string-name>, et&#x000a0;al. <article-title>Methionine restriction promotes cGAS activation and chromatin untethering through demethylation to enhance antitumor immunity</article-title>. <source>Cancer Cell</source>. <year>2023</year>;<volume>41</volume>(<issue>6</issue>):<fpage>1118</fpage>&#x02010;<lpage>33</lpage> e12.<pub-id pub-id-type="pmid">37267951</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0066"><label>66</label><mixed-citation publication-type="journal" id="cac270067-cite-0067">
<string-name>
<surname>Liu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Bu</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Chu</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Dai</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Asara</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Sicinski</surname>
<given-names>P</given-names>
</string-name>, et&#x000a0;al. <article-title>PRMT1 mediated methylation of cGAS suppresses anti&#x02010;tumor immunity</article-title>. <source>Nat Commun</source>. <year>2023</year>;<volume>14</volume>(<issue>1</issue>):<fpage>2806</fpage>.<pub-id pub-id-type="pmid">37193698</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0067"><label>67</label><mixed-citation publication-type="journal" id="cac270067-cite-0068">
<string-name>
<surname>Du</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>ZJ</given-names>
</string-name>. <article-title>DNA&#x02010;induced liquid phase condensation of cGAS activates innate immune signaling</article-title>. <source>Science</source>. <year>2018</year>;<volume>361</volume>(<issue>6403</issue>):<fpage>704</fpage>&#x02010;<lpage>9</lpage>.<pub-id pub-id-type="pmid">29976794</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0068"><label>68</label><mixed-citation publication-type="journal" id="cac270067-cite-0069">
<string-name>
<surname>Ablasser</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Hemmerling</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Schmid&#x02010;Burgk</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Behrendt</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Roers</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Hornung</surname>
<given-names>V</given-names>
</string-name>. <article-title>TREX1 deficiency triggers cell&#x02010;autonomous immunity in a cGAS&#x02010;dependent manner</article-title>. <source>J Immunol</source>. <year>2014</year>;<volume>192</volume>(<issue>12</issue>):<fpage>5993</fpage>&#x02010;<lpage>7</lpage>.<pub-id pub-id-type="pmid">24813208</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0069"><label>69</label><mixed-citation publication-type="journal" id="cac270067-cite-0070">
<string-name>
<surname>Toufektchan</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Dananberg</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Striepen</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Hickling</surname>
<given-names>JH</given-names>
</string-name>, <string-name>
<surname>Shim</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>Y</given-names>
</string-name>, et&#x000a0;al. <article-title>Intratumoral TREX1 Induction Promotes Immune Evasion by Limiting Type I IFN</article-title>. <source>Cancer Immunol Res</source>. <year>2024</year>;<volume>12</volume>(<issue>6</issue>):<fpage>673</fpage>&#x02010;<lpage>86</lpage>.<pub-id pub-id-type="pmid">38408184</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0070"><label>70</label><mixed-citation publication-type="journal" id="cac270067-cite-0071">
<string-name>
<surname>Lim</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Rodriguez</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Williams</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Silva</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Gutierrez</surname>
<given-names>AG</given-names>
</string-name>, <string-name>
<surname>Tyler</surname>
<given-names>P</given-names>
</string-name>, et&#x000a0;al. <article-title>The Exonuclease TREX1 Constitutes an Innate Immune Checkpoint Limiting cGAS/STING&#x02010;Mediated Antitumor Immunity</article-title>. <source>Cancer Immunol Res</source>. <year>2024</year>;<volume>12</volume>(<issue>6</issue>):<fpage>663</fpage>&#x02010;<lpage>72</lpage>.<pub-id pub-id-type="pmid">38489753</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0071"><label>71</label><mixed-citation publication-type="journal" id="cac270067-cite-0072">
<string-name>
<surname>Ahn</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Gutman</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Saijo</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Barber</surname>
<given-names>GN</given-names>
</string-name>. <article-title>STING manifests self DNA&#x02010;dependent inflammatory disease</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2012</year>;<volume>109</volume>(<issue>47</issue>):<fpage>19386</fpage>&#x02010;<lpage>91</lpage>.<pub-id pub-id-type="pmid">23132945</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0072"><label>72</label><mixed-citation publication-type="journal" id="cac270067-cite-0073">
<string-name>
<surname>Gao</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>XD</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>QZ</given-names>
</string-name>, <string-name>
<surname>Wight&#x02010;Carter</surname>
<given-names>M</given-names>
</string-name>, et&#x000a0;al. <article-title>Activation of cyclic GMP&#x02010;AMP synthase by self&#x02010;DNA causes autoimmune diseases</article-title>. <source>Proc Natl Acad Sci U S A.</source>
<year>2015</year>;<volume>112</volume>(<issue>42</issue>):<fpage>E5699</fpage>&#x02010;<lpage>705</lpage>.<pub-id pub-id-type="pmid">26371324</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0073"><label>73</label><mixed-citation publication-type="journal" id="cac270067-cite-0074">
<string-name>
<surname>Chen</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>ZG</given-names>
</string-name>, <string-name>
<surname>Luo</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Manne</surname>
<given-names>RK</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Hsu</surname>
<given-names>CC</given-names>
</string-name>, et&#x000a0;al. <article-title>NSUN2 is a glucose sensor suppressing cGAS/STING to maintain tumorigenesis and immunotherapy resistance</article-title>. <source>Cell Metab</source>. <year>2023</year>;<volume>35</volume>(<issue>10</issue>):<fpage>1782</fpage>&#x02010;<lpage>98</lpage> e8.<pub-id pub-id-type="pmid">37586363</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0074"><label>74</label><mixed-citation publication-type="journal" id="cac270067-cite-0075">
<string-name>
<surname>Harding</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Benci</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Irianto</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Discher</surname>
<given-names>DE</given-names>
</string-name>, <string-name>
<surname>Minn</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Greenberg</surname>
<given-names>RA</given-names>
</string-name>. <article-title>Mitotic progression following DNA damage enables pattern recognition within micronuclei</article-title>. <source>Nature</source>. <year>2017</year>;<volume>548</volume>(<issue>7668</issue>):<fpage>466</fpage>&#x02010;<lpage>70</lpage>.<pub-id pub-id-type="pmid">28759889</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0075"><label>75</label><mixed-citation publication-type="journal" id="cac270067-cite-0076">
<string-name>
<surname>Mackenzie</surname>
<given-names>KJ</given-names>
</string-name>, <string-name>
<surname>Carroll</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Martin</surname>
<given-names>CA</given-names>
</string-name>, <string-name>
<surname>Murina</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Fluteau</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Simpson</surname>
<given-names>DJ</given-names>
</string-name>, et&#x000a0;al. <article-title>cGAS surveillance of micronuclei links genome instability to innate immunity</article-title>. <source>Nature</source>. <year>2017</year>;<volume>548</volume>(<issue>7668</issue>):<fpage>461</fpage>&#x02010;<lpage>5</lpage>.<pub-id pub-id-type="pmid">28738408</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0076"><label>76</label><mixed-citation publication-type="journal" id="cac270067-cite-0077">
<string-name>
<surname>Hatch</surname>
<given-names>EM</given-names>
</string-name>, <string-name>
<surname>Fischer</surname>
<given-names>AH</given-names>
</string-name>, <string-name>
<surname>Deerinck</surname>
<given-names>TJ</given-names>
</string-name>, <string-name>
<surname>Hetzer</surname>
<given-names>MW</given-names>
</string-name>. <article-title>Catastrophic nuclear envelope collapse in cancer cell micronuclei</article-title>. <source>Cell</source>. <year>2013</year>;<volume>154</volume>(<issue>1</issue>):<fpage>47</fpage>&#x02010;<lpage>60</lpage>.<pub-id pub-id-type="pmid">23827674</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0077"><label>77</label><mixed-citation publication-type="journal" id="cac270067-cite-0078">
<string-name>
<surname>Gluck</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Guey</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Gulen</surname>
<given-names>MF</given-names>
</string-name>, <string-name>
<surname>Wolter</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Kang</surname>
<given-names>TW</given-names>
</string-name>, <string-name>
<surname>Schmacke</surname>
<given-names>NA</given-names>
</string-name>, et&#x000a0;al. <article-title>Innate immune sensing of cytosolic chromatin fragments through cGAS promotes senescence</article-title>. <source>Nat Cell Biol</source>. <year>2017</year>;<volume>19</volume>(<issue>9</issue>):<fpage>1061</fpage>&#x02010;<lpage>70</lpage>.<pub-id pub-id-type="pmid">28759028</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0078"><label>78</label><mixed-citation publication-type="journal" id="cac270067-cite-0079">
<string-name>
<surname>Denais</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Gilbert</surname>
<given-names>RM</given-names>
</string-name>, <string-name>
<surname>Isermann</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>McGregor</surname>
<given-names>AL</given-names>
</string-name>, <string-name>
<surname>te Lindert</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Weigelin</surname>
<given-names>B</given-names>
</string-name>, et&#x000a0;al. <article-title>Nuclear envelope rupture and repair during cancer cell migration</article-title>. <source>Science</source>. <year>2016</year>;<volume>352</volume>(<issue>6283</issue>):<fpage>353</fpage>&#x02010;<lpage>8</lpage>.<pub-id pub-id-type="pmid">27013428</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0079"><label>79</label><mixed-citation publication-type="journal" id="cac270067-cite-0080">
<string-name>
<surname>Frittoli</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Palamidessi</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Iannelli</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Zanardi</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Villa</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Barzaghi</surname>
<given-names>L</given-names>
</string-name>, et&#x000a0;al. <article-title>Tissue fluidification promotes a cGAS&#x02010;STING cytosolic DNA response in invasive breast cancer</article-title>. <source>Nat Mater</source>. <year>2023</year>;<volume>22</volume>(<issue>5</issue>):<fpage>644</fpage>&#x02010;<lpage>55</lpage>.<pub-id pub-id-type="pmid">36581770</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0080"><label>80</label><mixed-citation publication-type="journal" id="cac270067-cite-0081">
<string-name>
<surname>West</surname>
<given-names>AP</given-names>
</string-name>, <string-name>
<surname>Khoury&#x02010;Hanold</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Staron</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Tal</surname>
<given-names>MC</given-names>
</string-name>, <string-name>
<surname>Pineda</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Lang</surname>
<given-names>SM</given-names>
</string-name>, et&#x000a0;al. <article-title>Mitochondrial DNA stress primes the antiviral innate immune response</article-title>. <source>Nature</source>. <year>2015</year>;<volume>520</volume>(<issue>7548</issue>):<fpage>553</fpage>&#x02010;<lpage>7</lpage>.<pub-id pub-id-type="pmid">25642965</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0081"><label>81</label><mixed-citation publication-type="journal" id="cac270067-cite-0082">
<string-name>
<surname>Luo</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Yu</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Tan</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>M</given-names>
</string-name>. <article-title>Gasdermin E benefits CD8(+)T cell mediated anti&#x02010;immunity through mitochondrial damage to activate cGAS&#x02010;STING&#x02010;interferonbeta axis in colorectal cancer</article-title>. <source>Biomark Res</source>. <year>2024</year>;<volume>12</volume>(<issue>1</issue>):<fpage>59</fpage>.<pub-id pub-id-type="pmid">38853246</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0082"><label>82</label><mixed-citation publication-type="journal" id="cac270067-cite-0083">
<string-name>
<surname>Boyer</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Spangler</surname>
<given-names>CJ</given-names>
</string-name>, <string-name>
<surname>Strauss</surname>
<given-names>JD</given-names>
</string-name>, <string-name>
<surname>Cesmat</surname>
<given-names>AP</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>McGinty</surname>
<given-names>RK</given-names>
</string-name>, et&#x000a0;al. <article-title>Structural basis of nucleosome&#x02010;dependent cGAS inhibition</article-title>. <source>Science</source>. <year>2020</year>;<volume>370</volume>(<issue>6515</issue>):<fpage>450</fpage>&#x02010;<lpage>4</lpage>.<pub-id pub-id-type="pmid">32913000</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0083"><label>83</label><mixed-citation publication-type="journal" id="cac270067-cite-0084">
<string-name>
<surname>Cao</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Han</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Fan</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>RM</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>X</given-names>
</string-name>. <article-title>Structural basis for nucleosome&#x02010;mediated inhibition of cGAS activity</article-title>. <source>Cell Res</source>. <year>2020</year>;<volume>30</volume>(<issue>12</issue>):<fpage>1088</fpage>&#x02010;<lpage>97</lpage>.<pub-id pub-id-type="pmid">33051594</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0084"><label>84</label><mixed-citation publication-type="journal" id="cac270067-cite-0085">
<string-name>
<surname>Michalski</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>de Oliveira Mann</surname>
<given-names>CC</given-names>
</string-name>, <string-name>
<surname>Stafford</surname>
<given-names>CA</given-names>
</string-name>, <string-name>
<surname>Witte</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Bartho</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Lammens</surname>
<given-names>K</given-names>
</string-name>, et&#x000a0;al. <article-title>Structural basis for sequestration and autoinhibition of cGAS by chromatin</article-title>. <source>Nature</source>. <year>2020</year>;<volume>587</volume>(<issue>7835</issue>):<fpage>678</fpage>&#x02010;<lpage>82</lpage>.<pub-id pub-id-type="pmid">32911480</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0085"><label>85</label><mixed-citation publication-type="journal" id="cac270067-cite-0086">
<string-name>
<surname>Sun</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Mei</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>F</given-names>
</string-name>, et&#x000a0;al. <article-title>A Nuclear Export Signal Is Required for cGAS to Sense Cytosolic DNA</article-title>. <source>Cell Rep</source>. <year>2021</year>;<volume>34</volume>(<issue>1</issue>):<elocation-id>108586</elocation-id>.<pub-id pub-id-type="pmid">33406424</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0086"><label>86</label><mixed-citation publication-type="journal" id="cac270067-cite-0087">
<string-name>
<surname>Luo</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Lu</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Zhu</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Cui</surname>
<given-names>W</given-names>
</string-name>, et&#x000a0;al. <article-title>Nuclear translocation of cGAS orchestrates VEGF&#x02010;A&#x02010;mediated angiogenesis</article-title>. <source>Cell Rep</source>. <year>2023</year>;<volume>42</volume>(<issue>4</issue>):<elocation-id>112328</elocation-id>.<pub-id pub-id-type="pmid">37027305</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0087"><label>87</label><mixed-citation publication-type="journal" id="cac270067-cite-0088">
<string-name>
<surname>Liu</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Ma</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>L</given-names>
</string-name>, et&#x000a0;al. <article-title>Nuclear cGAS suppresses DNA repair and promotes tumorigenesis</article-title>. <source>Nature</source>. <year>2018</year>;<volume>563</volume>(<issue>7729</issue>):<fpage>131</fpage>&#x02010;<lpage>6</lpage>.<pub-id pub-id-type="pmid">30356214</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0088"><label>88</label><mixed-citation publication-type="journal" id="cac270067-cite-0089">
<string-name>
<surname>Dvorkin</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Cambier</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Volkman</surname>
<given-names>HE</given-names>
</string-name>, <string-name>
<surname>Stetson</surname>
<given-names>DB</given-names>
</string-name>. <article-title>New frontiers in the cGAS&#x02010;STING intracellular DNA&#x02010;sensing pathway</article-title>. <source>Immunity</source>. <year>2024</year>;<volume>57</volume>(<issue>4</issue>):<fpage>718</fpage>&#x02010;<lpage>30</lpage>.<pub-id pub-id-type="pmid">38599167</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0089"><label>89</label><mixed-citation publication-type="journal" id="cac270067-cite-0090">
<string-name>
<surname>Ablasser</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Schmid&#x02010;Burgk</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Hemmerling</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Horvath</surname>
<given-names>GL</given-names>
</string-name>, <string-name>
<surname>Schmidt</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Latz</surname>
<given-names>E</given-names>
</string-name>, et&#x000a0;al. <article-title>Cell intrinsic immunity spreads to bystander cells via the intercellular transfer of cGAMP</article-title>. <source>Nature</source>. <year>2013</year>;<volume>503</volume>(<issue>7477</issue>):<fpage>530</fpage>&#x02010;<lpage>4</lpage>.<pub-id pub-id-type="pmid">24077100</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0090"><label>90</label><mixed-citation publication-type="journal" id="cac270067-cite-0091">
<string-name>
<surname>Xie</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Patel</surname>
<given-names>DJ</given-names>
</string-name>. <article-title>Structure&#x02010;based mechanisms of 2&#x02032;3&#x02032;&#x02010;cGAMP intercellular transport in the cGAS&#x02010;STING immune pathway</article-title>. <source>Trends Immunol</source>. <year>2023</year>;<volume>44</volume>(<issue>6</issue>):<fpage>450</fpage>&#x02010;<lpage>67</lpage>.<pub-id pub-id-type="pmid">37147228</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0091"><label>91</label><mixed-citation publication-type="journal" id="cac270067-cite-0092">
<string-name>
<surname>Gentili</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kowal</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Tkach</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Satoh</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Lahaye</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Conrad</surname>
<given-names>C</given-names>
</string-name>, et&#x000a0;al. <article-title>Transmission of innate immune signaling by packaging of cGAMP in viral particles</article-title>. <source>Science</source>. <year>2015</year>;<volume>349</volume>(<issue>6253</issue>):<fpage>1232</fpage>&#x02010;<lpage>6</lpage>.<pub-id pub-id-type="pmid">26229115</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0092"><label>92</label><mixed-citation publication-type="journal" id="cac270067-cite-0093">
<string-name>
<surname>Bridgeman</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Maelfait</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Davenne</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Partridge</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Peng</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Mayer</surname>
<given-names>A</given-names>
</string-name>, et&#x000a0;al. <article-title>Viruses transfer the antiviral second messenger cGAMP between cells</article-title>. <source>Science</source>. <year>2015</year>;<volume>349</volume>(<issue>6253</issue>):<fpage>1228</fpage>&#x02010;<lpage>32</lpage>.<pub-id pub-id-type="pmid">26229117</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0093"><label>93</label><mixed-citation publication-type="journal" id="cac270067-cite-0094">
<string-name>
<surname>Carozza</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Bohnert</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Nguyen</surname>
<given-names>KC</given-names>
</string-name>, <string-name>
<surname>Skariah</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Shaw</surname>
<given-names>KE</given-names>
</string-name>, <string-name>
<surname>Brown</surname>
<given-names>JA</given-names>
</string-name>, et&#x000a0;al. <article-title>Extracellular cGAMP is a cancer cell&#x02010;produced immunotransmitter involved in radiation&#x02010;induced anti&#x02010;cancer immunity</article-title>. <source>Nat Cancer</source>. <year>2020</year>;<volume>1</volume>(<issue>2</issue>):<fpage>184</fpage>&#x02010;<lpage>96</lpage>.<pub-id pub-id-type="pmid">33768207</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0094"><label>94</label><mixed-citation publication-type="journal" id="cac270067-cite-0095">
<string-name>
<surname>Shinde</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Boyer</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Cambier</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>VanPortfliet</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>Sui</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Yadav</surname>
<given-names>GP</given-names>
</string-name>, et&#x000a0;al. <article-title>Structures of ATP&#x02010;binding cassette transporter ABCC1 reveal the molecular basis of cyclic dinucleotide cGAMP export</article-title>. <source>Immunity</source>. <year>2025</year>;<volume>58</volume>(<issue>1</issue>):<fpage>59</fpage>&#x02010;<lpage>73</lpage> e5.<pub-id pub-id-type="pmid">39765229</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0095"><label>95</label><mixed-citation publication-type="journal" id="cac270067-cite-0096">
<string-name>
<surname>Maltbaek</surname>
<given-names>JH</given-names>
</string-name>, <string-name>
<surname>Cambier</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Snyder</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Stetson</surname>
<given-names>DB</given-names>
</string-name>. <article-title>ABCC1 transporter exports the immunostimulatory cyclic dinucleotide cGAMP</article-title>. <source>Immunity</source>. <year>2022</year>;<volume>55</volume>(<issue>10</issue>):<fpage>1799</fpage>&#x02010;<lpage>812</lpage> e4.<pub-id pub-id-type="pmid">36070769</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0096"><label>96</label><mixed-citation publication-type="journal" id="cac270067-cite-0097">
<string-name>
<surname>Lahey</surname>
<given-names>LJ</given-names>
</string-name>, <string-name>
<surname>Mardjuki</surname>
<given-names>RE</given-names>
</string-name>, <string-name>
<surname>Wen</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Hess</surname>
<given-names>GT</given-names>
</string-name>, <string-name>
<surname>Ritchie</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Carozza</surname>
<given-names>JA</given-names>
</string-name>, et&#x000a0;al. <article-title>LRRC8A:C/E Heteromeric Channels Are Ubiquitous Transporters of cGAMP</article-title>. <source>Mol Cell</source>. <year>2020</year>;<volume>80</volume>(<issue>4</issue>):<fpage>578</fpage>&#x02010;<lpage>91</lpage> e5.<pub-id pub-id-type="pmid">33171122</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0097"><label>97</label><mixed-citation publication-type="journal" id="cac270067-cite-0098">
<string-name>
<surname>Zhou</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Planells&#x02010;Cases</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Chu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Cao</surname>
<given-names>L</given-names>
</string-name>, et&#x000a0;al. <article-title>Transfer of cGAMP into Bystander Cells via LRRC8 Volume&#x02010;Regulated Anion Channels Augments STING&#x02010;Mediated Interferon Responses and Anti&#x02010;viral Immunity</article-title>. <source>Immunity</source>. <year>2020</year>;<volume>52</volume>(<issue>5</issue>):<fpage>767</fpage>&#x02010;<lpage>81</lpage> e6.<pub-id pub-id-type="pmid">32277911</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0098"><label>98</label><mixed-citation publication-type="journal" id="cac270067-cite-0099">
<string-name>
<surname>Wei</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Hou</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>Z</given-names>
</string-name>, et&#x000a0;al. <article-title>LL&#x02010;37 transports immunoreactive cGAMP to activate STING signaling and enhance interferon&#x02010;mediated host antiviral immunity</article-title>. <source>Cell Rep</source>. <year>2022</year>;<volume>39</volume>(<issue>9</issue>):<elocation-id>110880</elocation-id>.<pub-id pub-id-type="pmid">35649354</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0099"><label>99</label><mixed-citation publication-type="journal" id="cac270067-cite-0100">
<string-name>
<surname>Luteijn</surname>
<given-names>RD</given-names>
</string-name>, <string-name>
<surname>Zaver</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>Gowen</surname>
<given-names>BG</given-names>
</string-name>, <string-name>
<surname>Wyman</surname>
<given-names>SK</given-names>
</string-name>, <string-name>
<surname>Garelis</surname>
<given-names>NE</given-names>
</string-name>, <string-name>
<surname>Onia</surname>
<given-names>L</given-names>
</string-name>, et&#x000a0;al. <article-title>SLC19A1 transports immunoreactive cyclic dinucleotides</article-title>. <source>Nature</source>. <year>2019</year>;<volume>573</volume>(<issue>7774</issue>):<fpage>434</fpage>&#x02010;<lpage>8</lpage>.<pub-id pub-id-type="pmid">31511694</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0100"><label>100</label><mixed-citation publication-type="journal" id="cac270067-cite-0101">
<string-name>
<surname>Ritchie</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Cordova</surname>
<given-names>AF</given-names>
</string-name>, <string-name>
<surname>Hess</surname>
<given-names>GT</given-names>
</string-name>, <string-name>
<surname>Bassik</surname>
<given-names>MC</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>L</given-names>
</string-name>. <article-title>SLC19A1 Is an Importer of the Immunotransmitter cGAMP</article-title>. <source>Mol Cell</source>. <year>2019</year>;<volume>75</volume>(<issue>2</issue>):<fpage>372</fpage>&#x02010;<lpage>81</lpage> e5.<pub-id pub-id-type="pmid">31126740</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0101"><label>101</label><mixed-citation publication-type="journal" id="cac270067-cite-0102">
<string-name>
<surname>Zhou</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Fei</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Liang</surname>
<given-names>WC</given-names>
</string-name>, <string-name>
<surname>Lin</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>Y</given-names>
</string-name>, et&#x000a0;al. <article-title>Blockade of the Phagocytic Receptor MerTK on Tumor&#x02010;Associated Macrophages Enhances P2&#x000d7;7R&#x02010;Dependent STING Activation by Tumor&#x02010;Derived cGAMP</article-title>. <source>Immunity</source>. <year>2020</year>;<volume>52</volume>(<issue>2</issue>):<fpage>357</fpage>&#x02010;<lpage>73</lpage> e9.<pub-id pub-id-type="pmid">32049051</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0102"><label>102</label><mixed-citation publication-type="journal" id="cac270067-cite-0103">
<string-name>
<surname>Kato</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Nishimasu</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Oikawa</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Hirano</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Hirano</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Kasuya</surname>
<given-names>G</given-names>
</string-name>, et&#x000a0;al. <article-title>Structural insights into cGAMP degradation by Ecto&#x02010;nucleotide pyrophosphatase phosphodiesterase 1</article-title>. <source>Nat Commun</source>. <year>2018</year>;<volume>9</volume>(<issue>1</issue>):<fpage>4424</fpage>.<pub-id pub-id-type="pmid">30356045</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0103"><label>103</label><mixed-citation publication-type="journal" id="cac270067-cite-0104">
<string-name>
<surname>Carozza</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Cordova</surname>
<given-names>AF</given-names>
</string-name>, <string-name>
<surname>Brown</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>AlSaif</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Bohnert</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Cao</surname>
<given-names>X</given-names>
</string-name>, et&#x000a0;al. <article-title>ENPP1's regulation of extracellular cGAMP is a ubiquitous mechanism of attenuating STING signaling</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2022</year>;<volume>119</volume>(<issue>21</issue>):<elocation-id>e2119189119</elocation-id>.<pub-id pub-id-type="pmid">35588451</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0104"><label>104</label><mixed-citation publication-type="journal" id="cac270067-cite-0105">
<string-name>
<surname>Wang</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Bohnert</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Joseph</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Sudaryo</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Skariah</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Swinderman</surname>
<given-names>JT</given-names>
</string-name>, et&#x000a0;al. <article-title>ENPP1 is an innate immune checkpoint of the anticancer cGAMP&#x02010;STING pathway in breast cancer</article-title>. <source>Proc Natl Acad Sci U S A.</source>
<year>2023</year>;<volume>120</volume>(<issue>52</issue>):<elocation-id>e2313693120</elocation-id>.<pub-id pub-id-type="pmid">38117852</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0105"><label>105</label><mixed-citation publication-type="journal" id="cac270067-cite-0106">
<string-name>
<surname>An</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Zhu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Xie</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Feng</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Gong</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Fan</surname>
<given-names>Q</given-names>
</string-name>, et&#x000a0;al. <article-title>Tumor Exosomal ENPP1 Hydrolyzes cGAMP to Inhibit cGAS&#x02010;STING Signaling</article-title>. <source>Adv Sci (Weinh)</source>. <year>2024</year>;<volume>11</volume>(<issue>20</issue>):<elocation-id>e2308131</elocation-id>.<pub-id pub-id-type="pmid">38498770</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0106"><label>106</label><mixed-citation publication-type="journal" id="cac270067-cite-0107">
<string-name>
<surname>Hou</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Wei</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Fan</surname>
<given-names>S</given-names>
</string-name>, et&#x000a0;al. <article-title>SMPDL3A is a cGAMP&#x02010;degrading enzyme induced by LXR&#x02010;mediated lipid metabolism to restrict cGAS&#x02010;STING DNA sensing</article-title>. <source>Immunity</source>. <year>2023</year>;<volume>56</volume>(<issue>11</issue>):<fpage>2492</fpage>&#x02010;<lpage>507</lpage> e10.<pub-id pub-id-type="pmid">37890481</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0107"><label>107</label><mixed-citation publication-type="journal" id="cac270067-cite-0108">
<string-name>
<surname>Mardjuki</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Carozza</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Zirak</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Subramanyam</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Abhiraman</surname>
<given-names>G</given-names>
</string-name>, et&#x000a0;al. <article-title>Identification of the extracellular membrane protein ENPP3 as a major cGAMP hydrolase and innate immune checkpoint</article-title>. <source>Cell Rep</source>. <year>2024</year>;<volume>43</volume>(<issue>5</issue>):<elocation-id>114209</elocation-id>.<pub-id pub-id-type="pmid">38749434</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0108"><label>108</label><mixed-citation publication-type="journal" id="cac270067-cite-0109">
<string-name>
<surname>Zhou</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Qin</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Liao</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</string-name>, et&#x000a0;al. <article-title>Targeting USP1 Potentiates Radiation&#x02010;Induced Type I IFN&#x02010;Dependent Antitumor Immunity by Enhancing Oligo&#x02010;Ubiquitinated SAR1A&#x02010;Mediated STING Trafficking and Activation</article-title>. <source>Adv Sci (Weinh)</source>. <year>2025</year>:<elocation-id>e2412687</elocation-id>.<pub-id pub-id-type="pmid">39976106</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0109"><label>109</label><mixed-citation publication-type="journal" id="cac270067-cite-0110">
<string-name>
<surname>Zhang</surname>
<given-names>BC</given-names>
</string-name>, <string-name>
<surname>Nandakumar</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Reinert</surname>
<given-names>LS</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Laustsen</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Gao</surname>
<given-names>ZL</given-names>
</string-name>, et&#x000a0;al. <article-title>STEEP mediates STING ER exit and activation of signaling</article-title>. <source>Nat Immunol</source>. <year>2020</year>;<volume>21</volume>(<issue>8</issue>):<fpage>868</fpage>&#x02010;<lpage>79</lpage>.<pub-id pub-id-type="pmid">32690950</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0110"><label>110</label><mixed-citation publication-type="journal" id="cac270067-cite-0111">
<string-name>
<surname>Luo</surname>
<given-names>WW</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Lian</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Zhong</surname>
<given-names>B</given-names>
</string-name>, et&#x000a0;al. <article-title>iRhom2 is essential for innate immunity to DNA viruses by mediating trafficking and stability of the adaptor STING</article-title>. <source>Nat Immunol</source>. <year>2016</year>;<volume>17</volume>(<issue>9</issue>):<fpage>1057</fpage>&#x02010;<lpage>66</lpage>.<pub-id pub-id-type="pmid">27428826</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0111"><label>111</label><mixed-citation publication-type="journal" id="cac270067-cite-0112">
<string-name>
<surname>Ran</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Xiong</surname>
<given-names>MG</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>ZS</given-names>
</string-name>, <string-name>
<surname>Luo</surname>
<given-names>WW</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>SY</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>YY</given-names>
</string-name>. <article-title>YIPF5 Is Essential for Innate Immunity to DNA Virus and Facilitates COPII&#x02010;Dependent STING Trafficking</article-title>. <source>J Immunol</source>. <year>2019</year>;<volume>203</volume>(<issue>6</issue>):<fpage>1560</fpage>&#x02010;<lpage>70</lpage>.<pub-id pub-id-type="pmid">31391232</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0112"><label>112</label><mixed-citation publication-type="journal" id="cac270067-cite-0113">
<string-name>
<surname>Schiantarelli</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Benamar</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Park</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Sax</surname>
<given-names>HE</given-names>
</string-name>, <string-name>
<surname>Oliveira</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Bosma&#x02010;Moody</surname>
<given-names>A</given-names>
</string-name>, et&#x000a0;al. <article-title>Genomic mediators of acquired resistance to immunotherapy in metastatic melanoma</article-title>. <source>Cancer Cell</source>. <year>2025</year>;<volume>43</volume>(<issue>2</issue>):<fpage>308</fpage>&#x02010;<lpage>16</lpage> e6.<pub-id pub-id-type="pmid">39933900</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0113"><label>113</label><mixed-citation publication-type="journal" id="cac270067-cite-0114">
<string-name>
<surname>Srikanth</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Woo</surname>
<given-names>JS</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>El&#x02010;Sherbiny</surname>
<given-names>YM</given-names>
</string-name>, <string-name>
<surname>Leung</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Chupradit</surname>
<given-names>K</given-names>
</string-name>, et&#x000a0;al. <article-title>The Ca(2+) sensor STIM1 regulates the type I interferon response by retaining the signaling adaptor STING at the endoplasmic reticulum</article-title>. <source>Nat Immunol</source>. <year>2019</year>;<volume>20</volume>(<issue>2</issue>):<fpage>152</fpage>&#x02010;<lpage>62</lpage>.<pub-id pub-id-type="pmid">30643259</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0114"><label>114</label><mixed-citation publication-type="journal" id="cac270067-cite-0115">
<string-name>
<surname>Zhang</surname>
<given-names>CX</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Baloche</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>JX</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>BW</given-names>
</string-name>, et&#x000a0;al. <article-title>Galectin&#x02010;9 promotes a suppressive microenvironment in human cancer by enhancing STING degradation</article-title>. <source>Oncogenesis</source>. <year>2020</year>;<volume>9</volume>(<issue>7</issue>):<fpage>65</fpage>.<pub-id pub-id-type="pmid">32632113</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0115"><label>115</label><mixed-citation publication-type="journal" id="cac270067-cite-0116">
<string-name>
<surname>Tao</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Yin</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Han</surname>
<given-names>D</given-names>
</string-name>, et&#x000a0;al. <article-title>UFL1 promotes antiviral immune response by maintaining STING stability independent of UFMylation</article-title>. <source>Cell Death Differ</source>. <year>2023</year>;<volume>30</volume>(<issue>1</issue>):<fpage>16</fpage>&#x02010;<lpage>26</lpage>.<pub-id pub-id-type="pmid">35871231</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0116"><label>116</label><mixed-citation publication-type="journal" id="cac270067-cite-0117">
<string-name>
<surname>Li</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Yu</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Fang</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>Z</given-names>
</string-name>, et&#x000a0;al. <article-title>The transmembrane endoplasmic reticulum&#x02010;associated E3 ubiquitin ligase TRIM13 restrains the pathogenic&#x02010;DNA&#x02010;triggered inflammatory response</article-title>. <source>Sci Adv</source>. <year>2022</year>;<volume>8</volume>(<issue>4</issue>):<elocation-id>eabh0496</elocation-id>.<pub-id pub-id-type="pmid">35080984</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0117"><label>117</label><mixed-citation publication-type="journal" id="cac270067-cite-0118">
<string-name>
<surname>Ji</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Luo</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Xue</surname>
<given-names>Z</given-names>
</string-name>, et&#x000a0;al. <article-title>SEL1L&#x02010;HRD1 endoplasmic reticulum&#x02010;associated degradation controls STING&#x02010;mediated innate immunity by limiting the size of the activable STING pool</article-title>. <source>Nat Cell Biol</source>. <year>2023</year>;<volume>25</volume>(<issue>5</issue>):<fpage>726</fpage>&#x02010;<lpage>39</lpage>.<pub-id pub-id-type="pmid">37142791</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0118"><label>118</label><mixed-citation publication-type="journal" id="cac270067-cite-0119">
<string-name>
<surname>Pokatayev</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Tu</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Dobbs</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Kalb</surname>
<given-names>RG</given-names>
</string-name>, et&#x000a0;al. <article-title>Homeostatic regulation of STING protein at the resting state by stabilizer TOLLIP</article-title>. <source>Nat Immunol</source>. <year>2020</year>;<volume>21</volume>(<issue>2</issue>):<fpage>158</fpage>&#x02010;<lpage>67</lpage>.<pub-id pub-id-type="pmid">31932809</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0119"><label>119</label><mixed-citation publication-type="journal" id="cac270067-cite-0120">
<string-name>
<surname>Deng</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Chong</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Law</surname>
<given-names>CS</given-names>
</string-name>, <string-name>
<surname>Mukai</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Ho</surname>
<given-names>FO</given-names>
</string-name>, <string-name>
<surname>Martinu</surname>
<given-names>T</given-names>
</string-name>, et&#x000a0;al. <article-title>A defect in COPI&#x02010;mediated transport of STING causes immune dysregulation in COPA syndrome</article-title>. <source>J Exp Med</source>. <year>2020</year>;<volume>217</volume>(<issue>11</issue>):<elocation-id>e20201045</elocation-id>.<pub-id pub-id-type="pmid">32725126</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0120"><label>120</label><mixed-citation publication-type="journal" id="cac270067-cite-0121">
<string-name>
<surname>Lepelley</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Martin&#x02010;Niclos</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Le Bihan</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Marsh</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Uggenti</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Rice</surname>
<given-names>GI</given-names>
</string-name>, et&#x000a0;al. <article-title>Mutations in COPA lead to abnormal trafficking of STING to the Golgi and interferon signaling</article-title>. <source>J Exp Med</source>. <year>2020</year>;<volume>217</volume>(<issue>11</issue>):<elocation-id>e20200600</elocation-id>.<pub-id pub-id-type="pmid">32725128</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0121"><label>121</label><mixed-citation publication-type="journal" id="cac270067-cite-0122">
<string-name>
<surname>Mukai</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Ogawa</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Uematsu</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Kuchitsu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Kiku</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Uemura</surname>
<given-names>T</given-names>
</string-name>, et&#x000a0;al. <article-title>Homeostatic regulation of STING by retrograde membrane traffic to the ER</article-title>. <source>Nat Commun</source>. <year>2021</year>;<volume>12</volume>(<issue>1</issue>):<fpage>61</fpage>.<pub-id pub-id-type="pmid">33397928</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0122"><label>122</label><mixed-citation publication-type="journal" id="cac270067-cite-0123">
<string-name>
<surname>Kim</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Hong</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Nam</surname>
<given-names>JH</given-names>
</string-name>, <string-name>
<surname>Yeo</surname>
<given-names>HJ</given-names>
</string-name>, <string-name>
<surname>Cho</surname>
<given-names>WH</given-names>
</string-name>, et&#x000a0;al. <article-title>Novel endogenous endoplasmic reticulum transmembrane protein suppresses cell death by negatively regulating the STING&#x02010;STAT6 axis in myeloid leukemia</article-title>. <source>Cancer Commun (Lond)</source>. <year>2023</year>;<volume>43</volume>(<issue>3</issue>):<fpage>395</fpage>&#x02010;<lpage>9</lpage>.<pub-id pub-id-type="pmid">36336958</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0123"><label>123</label><mixed-citation publication-type="journal" id="cac270067-cite-0124">
<string-name>
<surname>Hirschenberger</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Lepelley</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Rupp</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Klute</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Hunszinger</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Koepke</surname>
<given-names>L</given-names>
</string-name>, et&#x000a0;al. <article-title>ARF1 prevents aberrant type I interferon induction by regulating STING activation and recycling</article-title>. <source>Nat Commun</source>. <year>2023</year>;<volume>14</volume>(<issue>1</issue>):<fpage>6770</fpage>.<pub-id pub-id-type="pmid">37914730</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0124"><label>124</label><mixed-citation publication-type="journal" id="cac270067-cite-0125">
<string-name>
<surname>Gentili</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Papanastasiou</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Dele&#x02010;Oni</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Schwartz</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Carlson</surname>
<given-names>RJ</given-names>
</string-name>, et&#x000a0;al. <article-title>ESCRT&#x02010;dependent STING degradation inhibits steady&#x02010;state and cGAMP&#x02010;induced signalling</article-title>. <source>Nat Commun</source>. <year>2023</year>;<volume>14</volume>(<issue>1</issue>):<fpage>611</fpage>.<pub-id pub-id-type="pmid">36739287</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0125"><label>125</label><mixed-citation publication-type="journal" id="cac270067-cite-0126">
<string-name>
<surname>Liu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Rivara</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Ricci</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Ren</surname>
<given-names>X</given-names>
</string-name>, et&#x000a0;al. <article-title>Clathrin&#x02010;associated AP&#x02010;1 controls termination of STING signalling</article-title>. <source>Nature</source>. <year>2022</year>;<volume>610</volume>(<issue>7933</issue>):<fpage>761</fpage>&#x02010;<lpage>7</lpage>.<pub-id pub-id-type="pmid">36261523</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0126"><label>126</label><mixed-citation publication-type="journal" id="cac270067-cite-0127">
<string-name>
<surname>Chu</surname>
<given-names>TT</given-names>
</string-name>, <string-name>
<surname>Tu</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Repa</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>Yan</surname>
<given-names>N</given-names>
</string-name>. <article-title>Tonic prime&#x02010;boost of STING signalling mediates Niemann&#x02010;Pick disease type C</article-title>. <source>Nature</source>. <year>2021</year>;<volume>596</volume>(<issue>7873</issue>):<fpage>570</fpage>&#x02010;<lpage>5</lpage>.<pub-id pub-id-type="pmid">34290407</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0127"><label>127</label><mixed-citation publication-type="journal" id="cac270067-cite-0128">
<string-name>
<surname>Tu</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Chu</surname>
<given-names>TT</given-names>
</string-name>, <string-name>
<surname>Jeltema</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Abbott</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Xing</surname>
<given-names>C</given-names>
</string-name>, et&#x000a0;al. <article-title>Interruption of post&#x02010;Golgi STING trafficking activates tonic interferon signaling</article-title>. <source>Nat Commun</source>. <year>2022</year>;<volume>13</volume>(<issue>1</issue>):<fpage>6977</fpage>.<pub-id pub-id-type="pmid">36379959</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0128"><label>128</label><mixed-citation publication-type="journal" id="cac270067-cite-0129">
<string-name>
<surname>Schoggins</surname>
<given-names>JW</given-names>
</string-name>, <string-name>
<surname>MacDuff</surname>
<given-names>DA</given-names>
</string-name>, <string-name>
<surname>Imanaka</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Gainey</surname>
<given-names>MD</given-names>
</string-name>, <string-name>
<surname>Shrestha</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Eitson</surname>
<given-names>JL</given-names>
</string-name>, et&#x000a0;al. <article-title>Pan&#x02010;viral specificity of IFN&#x02010;induced genes reveals new roles for cGAS in innate immunity</article-title>. <source>Nature</source>. <year>2014</year>;<volume>505</volume>(<issue>7485</issue>):<fpage>691</fpage>&#x02010;<lpage>5</lpage>.<pub-id pub-id-type="pmid">24284630</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0129"><label>129</label><mixed-citation publication-type="journal" id="cac270067-cite-0130">
<string-name>
<surname>Aguirre</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Luthra</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Sanchez&#x02010;Aparicio</surname>
<given-names>MT</given-names>
</string-name>, <string-name>
<surname>Maestre</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Patel</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Lamothe</surname>
<given-names>F</given-names>
</string-name>, et&#x000a0;al. <article-title>Dengue virus NS2B protein targets cGAS for degradation and prevents mitochondrial DNA sensing during infection</article-title>. <source>Nat Microbiol</source>. <year>2017</year>;<volume>2</volume>:<elocation-id>17037</elocation-id>.<pub-id pub-id-type="pmid">28346446</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0130"><label>130</label><mixed-citation publication-type="journal" id="cac270067-cite-0131">
<string-name>
<surname>Brown Harding</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Kwaku</surname>
<given-names>GN</given-names>
</string-name>, <string-name>
<surname>Reardon</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Khan</surname>
<given-names>NS</given-names>
</string-name>, <string-name>
<surname>Zamith&#x02010;Miranda</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Zarnowski</surname>
<given-names>R</given-names>
</string-name>, et&#x000a0;al. <article-title>Candida albicans extracellular vesicles trigger type I IFN signalling via cGAS and STING</article-title>. <source>Nat Microbiol</source>. <year>2024</year>;<volume>9</volume>(<issue>1</issue>):<fpage>95</fpage>&#x02010;<lpage>107</lpage>.<pub-id pub-id-type="pmid">38168615</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0131"><label>131</label><mixed-citation publication-type="journal" id="cac270067-cite-0132">
<string-name>
<surname>Wu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Dobbs</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Yan</surname>
<given-names>N</given-names>
</string-name>. <article-title>Interferon&#x02010;Independent Activities of Mammalian STING Mediate Antiviral Response and Tumor Immune Evasion</article-title>. <source>Immunity</source>. <year>2020</year>;<volume>53</volume>(<issue>1</issue>):<fpage>115</fpage>&#x02010;<lpage>26</lpage>.e5.<pub-id pub-id-type="pmid">32640258</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0132"><label>132</label><mixed-citation publication-type="journal" id="cac270067-cite-0133">
<string-name>
<surname>Yamashiro</surname>
<given-names>LH</given-names>
</string-name>, <string-name>
<surname>Wilson</surname>
<given-names>SC</given-names>
</string-name>, <string-name>
<surname>Morrison</surname>
<given-names>HM</given-names>
</string-name>, <string-name>
<surname>Karalis</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Chung</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>KJ</given-names>
</string-name>, et&#x000a0;al. <article-title>Interferon&#x02010;independent STING signaling promotes resistance to HSV&#x02010;1 in vivo</article-title>. <source>Nat Commun</source>. <year>2020</year>;<volume>11</volume>(<issue>1</issue>):<fpage>3382</fpage>.<pub-id pub-id-type="pmid">32636381</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0133"><label>133</label><mixed-citation publication-type="journal" id="cac270067-cite-0134">
<string-name>
<surname>Hertzog</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Fowler</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Rigby</surname>
<given-names>RE</given-names>
</string-name>, <string-name>
<surname>Bridgeman</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Blest</surname>
<given-names>HT</given-names>
</string-name>, et&#x000a0;al. <article-title>Varicella&#x02010;Zoster virus ORF9 is an antagonist of the DNA sensor cGAS</article-title>. <source>EMBO J</source>. <year>2022</year>;<volume>41</volume>(<issue>14</issue>):<elocation-id>e109217</elocation-id>.<pub-id pub-id-type="pmid">35670106</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0134"><label>134</label><mixed-citation publication-type="journal" id="cac270067-cite-0135">
<string-name>
<surname>Hobbs</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Nomburg</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Doudna</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Kranzusch</surname>
<given-names>PJ</given-names>
</string-name>. <article-title>Animal and bacterial viruses share conserved mechanisms of immune evasion</article-title>. <source>Cell</source>. <year>2024</year>;<volume>187</volume>(<issue>20</issue>):<fpage>5530</fpage>&#x02010;<lpage>9</lpage>.<pub-id pub-id-type="pmid">39197447</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0135"><label>135</label><mixed-citation publication-type="journal" id="cac270067-cite-0136">
<string-name>
<surname>Fischer</surname>
<given-names>TD</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Padman</surname>
<given-names>BS</given-names>
</string-name>, <string-name>
<surname>Lazarou</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Youle</surname>
<given-names>RJ</given-names>
</string-name>. <article-title>STING induces LC3B lipidation onto single&#x02010;membrane vesicles via the V&#x02010;ATPase and ATG16L1&#x02010;WD40 domain</article-title>. <source>J Cell Biol</source>. <year>2020</year>;<volume>219</volume>(<issue>12</issue>):<elocation-id>e202009128</elocation-id>.<pub-id pub-id-type="pmid">33201170</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0136"><label>136</label><mixed-citation publication-type="journal" id="cac270067-cite-0137">
<string-name>
<surname>Liu</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Tian</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Siraj</surname>
<given-names>S</given-names>
</string-name>, et&#x000a0;al. <article-title>STING directly activates autophagy to tune the innate immune response</article-title>. <source>Cell Death Differ</source>. <year>2019</year>;<volume>26</volume>(<issue>9</issue>):<fpage>1735</fpage>&#x02010;<lpage>49</lpage>.<pub-id pub-id-type="pmid">30568238</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0137"><label>137</label><mixed-citation publication-type="journal" id="cac270067-cite-0138">
<string-name>
<surname>Wan</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Qian</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>L</given-names>
</string-name>, et&#x000a0;al. <article-title>STING directly recruits WIPI2 for autophagosome formation during STING&#x02010;induced autophagy</article-title>. <source>EMBO J</source>. <year>2023</year>;<volume>42</volume>(<issue>8</issue>):<elocation-id>e112387</elocation-id>.<pub-id pub-id-type="pmid">36872914</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0138"><label>138</label><mixed-citation publication-type="journal" id="cac270067-cite-0139">
<string-name>
<surname>Wan</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>W</given-names>
</string-name>. <article-title>STING recruits WIPI2 for autophagosome formation</article-title>. <source>Autophagy</source>. <year>2024</year>;<volume>20</volume>(<issue>4</issue>):<fpage>928</fpage>&#x02010;<lpage>9</lpage>.<pub-id pub-id-type="pmid">37041719</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0139"><label>139</label><mixed-citation publication-type="journal" id="cac270067-cite-0140">
<string-name>
<surname>Liu</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Carlson</surname>
<given-names>RJ</given-names>
</string-name>, <string-name>
<surname>Pires</surname>
<given-names>IS</given-names>
</string-name>, <string-name>
<surname>Gentili</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Feng</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Hellier</surname>
<given-names>Q</given-names>
</string-name>, et&#x000a0;al. <article-title>Human STING is a proton channel</article-title>. <source>Science</source>. <year>2023</year>;<volume>381</volume>(<issue>6657</issue>):<fpage>508</fpage>&#x02010;<lpage>14</lpage>.<pub-id pub-id-type="pmid">37535724</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0140"><label>140</label><mixed-citation publication-type="journal" id="cac270067-cite-0141">
<collab collab-type="authors">Human STING Enables Transmembrane Proton Transport. Cancer Discov</collab>
. <year>2023</year>;<volume>13</volume>(<issue>10</issue>):<fpage>2118</fpage>.</mixed-citation></ref><ref id="cac270067-bib-0141"><label>141</label><mixed-citation publication-type="journal" id="cac270067-cite-0142">
<string-name>
<surname>Poddar</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Chauvin</surname>
<given-names>SD</given-names>
</string-name>, <string-name>
<surname>Archer</surname>
<given-names>CH</given-names>
</string-name>, <string-name>
<surname>Qian</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Castillo&#x02010;Badillo</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Yin</surname>
<given-names>X</given-names>
</string-name>, et&#x000a0;al. <article-title>ArfGAP2 promotes STING proton channel activity, cytokine transit, and autoinflammation</article-title>. <source>Cell</source>. <year>2025</year>;<volume>188</volume>(<issue>6</issue>):<fpage>1605</fpage>&#x02010;<lpage>22</lpage> e26.<pub-id pub-id-type="pmid">39947179</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0142"><label>142</label><mixed-citation publication-type="journal" id="cac270067-cite-0143">
<string-name>
<surname>Huang</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Du</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>ZJ</given-names>
</string-name>. <article-title>STING&#x02010;induced noncanonical autophagy regulates endolysosomal homeostasis</article-title>. <source>Proc Natl Acad Sci U S A.</source>
<year>2025</year>;<volume>122</volume>(<issue>8</issue>):<elocation-id>e2415422122</elocation-id>.<pub-id pub-id-type="pmid">39982740</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0143"><label>143</label><mixed-citation publication-type="journal" id="cac270067-cite-0144">
<string-name>
<surname>Xu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Qian</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Lu</surname>
<given-names>S</given-names>
</string-name>, et&#x000a0;al. <article-title>The cGAS&#x02010;STING pathway activates transcription factor TFEB to stimulate lysosome biogenesis and pathogen clearance</article-title>. <source>Immunity</source>. <year>2025</year>;<volume>58</volume>(<issue>2</issue>):<fpage>309</fpage>&#x02010;<lpage>25</lpage>.e6.<pub-id pub-id-type="pmid">39689715</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0144"><label>144</label><mixed-citation publication-type="journal" id="cac270067-cite-0145">
<string-name>
<surname>Lv</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Dion</surname>
<given-names>WA</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Xun</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>DH</given-names>
</string-name>, <string-name>
<surname>Zhu</surname>
<given-names>B</given-names>
</string-name>, et&#x000a0;al. <article-title>A TBK1&#x02010;independent primordial function of STING in lysosomal biogenesis</article-title>. <source>Mol Cell</source>. <year>2024</year>;<volume>84</volume>(<issue>20</issue>):<fpage>3979</fpage>&#x02010;<lpage>96</lpage>.e9.<pub-id pub-id-type="pmid">39423796</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0145"><label>145</label><mixed-citation publication-type="journal" id="cac270067-cite-0146">
<string-name>
<surname>Settembre</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Zoncu</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Medina</surname>
<given-names>DL</given-names>
</string-name>, <string-name>
<surname>Vetrini</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Erdin</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Erdin</surname>
<given-names>S</given-names>
</string-name>, et&#x000a0;al. <article-title>A lysosome&#x02010;to&#x02010;nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB</article-title>. <source>EMBO J</source>. <year>2012</year>;<volume>31</volume>(<issue>5</issue>):<fpage>1095</fpage>&#x02010;<lpage>108</lpage>.<pub-id pub-id-type="pmid">22343943</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0146"><label>146</label><mixed-citation publication-type="journal" id="cac270067-cite-0147">
<string-name>
<surname>Roczniak&#x02010;Ferguson</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Petit</surname>
<given-names>CS</given-names>
</string-name>, <string-name>
<surname>Froehlich</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Qian</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Ky</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Angarola</surname>
<given-names>B</given-names>
</string-name>, et&#x000a0;al. <article-title>The transcription factor TFEB links mTORC1 signaling to transcriptional control of lysosome homeostasis</article-title>. <source>Sci Signal</source>. <year>2012</year>;<volume>5</volume>(<issue>228</issue>):<fpage>ra42</fpage>.<pub-id pub-id-type="pmid">22692423</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0147"><label>147</label><mixed-citation publication-type="journal" id="cac270067-cite-0148">
<string-name>
<surname>Vega&#x02010;Rubin&#x02010;de&#x02010;Celis</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Pena&#x02010;Llopis</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Konda</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Brugarolas</surname>
<given-names>J</given-names>
</string-name>. <article-title>Multistep regulation of TFEB by MTORC1</article-title>. <source>Autophagy</source>. <year>2017</year>;<volume>13</volume>(<issue>3</issue>):<fpage>464</fpage>&#x02010;<lpage>72</lpage>.<pub-id pub-id-type="pmid">28055300</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0148"><label>148</label><mixed-citation publication-type="journal" id="cac270067-cite-0149">
<string-name>
<surname>Sardiello</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Palmieri</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>di Ronza</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Medina</surname>
<given-names>DL</given-names>
</string-name>, <string-name>
<surname>Valenza</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Gennarino</surname>
<given-names>VA</given-names>
</string-name>, et&#x000a0;al. <article-title>A gene network regulating lysosomal biogenesis and function</article-title>. <source>Science</source>. <year>2009</year>;<volume>325</volume>(<issue>5939</issue>):<fpage>473</fpage>&#x02010;<lpage>7</lpage>.<pub-id pub-id-type="pmid">19556463</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0149"><label>149</label><mixed-citation publication-type="journal" id="cac270067-cite-0150">
<string-name>
<surname>Munoz&#x02010;Espin</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Serrano</surname>
<given-names>M</given-names>
</string-name>. <article-title>Cellular senescence: from physiology to pathology</article-title>. <source>Nat Rev Mol Cell Biol</source>. <year>2014</year>;<volume>15</volume>(<issue>7</issue>):<fpage>482</fpage>&#x02010;<lpage>96</lpage>.<pub-id pub-id-type="pmid">24954210</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0150"><label>150</label><mixed-citation publication-type="journal" id="cac270067-cite-0151">
<string-name>
<surname>Hernandez&#x02010;Segura</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Nehme</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Demaria</surname>
<given-names>M</given-names>
</string-name>. <article-title>Hallmarks of Cellular Senescence</article-title>. <source>Trends Cell Biol</source>. <year>2018</year>;<volume>28</volume>(<issue>6</issue>):<fpage>436</fpage>&#x02010;<lpage>53</lpage>.<pub-id pub-id-type="pmid">29477613</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0151"><label>151</label><mixed-citation publication-type="journal" id="cac270067-cite-0152">
<string-name>
<surname>Gorgoulis</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Adams</surname>
<given-names>PD</given-names>
</string-name>, <string-name>
<surname>Alimonti</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Bennett</surname>
<given-names>DC</given-names>
</string-name>, <string-name>
<surname>Bischof</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Bishop</surname>
<given-names>C</given-names>
</string-name>, et&#x000a0;al. <article-title>Cellular Senescence: Defining a Path Forward</article-title>. <source>Cell</source>. <year>2019</year>;<volume>179</volume>(<issue>4</issue>):<fpage>813</fpage>&#x02010;<lpage>27</lpage>.<pub-id pub-id-type="pmid">31675495</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0152"><label>152</label><mixed-citation publication-type="journal" id="cac270067-cite-0153">
<string-name>
<surname>Loo</surname>
<given-names>TM</given-names>
</string-name>, <string-name>
<surname>Miyata</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Tanaka</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Takahashi</surname>
<given-names>A</given-names>
</string-name>. <article-title>Cellular senescence and senescence&#x02010;associated secretory phenotype via the cGAS&#x02010;STING signaling pathway in cancer</article-title>. <source>Cancer Sci</source>. <year>2020</year>;<volume>111</volume>(<issue>2</issue>):<fpage>304</fpage>&#x02010;<lpage>11</lpage>.<pub-id pub-id-type="pmid">31799772</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0153"><label>153</label><mixed-citation publication-type="journal" id="cac270067-cite-0154">
<string-name>
<surname>Yang</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Ren</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>ZJ</given-names>
</string-name>. <article-title>cGAS is essential for cellular senescence</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2017</year>;<volume>114</volume>(<issue>23</issue>):<fpage>E4612</fpage>&#x02010;<lpage>E20</lpage>.<pub-id pub-id-type="pmid">28533362</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0154"><label>154</label><mixed-citation publication-type="journal" id="cac270067-cite-0155">
<string-name>
<surname>Yu</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>P</given-names>
</string-name>. <article-title>cGAS/STING signalling pathway in senescence and oncogenesis</article-title>. <source>Semin Cancer Biol</source>. <year>2024</year>;<volume>106&#x02010;107</volume>:<fpage>87</fpage>&#x02010;<lpage>102</lpage>.</mixed-citation></ref><ref id="cac270067-bib-0155"><label>155</label><mixed-citation publication-type="journal" id="cac270067-cite-0156">
<string-name>
<surname>Nihira</surname>
<given-names>NT</given-names>
</string-name>, <string-name>
<surname>Kudo</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Ohta</surname>
<given-names>T</given-names>
</string-name>. <article-title>Inflammation and tumor immune escape in response to DNA damage</article-title>. <source>Semin Cancer Biol</source>. <year>2025</year>;<volume>110</volume>:<fpage>36</fpage>&#x02010;<lpage>45</lpage>.<pub-id pub-id-type="pmid">39938581</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0156"><label>156</label><mixed-citation publication-type="journal" id="cac270067-cite-0157">
<string-name>
<surname>Chen</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Tang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Wan</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Yu</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Dong</surname>
<given-names>Y</given-names>
</string-name>, et&#x000a0;al. <article-title>STING up&#x02010;regulates VEGF expression in oxidative stress&#x02010;induced senescence of retinal pigment epithelium via NF&#x02010;kappaB/HIF&#x02010;1alpha pathway</article-title>. <source>Life Sci</source>. <year>2022</year>;<volume>293</volume>:<elocation-id>120089</elocation-id>.<pub-id pub-id-type="pmid">35007563</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0157"><label>157</label><mixed-citation publication-type="journal" id="cac270067-cite-0158">
<string-name>
<surname>Li</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Xie</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Cai</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Jin</surname>
<given-names>H</given-names>
</string-name>, et&#x000a0;al. <article-title>cGAS guards against chromosome end&#x02010;to&#x02010;end fusions during mitosis and facilitates replicative senescence</article-title>. <source>Protein Cell</source>. <year>2022</year>;<volume>13</volume>(<issue>1</issue>):<fpage>47</fpage>&#x02010;<lpage>64</lpage>.<pub-id pub-id-type="pmid">34676498</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0158"><label>158</label><mixed-citation publication-type="journal" id="cac270067-cite-0159">
<string-name>
<surname>Zhu</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Blake</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kusuma</surname>
<given-names>FK</given-names>
</string-name>, <string-name>
<surname>Pearson</surname>
<given-names>RB</given-names>
</string-name>, <string-name>
<surname>Kang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Chan</surname>
<given-names>KT</given-names>
</string-name>. <article-title>Oncogene&#x02010;induced senescence: From biology to therapy</article-title>. <source>Mech Ageing Dev</source>. <year>2020</year>;<volume>187</volume>:<elocation-id>111229</elocation-id>.<pub-id pub-id-type="pmid">32171687</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0159"><label>159</label><mixed-citation publication-type="journal" id="cac270067-cite-0160">
<string-name>
<surname>Victorelli</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Salmonowicz</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Chapman</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Martini</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Vizioli</surname>
<given-names>MG</given-names>
</string-name>, <string-name>
<surname>Riley</surname>
<given-names>JS</given-names>
</string-name>, et&#x000a0;al. <article-title>Apoptotic stress causes mtDNA release during senescence and drives the SASP</article-title>. <source>Nature</source>. <year>2023</year>;<volume>622</volume>(<issue>7983</issue>):<fpage>627</fpage>&#x02010;<lpage>36</lpage>.<pub-id pub-id-type="pmid">37821702</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0160"><label>160</label><mixed-citation publication-type="journal" id="cac270067-cite-0161">
<string-name>
<surname>Jim&#x000e9;nez&#x02010;Loygorri</surname>
<given-names>JI</given-names>
</string-name>, <string-name>
<surname>Villarejo&#x02010;Zori</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Viedma&#x02010;Poyatos</surname>
<given-names>&#x000c1;</given-names>
</string-name>, <string-name>
<surname>Zapata&#x02010;Mu&#x000f1;oz</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Ben&#x000ed;tez&#x02010;Fern&#x000e1;ndez</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Frutos&#x02010;Lis&#x000f3;n</surname>
<given-names>MD</given-names>
</string-name>, et&#x000a0;al. <article-title>Mitophagy curtails cytosolic mtDNA&#x02010;dependent activation of cGAS/STING inflammation during aging</article-title>. <source>Nat Commun</source>. <year>2024</year>;<volume>15</volume>(<issue>1</issue>):<fpage>830</fpage>.<pub-id pub-id-type="pmid">38280852</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0161"><label>161</label><mixed-citation publication-type="journal" id="cac270067-cite-0162">
<string-name>
<surname>Thomas</surname>
<given-names>CA</given-names>
</string-name>, <string-name>
<surname>Tejwani</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Trujillo</surname>
<given-names>CA</given-names>
</string-name>, <string-name>
<surname>Negraes</surname>
<given-names>PD</given-names>
</string-name>, <string-name>
<surname>Herai</surname>
<given-names>RH</given-names>
</string-name>, <string-name>
<surname>Mesci</surname>
<given-names>P</given-names>
</string-name>, et&#x000a0;al. <article-title>Modeling of TREX1&#x02010;Dependent Autoimmune Disease using Human Stem Cells Highlights L1 Accumulation as a Source of Neuroinflammation</article-title>. <source>Cell Stem Cell</source>. <year>2017</year>;<volume>21</volume>(<issue>3</issue>):<fpage>319</fpage>&#x02010;<lpage>31</lpage> e8.<pub-id pub-id-type="pmid">28803918</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0162"><label>162</label><mixed-citation publication-type="journal" id="cac270067-cite-0163">
<string-name>
<surname>De Cecco</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ito</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Petrashen</surname>
<given-names>AP</given-names>
</string-name>, <string-name>
<surname>Elias</surname>
<given-names>AE</given-names>
</string-name>, <string-name>
<surname>Skvir</surname>
<given-names>NJ</given-names>
</string-name>, <string-name>
<surname>Criscione</surname>
<given-names>SW</given-names>
</string-name>, et&#x000a0;al. <article-title>L1 drives IFN in senescent cells and promotes age&#x02010;associated inflammation</article-title>. <source>Nature</source>. <year>2019</year>;<volume>566</volume>(<issue>7742</issue>):<fpage>73</fpage>&#x02010;<lpage>8</lpage>.<pub-id pub-id-type="pmid">30728521</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0163"><label>163</label><mixed-citation publication-type="journal" id="cac270067-cite-0164">
<string-name>
<surname>Simon</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Van Meter</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ablaeva</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Ke</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Gonzalez</surname>
<given-names>RS</given-names>
</string-name>, <string-name>
<surname>Taguchi</surname>
<given-names>T</given-names>
</string-name>, et&#x000a0;al. <article-title>LINE1 Derepression in Aged Wild&#x02010;Type and SIRT6&#x02010;Deficient Mice Drives Inflammation</article-title>. <source>Cell Metab</source>. <year>2019</year>;<volume>29</volume>(<issue>4</issue>):<fpage>871</fpage>&#x02010;<lpage>85</lpage> e5.<pub-id pub-id-type="pmid">30853213</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0164"><label>164</label><mixed-citation publication-type="journal" id="cac270067-cite-0165">
<string-name>
<surname>Liu</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Ren</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Fan</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>L</given-names>
</string-name>, et&#x000a0;al. <article-title>Resurrection of endogenous retroviruses during aging reinforces senescence</article-title>. <source>Cell</source>. <year>2023</year>;<volume>186</volume>(<issue>2</issue>):<fpage>287</fpage>&#x02010;<lpage>304</lpage> e26.<pub-id pub-id-type="pmid">36610399</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0165"><label>165</label><mixed-citation publication-type="journal" id="cac270067-cite-0166">
<string-name>
<surname>Zhen</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Tang</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>H</given-names>
</string-name>, et&#x000a0;al. <article-title>Nuclear cGAS restricts L1 retrotransposition by promoting TRIM41&#x02010;mediated ORF2p ubiquitination and degradation</article-title>. <source>Nat Commun</source>. <year>2023</year>;<volume>14</volume>(<issue>1</issue>):<fpage>8217</fpage>.<pub-id pub-id-type="pmid">38086852</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0166"><label>166</label><mixed-citation publication-type="journal" id="cac270067-cite-0167">
<string-name>
<surname>Hao</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Towers</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Liao</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Monteiro</surname>
<given-names>EL</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>X</given-names>
</string-name>, et&#x000a0;al. <article-title>TXNRD1 drives the innate immune response in senescent cells with implications for age&#x02010;associated inflammation</article-title>. <source>Nat Aging</source>. <year>2024</year>;<volume>4</volume>(<issue>2</issue>):<fpage>185</fpage>&#x02010;<lpage>97</lpage>.<pub-id pub-id-type="pmid">38267705</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0167"><label>167</label><mixed-citation publication-type="journal" id="cac270067-cite-0168">
<string-name>
<surname>Takahashi</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Loo</surname>
<given-names>TM</given-names>
</string-name>, <string-name>
<surname>Okada</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Kamachi</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Watanabe</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Wakita</surname>
<given-names>M</given-names>
</string-name>, et&#x000a0;al. <article-title>Downregulation of cytoplasmic DNases is implicated in cytoplasmic DNA accumulation and SASP in senescent cells</article-title>. <source>Nat Commun</source>. <year>2018</year>;<volume>9</volume>(<issue>1</issue>):<fpage>1249</fpage>.<pub-id pub-id-type="pmid">29593264</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0168"><label>168</label><mixed-citation publication-type="journal" id="cac270067-cite-0169">
<string-name>
<surname>Sladitschek&#x02010;Martens</surname>
<given-names>HL</given-names>
</string-name>, <string-name>
<surname>Guarnieri</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Brumana</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Zanconato</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Battilana</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Xiccato</surname>
<given-names>RL</given-names>
</string-name>, et&#x000a0;al. <article-title>YAP/TAZ activity in stromal cells prevents ageing by controlling cGAS&#x02010;STING</article-title>. <source>Nature</source>. <year>2022</year>;<volume>607</volume>(<issue>7920</issue>):<fpage>790</fpage>&#x02010;<lpage>8</lpage>.<pub-id pub-id-type="pmid">35768505</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0169"><label>169</label><mixed-citation publication-type="journal" id="cac270067-cite-0170">
<string-name>
<surname>Wu</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Leng</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Zhu</surname>
<given-names>YZ</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>Y</given-names>
</string-name>, et&#x000a0;al. <article-title>IRF3 activates RB to authorize cGAS&#x02010;STING&#x02010;induced senescence and mitigate liver fibrosis</article-title>. <source>Sci Adv</source>. <year>2024</year>;<volume>10</volume>(<issue>9</issue>):<elocation-id>eadj2102</elocation-id>.<pub-id pub-id-type="pmid">38416816</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0170"><label>170</label><mixed-citation publication-type="journal" id="cac270067-cite-0171">
<string-name>
<surname>Zhou</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Chu</surname>
<given-names>WK</given-names>
</string-name>. <article-title>A novel innate immunity&#x02010;mediated senescence mechanism regulated by cGAS&#x02010;STING&#x02010;IRF3&#x02010;pRB</article-title>. <source>MedComm (2020)</source>. <year>2025</year>;<volume>6</volume>(<issue>2</issue>):<elocation-id>e70072</elocation-id>.<pub-id pub-id-type="pmid">39822758</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0171"><label>171</label><mixed-citation publication-type="journal" id="cac270067-cite-0172">
<string-name>
<surname>Zhang</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Zhu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Guan</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>S</given-names>
</string-name>, et&#x000a0;al. <article-title>A non&#x02010;canonical cGAS&#x02010;STING&#x02010;PERK pathway facilitates the translational program critical for senescence and organ fibrosis</article-title>. <source>Nat Cell Biol</source>. <year>2022</year>;<volume>24</volume>(<issue>5</issue>):<fpage>766</fpage>&#x02010;<lpage>82</lpage>.<pub-id pub-id-type="pmid">35501370</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0172"><label>172</label><mixed-citation publication-type="journal" id="cac270067-cite-0173">
<string-name>
<surname>Gulen</surname>
<given-names>MF</given-names>
</string-name>, <string-name>
<surname>Koch</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Haag</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Schuler</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Apetoh</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Villunger</surname>
<given-names>A</given-names>
</string-name>, et&#x000a0;al. <article-title>Signalling strength determines proapoptotic functions of STING</article-title>. <source>Nat Commun</source>. <year>2017</year>;<volume>8</volume>(<issue>1</issue>):<fpage>427</fpage>.<pub-id pub-id-type="pmid">28874664</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0173"><label>173</label><mixed-citation publication-type="journal" id="cac270067-cite-0174">
<string-name>
<surname>Tang</surname>
<given-names>CH</given-names>
</string-name>, <string-name>
<surname>Zundell</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Ranatunga</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Lin</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Nefedova</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Del Valle</surname>
<given-names>JR</given-names>
</string-name>, et&#x000a0;al. <article-title>Agonist&#x02010;Mediated Activation of STING Induces Apoptosis in Malignant B Cells</article-title>. <source>Cancer Res</source>. <year>2016</year>;<volume>76</volume>(<issue>8</issue>):<fpage>2137</fpage>&#x02010;<lpage>52</lpage>.<pub-id pub-id-type="pmid">26951929</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0174"><label>174</label><mixed-citation publication-type="journal" id="cac270067-cite-0175">
<string-name>
<surname>Chattopadhyay</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Marques</surname>
<given-names>JT</given-names>
</string-name>, <string-name>
<surname>Yamashita</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Peters</surname>
<given-names>KL</given-names>
</string-name>, <string-name>
<surname>Smith</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Desai</surname>
<given-names>A</given-names>
</string-name>, et&#x000a0;al. <article-title>Viral apoptosis is induced by IRF&#x02010;3&#x02010;mediated activation of Bax</article-title>. <source>EMBO J</source>. <year>2010</year>;<volume>29</volume>(<issue>10</issue>):<fpage>1762</fpage>&#x02010;<lpage>73</lpage>.<pub-id pub-id-type="pmid">20360684</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0175"><label>175</label><mixed-citation publication-type="journal" id="cac270067-cite-0176">
<string-name>
<surname>McArthur</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Whitehead</surname>
<given-names>LW</given-names>
</string-name>, <string-name>
<surname>Heddleston</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Padman</surname>
<given-names>BS</given-names>
</string-name>, <string-name>
<surname>Oorschot</surname>
<given-names>V</given-names>
</string-name>, et&#x000a0;al. <article-title>BAK/BAX macropores facilitate mitochondrial herniation and mtDNA efflux during apoptosis</article-title>. <source>Science</source>. <year>2018</year>;<volume>359</volume>(<issue>6378</issue>):<elocation-id>eaao6047</elocation-id>.<pub-id pub-id-type="pmid">29472455</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0176"><label>176</label><mixed-citation publication-type="journal" id="cac270067-cite-0177">
<string-name>
<surname>Riley</surname>
<given-names>JS</given-names>
</string-name>, <string-name>
<surname>Quarato</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Cloix</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Lopez</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>O'Prey</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Pearson</surname>
<given-names>M</given-names>
</string-name>, et&#x000a0;al. <article-title>Mitochondrial inner membrane permeabilisation enables mtDNA release during apoptosis</article-title>. <source>EMBO J</source>. <year>2018</year>;<volume>37</volume>(<issue>17</issue>):<elocation-id>e99238</elocation-id>.<pub-id pub-id-type="pmid">30049712</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0177"><label>177</label><mixed-citation publication-type="journal" id="cac270067-cite-0178">
<string-name>
<surname>Ning</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Jing</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Sha</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Lv</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Gao</surname>
<given-names>P</given-names>
</string-name>, et&#x000a0;al. <article-title>Apoptotic Caspases Suppress Type I Interferon Production via the Cleavage of cGAS, MAVS, and IRF3</article-title>. <source>Mol Cell</source>. <year>2019</year>;<volume>74</volume>(<issue>1</issue>):<fpage>19</fpage>&#x02010;<lpage>31</lpage> e7.<pub-id pub-id-type="pmid">30878284</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0178"><label>178</label><mixed-citation publication-type="journal" id="cac270067-cite-0179">
<string-name>
<surname>Galluzzi</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Kepp</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Chan</surname>
<given-names>FK</given-names>
</string-name>, <string-name>
<surname>Kroemer</surname>
<given-names>G</given-names>
</string-name>. <article-title>Necroptosis: Mechanisms and Relevance to Disease</article-title>. <source>Annu Rev Pathol</source>. <year>2017</year>;<volume>12</volume>:<fpage>103</fpage>&#x02010;<lpage>30</lpage>.<pub-id pub-id-type="pmid">27959630</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0179"><label>179</label><mixed-citation publication-type="journal" id="cac270067-cite-0180">
<string-name>
<surname>Wegner</surname>
<given-names>KW</given-names>
</string-name>, <string-name>
<surname>Saleh</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Degterev</surname>
<given-names>A</given-names>
</string-name>. <article-title>Complex Pathologic Roles of RIPK1 and RIPK3: Moving Beyond Necroptosis</article-title>. <source>Trends Pharmacol Sci</source>. <year>2017</year>;<volume>38</volume>(<issue>3</issue>):<fpage>202</fpage>&#x02010;<lpage>25</lpage>.<pub-id pub-id-type="pmid">28126382</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0180"><label>180</label><mixed-citation publication-type="journal" id="cac270067-cite-0181">
<string-name>
<surname>Sarhan</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>BC</given-names>
</string-name>, <string-name>
<surname>Muendlein</surname>
<given-names>HI</given-names>
</string-name>, <string-name>
<surname>Weindel</surname>
<given-names>CG</given-names>
</string-name>, <string-name>
<surname>Smirnova</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Tang</surname>
<given-names>AY</given-names>
</string-name>, et&#x000a0;al. <article-title>Constitutive interferon signaling maintains critical threshold of MLKL expression to license necroptosis</article-title>. <source>Cell Death Differ</source>. <year>2019</year>;<volume>26</volume>(<issue>2</issue>):<fpage>332</fpage>&#x02010;<lpage>47</lpage>.<pub-id pub-id-type="pmid">29786074</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0181"><label>181</label><mixed-citation publication-type="journal" id="cac270067-cite-0182">
<string-name>
<surname>Luo</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Ren</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>Y</given-names>
</string-name>, et&#x000a0;al. <article-title>Critical Role of Cytosolic DNA and Its Sensing Adaptor STING in Aortic Degeneration, Dissection, and Rupture</article-title>. <source>Circulation</source>. <year>2020</year>;<volume>141</volume>(<issue>1</issue>):<fpage>42</fpage>&#x02010;<lpage>66</lpage>.<pub-id pub-id-type="pmid">31887080</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0182"><label>182</label><mixed-citation publication-type="journal" id="cac270067-cite-0183">
<string-name>
<surname>Schock</surname>
<given-names>SN</given-names>
</string-name>, <string-name>
<surname>Chandra</surname>
<given-names>NV</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Irie</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Kitagawa</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Gotoh</surname>
<given-names>B</given-names>
</string-name>, et&#x000a0;al. <article-title>Induction of necroptotic cell death by viral activation of the RIG&#x02010;I or STING pathway</article-title>. <source>Cell Death Differ</source>. <year>2017</year>;<volume>24</volume>(<issue>4</issue>):<fpage>615</fpage>&#x02010;<lpage>25</lpage>.<pub-id pub-id-type="pmid">28060376</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0183"><label>183</label><mixed-citation publication-type="journal" id="cac270067-cite-0184">
<string-name>
<surname>Brault</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Olsen</surname>
<given-names>TM</given-names>
</string-name>, <string-name>
<surname>Martinez</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Stetson</surname>
<given-names>DB</given-names>
</string-name>, <string-name>
<surname>Oberst</surname>
<given-names>A</given-names>
</string-name>. <article-title>Intracellular Nucleic Acid Sensing Triggers Necroptosis through Synergistic Type I IFN and TNF Signaling</article-title>. <source>J Immunol</source>. <year>2018</year>;<volume>200</volume>(<issue>8</issue>):<fpage>2748</fpage>&#x02010;<lpage>56</lpage>.<pub-id pub-id-type="pmid">29540580</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0184"><label>184</label><mixed-citation publication-type="journal" id="cac270067-cite-0185">
<string-name>
<surname>Cho</surname>
<given-names>MG</given-names>
</string-name>, <string-name>
<surname>Kumar</surname>
<given-names>RJ</given-names>
</string-name>, <string-name>
<surname>Lin</surname>
<given-names>CC</given-names>
</string-name>, <string-name>
<surname>Boyer</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Shahir</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Fagan&#x02010;Solis</surname>
<given-names>K</given-names>
</string-name>, et&#x000a0;al. <article-title>MRE11 liberates cGAS from nucleosome sequestration during tumorigenesis</article-title>. <source>Nature</source>. <year>2024</year>;<volume>625</volume>(<issue>7995</issue>):<fpage>585</fpage>&#x02010;<lpage>92</lpage>.<pub-id pub-id-type="pmid">38200309</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0185"><label>185</label><mixed-citation publication-type="journal" id="cac270067-cite-0186">
<string-name>
<surname>Xiaofeng</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>You</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Qi</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Hongwei</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Zhongmin</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Shiquan</surname>
<given-names>W</given-names>
</string-name>, et&#x000a0;al. <article-title>PERK&#x02010;STING&#x02010;RIPK3 pathway facilitates cognitive impairment by inducing neuronal necroptosis in sepsis&#x02010;associated encephalopathy</article-title>. <source>CNS Neurosci Ther</source>. <year>2023</year>;<volume>29</volume>(<issue>4</issue>):<fpage>1178</fpage>&#x02010;<lpage>91</lpage>.<pub-id pub-id-type="pmid">36694328</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0186"><label>186</label><mixed-citation publication-type="journal" id="cac270067-cite-0187">
<string-name>
<surname>Chen</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Tong</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Wei</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Stolz</surname>
<given-names>DB</given-names>
</string-name>, <string-name>
<surname>Yu</surname>
<given-names>J</given-names>
</string-name>, et&#x000a0;al. <article-title>PUMA amplifies necroptosis signaling by activating cytosolic DNA sensors</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2018</year>;<volume>115</volume>(<issue>15</issue>):<fpage>3930</fpage>&#x02010;<lpage>5</lpage>.<pub-id pub-id-type="pmid">29581256</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0187"><label>187</label><mixed-citation publication-type="journal" id="cac270067-cite-0188">
<string-name>
<surname>Liu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Luan</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Meng</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Liao</surname>
<given-names>W</given-names>
</string-name>, et&#x000a0;al. <article-title>cGAS&#x02010;STING, inflammasomes and pyroptosis: an overview of crosstalk mechanism of activation and regulation</article-title>. <source>Cell Commun Signal</source>. <year>2024</year>;<volume>22</volume>(<issue>1</issue>):<fpage>22</fpage>.<pub-id pub-id-type="pmid">38195584</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0188"><label>188</label><mixed-citation publication-type="journal" id="cac270067-cite-0189">
<string-name>
<surname>Gaidt</surname>
<given-names>MM</given-names>
</string-name>, <string-name>
<surname>Ebert</surname>
<given-names>TS</given-names>
</string-name>, <string-name>
<surname>Chauhan</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Ramshorn</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Pinci</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Zuber</surname>
<given-names>S</given-names>
</string-name>, et&#x000a0;al. <article-title>The DNA Inflammasome in Human Myeloid Cells Is Initiated by a STING&#x02010;Cell Death Program Upstream of NLRP3</article-title>. <source>Cell</source>. <year>2017</year>;<volume>171</volume>(<issue>5</issue>):<fpage>1110</fpage>&#x02010;<lpage>24</lpage> e18.<pub-id pub-id-type="pmid">29033128</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0189"><label>189</label><mixed-citation publication-type="journal" id="cac270067-cite-0190">
<string-name>
<surname>Webster</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Brode</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Ellis</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Fitzmaurice</surname>
<given-names>TJ</given-names>
</string-name>, <string-name>
<surname>Elder</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Gekara</surname>
<given-names>NO</given-names>
</string-name>, et&#x000a0;al. <article-title>Detection of a microbial metabolite by STING regulates inflammasome activation in response to Chlamydia trachomatis infection</article-title>. <source>PLoS Pathog</source>. <year>2017</year>;<volume>13</volume>(<issue>6</issue>):<elocation-id>e1006383</elocation-id>.<pub-id pub-id-type="pmid">28570638</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0190"><label>190</label><mixed-citation publication-type="journal" id="cac270067-cite-0191">
<string-name>
<surname>Zhong</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Rao</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Rao</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Han</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Jiang</surname>
<given-names>T</given-names>
</string-name>, et&#x000a0;al. <article-title>Aging aggravated liver ischemia and reperfusion injury by promoting STING&#x02010;mediated NLRP3 activation in macrophages</article-title>. <source>Aging Cell</source>. <year>2020</year>;<volume>19</volume>(<issue>8</issue>):<elocation-id>e13186</elocation-id>.<pub-id pub-id-type="pmid">32666684</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0191"><label>191</label><mixed-citation publication-type="journal" id="cac270067-cite-0192">
<string-name>
<surname>McLemore</surname>
<given-names>AF</given-names>
</string-name>, <string-name>
<surname>Hou</surname>
<given-names>HA</given-names>
</string-name>, <string-name>
<surname>Meyer</surname>
<given-names>BS</given-names>
</string-name>, <string-name>
<surname>Lam</surname>
<given-names>NB</given-names>
</string-name>, <string-name>
<surname>Ward</surname>
<given-names>GA</given-names>
</string-name>, <string-name>
<surname>Aldrich</surname>
<given-names>AL</given-names>
</string-name>, et&#x000a0;al. <article-title>Somatic gene mutations expose cytoplasmic DNA to co&#x02010;opt the cGAS/STING/NLRP3 axis in myelodysplastic syndromes</article-title>. <source>JCI Insight</source>. <year>2022</year>;<volume>7</volume>(<issue>15</issue>):<elocation-id>e159430</elocation-id>.<pub-id pub-id-type="pmid">35788117</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0192"><label>192</label><mixed-citation publication-type="journal" id="cac270067-cite-0193">
<string-name>
<surname>Peng</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Shi</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>R</given-names>
</string-name>, et&#x000a0;al. <article-title>Mitochondrial (mt)DNA&#x02010;cyclic GMP&#x02010;AMP synthase (cGAS)&#x02010;stimulator of interferon genes (STING) signaling promotes pyroptosis of macrophages via interferon regulatory factor (IRF)7/IRF3 activation to aggravate lung injury during severe acute pancreatitis</article-title>. <source>Cell Mol Biol Lett</source>. <year>2024</year>;<volume>29</volume>(<issue>1</issue>):<fpage>61</fpage>.<pub-id pub-id-type="pmid">38671352</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0193"><label>193</label><mixed-citation publication-type="journal" id="cac270067-cite-0194">
<string-name>
<surname>Liu</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Niu</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Fan</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Wei</surname>
<given-names>Z</given-names>
</string-name>, et&#x000a0;al. <article-title>Priming and Activation of Inflammasome by Canarypox Virus Vector ALVAC via the cGAS/IFI16&#x02010;STING&#x02010;Type I IFN Pathway and AIM2 Sensor</article-title>. <source>J Immunol</source>. <year>2017</year>;<volume>199</volume>(<issue>9</issue>):<fpage>3293</fpage>&#x02010;<lpage>305</lpage>.<pub-id pub-id-type="pmid">28947539</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0194"><label>194</label><mixed-citation publication-type="journal" id="cac270067-cite-0195">
<string-name>
<surname>Song</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Ma</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Herrup</surname>
<given-names>K</given-names>
</string-name>. <article-title>Accumulation of Cytoplasmic DNA Due to ATM Deficiency Activates the Microglial Viral Response System with Neurotoxic Consequences</article-title>. <source>J Neurosci</source>. <year>2019</year>;<volume>39</volume>(<issue>32</issue>):<fpage>6378</fpage>&#x02010;<lpage>94</lpage>.<pub-id pub-id-type="pmid">31189575</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0195"><label>195</label><mixed-citation publication-type="journal" id="cac270067-cite-0196">
<string-name>
<surname>Man</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Karki</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Malireddi</surname>
<given-names>RK</given-names>
</string-name>, <string-name>
<surname>Neale</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Vogel</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Yamamoto</surname>
<given-names>M</given-names>
</string-name>, et&#x000a0;al. <article-title>The transcription factor IRF1 and guanylate&#x02010;binding proteins target activation of the AIM2 inflammasome by Francisella infection</article-title>. <source>Nat Immunol</source>. <year>2015</year>;<volume>16</volume>(<issue>5</issue>):<fpage>467</fpage>&#x02010;<lpage>75</lpage>.<pub-id pub-id-type="pmid">25774715</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0196"><label>196</label><mixed-citation publication-type="journal" id="cac270067-cite-0197">
<string-name>
<surname>Costa Franco</surname>
<given-names>MM</given-names>
</string-name>, <string-name>
<surname>Marim</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Guimaraes</surname>
<given-names>ES</given-names>
</string-name>, <string-name>
<surname>Assis</surname>
<given-names>NRG</given-names>
</string-name>, <string-name>
<surname>Cerqueira</surname>
<given-names>DM</given-names>
</string-name>, <string-name>
<surname>Alves&#x02010;Silva</surname>
<given-names>J</given-names>
</string-name>, et&#x000a0;al. <article-title>Brucella abortus Triggers a cGAS&#x02010;Independent STING Pathway To Induce Host Protection That Involves Guanylate&#x02010;Binding Proteins and Inflammasome Activation</article-title>. <source>J Immunol</source>. <year>2018</year>;<volume>200</volume>(<issue>2</issue>):<fpage>607</fpage>&#x02010;<lpage>22</lpage>.<pub-id pub-id-type="pmid">29203515</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0197"><label>197</label><mixed-citation publication-type="journal" id="cac270067-cite-0198">
<string-name>
<surname>Miao</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Jiang</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Chang</surname>
<given-names>WY</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>An</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Ho</surname>
<given-names>F</given-names>
</string-name>, et&#x000a0;al. <article-title>Gasdermin D permeabilization of mitochondrial inner and outer membranes accelerates and enhances pyroptosis</article-title>. <source>Immunity</source>. <year>2023</year>;<volume>56</volume>(<issue>11</issue>):<fpage>2523</fpage>&#x02010;<lpage>41</lpage> e8.<pub-id pub-id-type="pmid">37924812</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0198"><label>198</label><mixed-citation publication-type="journal" id="cac270067-cite-0199">
<string-name>
<surname>Sun</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Jiao</surname>
<given-names>XD</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>ZG</given-names>
</string-name>, <string-name>
<surname>Cao</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Zhu</surname>
<given-names>JH</given-names>
</string-name>, <string-name>
<surname>Shen</surname>
<given-names>QR</given-names>
</string-name>, et&#x000a0;al. <article-title>Gasdermin&#x02010;E&#x02010;mediated pyroptosis drives immune checkpoint inhibitor&#x02010;associated myocarditis via cGAS&#x02010;STING activation</article-title>. <source>Nat Commun</source>. <year>2024</year>;<volume>15</volume>(<issue>1</issue>):<fpage>6640</fpage>.<pub-id pub-id-type="pmid">39103324</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0199"><label>199</label><mixed-citation publication-type="journal" id="cac270067-cite-0200">
<string-name>
<surname>Zheng</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Ma</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>T</given-names>
</string-name>, et&#x000a0;al. <article-title>Zika virus elicits inflammation to evade antiviral response by cleaving cGAS via NS1&#x02010;caspase&#x02010;1 axis</article-title>. <source>EMBO J</source>. <year>2018</year>;<volume>37</volume>(<issue>18</issue>):<elocation-id>e99347</elocation-id>.<pub-id pub-id-type="pmid">30065070</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0200"><label>200</label><mixed-citation publication-type="journal" id="cac270067-cite-0201">
<string-name>
<surname>Wu</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Gao</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Cui</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Guo</surname>
<given-names>W</given-names>
</string-name>, et&#x000a0;al. <article-title>NLRP3 protects mice from radiation&#x02010;induced colon and skin damage via attenuating cGAS&#x02010;STING signaling</article-title>. <source>Toxicol Appl Pharmacol</source>. <year>2021</year>;<volume>418</volume>:<elocation-id>115495</elocation-id>.<pub-id pub-id-type="pmid">33741346</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0201"><label>201</label><mixed-citation publication-type="journal" id="cac270067-cite-0202">
<string-name>
<surname>Baatarjav</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Komada</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Karasawa</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Yamada</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Sampilvanjil</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Matsumura</surname>
<given-names>T</given-names>
</string-name>, et&#x000a0;al. <article-title>dsDNA&#x02010;induced AIM2 pyroptosis halts aberrant inflammation during rhabdomyolysis&#x02010;induced acute kidney injury</article-title>. <source>Cell Death Differ</source>. <year>2022</year>;<volume>29</volume>(<issue>12</issue>):<fpage>2487</fpage>&#x02010;<lpage>502</lpage>.<pub-id pub-id-type="pmid">35739254</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0202"><label>202</label><mixed-citation publication-type="journal" id="cac270067-cite-0203">
<string-name>
<surname>Yan</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Shen</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Lian</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Jin</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Lin</surname>
<given-names>X</given-names>
</string-name>, et&#x000a0;al. <article-title>Deficiency of the AIM2&#x02010;ASC Signal Uncovers the STING&#x02010;Driven Overreactive Response of Type I IFN and Reciprocal Depression of Protective IFN&#x02010;gamma Immunity in Mycobacterial Infection</article-title>. <source>J Immunol</source>. <year>2018</year>;<volume>200</volume>(<issue>3</issue>):<fpage>1016</fpage>&#x02010;<lpage>26</lpage>.<pub-id pub-id-type="pmid">29255077</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0203"><label>203</label><mixed-citation publication-type="journal" id="cac270067-cite-0204">
<string-name>
<surname>Yang</surname>
<given-names>WS</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>KJ</given-names>
</string-name>, <string-name>
<surname>Gaschler</surname>
<given-names>MM</given-names>
</string-name>, <string-name>
<surname>Patel</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Shchepinov</surname>
<given-names>MS</given-names>
</string-name>, <string-name>
<surname>Stockwell</surname>
<given-names>BR</given-names>
</string-name>. <article-title>Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis</article-title>. <source>Proc Natl Acad Sci U S A.</source>
<year>2016</year>;<volume>113</volume>(<issue>34</issue>):<fpage>E4966</fpage>&#x02010;<lpage>75</lpage>.<pub-id pub-id-type="pmid">27506793</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0204"><label>204</label><mixed-citation publication-type="journal" id="cac270067-cite-0205">
<string-name>
<surname>Ru</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Min</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>F</given-names>
</string-name>. <article-title>Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects</article-title>. <source>Signal Transduct Target Ther</source>. <year>2024</year>;<volume>9</volume>(<issue>1</issue>):<fpage>271</fpage>.<pub-id pub-id-type="pmid">39396974</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0205"><label>205</label><mixed-citation publication-type="journal" id="cac270067-cite-0206">
<string-name>
<surname>Zheng</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Jin</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Ye</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Yu</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>Z</given-names>
</string-name>, et&#x000a0;al. <article-title>Ferroptosis: a novel regulated cell death participating in cellular stress response, radiotherapy, and immunotherapy</article-title>. <source>Exp Hematol Oncol</source>. <year>2023</year>;<volume>12</volume>(<issue>1</issue>):<fpage>65</fpage>.<pub-id pub-id-type="pmid">37501213</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0206"><label>206</label><mixed-citation publication-type="journal" id="cac270067-cite-0207">
<string-name>
<surname>Ding</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Du</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Pei</surname>
<given-names>D</given-names>
</string-name>. <article-title>The role of cGAS&#x02010;STING signaling pathway in ferroptosis</article-title>. <source>J Adv Res</source>. <year>2024</year>:<volume>S2090&#x02010;1232</volume>(<issue>24</issue>):<fpage>00606</fpage>&#x02010;<lpage>4</lpage>.</mixed-citation></ref><ref id="cac270067-bib-0207"><label>207</label><mixed-citation publication-type="journal" id="cac270067-cite-0208">
<string-name>
<surname>Wang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Cai</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>C</given-names>
</string-name>, et&#x000a0;al. <article-title>STING aggravates ferroptosis&#x02010;dependent myocardial ischemia&#x02010;reperfusion injury by targeting GPX4 for autophagic degradation</article-title>. <source>Signal Transduct Target Ther</source>. <year>2025</year>;<volume>10</volume>(<issue>1</issue>):<fpage>136</fpage>.<pub-id pub-id-type="pmid">40274801</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0208"><label>208</label><mixed-citation publication-type="journal" id="cac270067-cite-0209">
<string-name>
<surname>He</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Leong</surname>
<given-names>WZ</given-names>
</string-name>, <string-name>
<surname>Sharda</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Mayerhofer</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Mei</surname>
<given-names>S</given-names>
</string-name>, et&#x000a0;al. <article-title>PSTK inhibition activates cGAS&#x02010;STING, precipitating ferroptotic cell death in leukemic stem cells</article-title>. <source>Blood</source>. <year>2025</year>;<volume>145</volume>(<issue>17</issue>):<fpage>1903</fpage>&#x02010;<lpage>14</lpage>.<pub-id pub-id-type="pmid">39912669</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0209"><label>209</label><mixed-citation publication-type="journal" id="cac270067-cite-0210">
<string-name>
<surname>Li</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Kang</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Klionsky</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Tang</surname>
<given-names>D</given-names>
</string-name>. <article-title>Mitochondrial DNA stress triggers autophagy&#x02010;dependent ferroptotic death</article-title>. <source>Autophagy</source>. <year>2021</year>;<volume>17</volume>(<issue>4</issue>):<fpage>948</fpage>&#x02010;<lpage>60</lpage>.<pub-id pub-id-type="pmid">32186434</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0210"><label>210</label><mixed-citation publication-type="journal" id="cac270067-cite-0211">
<string-name>
<surname>Jia</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Qin</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Chai</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Yu</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>W</given-names>
</string-name>, et&#x000a0;al. <article-title>Redox homeostasis maintained by GPX4 facilitates STING activation</article-title>. <source>Nat Immunol</source>. <year>2020</year>;<volume>21</volume>(<issue>7</issue>):<fpage>727</fpage>&#x02010;<lpage>35</lpage>.<pub-id pub-id-type="pmid">32541831</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0211"><label>211</label><mixed-citation publication-type="journal" id="cac270067-cite-0212">
<string-name>
<surname>Bakhoum</surname>
<given-names>SF</given-names>
</string-name>, <string-name>
<surname>Ngo</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Laughney</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Cavallo</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Murphy</surname>
<given-names>CJ</given-names>
</string-name>, <string-name>
<surname>Ly</surname>
<given-names>P</given-names>
</string-name>, et&#x000a0;al. <article-title>Chromosomal instability drives metastasis through a cytosolic DNA response</article-title>. <source>Nature</source>. <year>2018</year>;<volume>553</volume>(<issue>7689</issue>):<fpage>467</fpage>&#x02010;<lpage>72</lpage>.<pub-id pub-id-type="pmid">29342134</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0212"><label>212</label><mixed-citation publication-type="journal" id="cac270067-cite-0213">
<string-name>
<surname>Guan</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Lu</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Jin</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Lu</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Tian</surname>
<given-names>L</given-names>
</string-name>, et&#x000a0;al. <article-title>MLH1 Deficiency&#x02010;Triggered DNA Hyperexcision by Exonuclease 1 Activates the cGAS&#x02010;STING Pathway</article-title>. <source>Cancer Cell</source>. <year>2021</year>;<volume>39</volume>(<issue>1</issue>):<fpage>109</fpage>&#x02010;<lpage>21</lpage> e5.<pub-id pub-id-type="pmid">33338427</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0213"><label>213</label><mixed-citation publication-type="journal" id="cac270067-cite-0214">
<string-name>
<surname>Li</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Tu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>J</given-names>
</string-name>, et&#x000a0;al. <article-title>ATM inhibition enhance immunotherapy by activating STING signaling and augmenting MHC Class I</article-title>. <source>Cell Death Dis</source>. <year>2024</year>;<volume>15</volume>(<issue>7</issue>):<fpage>519</fpage>.<pub-id pub-id-type="pmid">39033176</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0214"><label>214</label><mixed-citation publication-type="journal" id="cac270067-cite-0215">
<string-name>
<surname>Jiang</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Jia</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>Y</given-names>
</string-name>, et&#x000a0;al. <article-title>Alterations of DNA damage response pathway: Biomarker and therapeutic strategy for cancer immunotherapy</article-title>. <source>Acta Pharm Sin B</source>. <year>2021</year>;<volume>11</volume>(<issue>10</issue>):<fpage>2983</fpage>&#x02010;<lpage>94</lpage>.<pub-id pub-id-type="pmid">34729299</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0215"><label>215</label><mixed-citation publication-type="journal" id="cac270067-cite-0216">
<string-name>
<surname>Najafi</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Mortezaee</surname>
<given-names>K</given-names>
</string-name>. <article-title>Advances in dendritic cell vaccination therapy of cancer</article-title>. <source>Biomed Pharmacother</source>. <year>2023</year>;<volume>164</volume>:<elocation-id>114954</elocation-id>.<pub-id pub-id-type="pmid">37257227</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0216"><label>216</label><mixed-citation publication-type="journal" id="cac270067-cite-0217">
<string-name>
<surname>Ribeiro</surname>
<given-names>ARS</given-names>
</string-name>, <string-name>
<surname>Neuper</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Horejs&#x02010;Hoeck</surname>
<given-names>J</given-names>
</string-name>. <article-title>The Role of STING&#x02010;Mediated Activation of Dendritic Cells in Cancer Immunotherapy</article-title>. <source>Int J Nanomedicine</source>. <year>2024</year>;<volume>19</volume>:<fpage>10685</fpage>&#x02010;<lpage>97</lpage>.<pub-id pub-id-type="pmid">39464674</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0217"><label>217</label><mixed-citation publication-type="journal" id="cac270067-cite-0218">
<string-name>
<surname>Li</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Zheng</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Shen</surname>
<given-names>Y</given-names>
</string-name>, et&#x000a0;al. <article-title>cGAS&#x02010;STING pathway mediates activation of dendritic cell sensing of immunogenic tumors</article-title>. <source>Cell Mol Life Sci</source>. <year>2024</year>;<volume>81</volume>(<issue>1</issue>):<fpage>149</fpage>.<pub-id pub-id-type="pmid">38512518</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0218"><label>218</label><mixed-citation publication-type="journal" id="cac270067-cite-0219">
<string-name>
<surname>Park</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Ahn</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Barber</surname>
<given-names>GN</given-names>
</string-name>. <article-title>Antigen&#x02010;presenting cell activation requires intrinsic and extrinsic STING signaling after the phagocytosis of DNA&#x02010;damaged cells</article-title>. <source>Sci Immunol</source>. <year>2024</year>;<volume>9</volume>(<issue>102</issue>):<elocation-id>eadk7812</elocation-id>.<pub-id pub-id-type="pmid">39705336</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0219"><label>219</label><mixed-citation publication-type="journal" id="cac270067-cite-0220">
<string-name>
<surname>Fuertes</surname>
<given-names>MB</given-names>
</string-name>, <string-name>
<surname>Kacha</surname>
<given-names>AK</given-names>
</string-name>, <string-name>
<surname>Kline</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Woo</surname>
<given-names>SR</given-names>
</string-name>, <string-name>
<surname>Kranz</surname>
<given-names>DM</given-names>
</string-name>, <string-name>
<surname>Murphy</surname>
<given-names>KM</given-names>
</string-name>, et&#x000a0;al. <article-title>Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8alpha+ dendritic cells</article-title>. <source>J Exp Med</source>. <year>2011</year>;<volume>208</volume>(<issue>10</issue>):<fpage>2005</fpage>&#x02010;<lpage>16</lpage>.<pub-id pub-id-type="pmid">21930765</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0220"><label>220</label><mixed-citation publication-type="journal" id="cac270067-cite-0221">
<string-name>
<surname>Diamond</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Vanpouille&#x02010;Box</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Spada</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Rudqvist</surname>
<given-names>NP</given-names>
</string-name>, <string-name>
<surname>Chapman</surname>
<given-names>JR</given-names>
</string-name>, <string-name>
<surname>Ueberheide</surname>
<given-names>BM</given-names>
</string-name>, et&#x000a0;al. <article-title>Exosomes Shuttle TREX1&#x02010;Sensitive IFN&#x02010;Stimulatory dsDNA from Irradiated Cancer Cells to DCs</article-title>. <source>Cancer Immunol Res</source>. <year>2018</year>;<volume>6</volume>(<issue>8</issue>):<fpage>910</fpage>&#x02010;<lpage>20</lpage>.<pub-id pub-id-type="pmid">29907693</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0221"><label>221</label><mixed-citation publication-type="journal" id="cac270067-cite-0222">
<string-name>
<surname>Wang</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Hu</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Shi</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>L</given-names>
</string-name>, et&#x000a0;al. <article-title>cGAS is essential for the antitumor effect of immune checkpoint blockade</article-title>. <source>Proc Natl Acad Sci U S A.</source>
<year>2017</year>;<volume>114</volume>(<issue>7</issue>):<fpage>1637</fpage>&#x02010;<lpage>42</lpage>.<pub-id pub-id-type="pmid">28137885</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0222"><label>222</label><mixed-citation publication-type="journal" id="cac270067-cite-0223">
<string-name>
<surname>Woo</surname>
<given-names>SR</given-names>
</string-name>, <string-name>
<surname>Fuertes</surname>
<given-names>MB</given-names>
</string-name>, <string-name>
<surname>Corrales</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Spranger</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Furdyna</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Leung</surname>
<given-names>MY</given-names>
</string-name>, et&#x000a0;al. <article-title>STING&#x02010;dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors</article-title>. <source>Immunity</source>. <year>2014</year>;<volume>41</volume>(<issue>5</issue>):<fpage>830</fpage>&#x02010;<lpage>42</lpage>.<pub-id pub-id-type="pmid">25517615</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0223"><label>223</label><mixed-citation publication-type="journal" id="cac270067-cite-0224">
<string-name>
<surname>Duong</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Fessenden</surname>
<given-names>TB</given-names>
</string-name>, <string-name>
<surname>Lutz</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Dinter</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Yim</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Blatt</surname>
<given-names>S</given-names>
</string-name>, et&#x000a0;al. <article-title>Type I interferon activates MHC class I&#x02010;dressed CD11b(+) conventional dendritic cells to promote protective anti&#x02010;tumor CD8(+) T cell immunity</article-title>. <source>Immunity</source>. <year>2022</year>;<volume>55</volume>(<issue>2</issue>):<fpage>308</fpage>&#x02010;<lpage>23</lpage> e9.<pub-id pub-id-type="pmid">34800368</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0224"><label>224</label><mixed-citation publication-type="journal" id="cac270067-cite-0225">
<string-name>
<surname>Cheng</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Cai</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Zhu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Liang</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>W</given-names>
</string-name>. <article-title>Tumor&#x02010;associated macrophages in liver cancer: From mechanisms to therapy</article-title>. <source>Cancer Commun (Lond)</source>. <year>2022</year>;<volume>42</volume>(<issue>11</issue>):<fpage>1112</fpage>&#x02010;<lpage>40</lpage>.<pub-id pub-id-type="pmid">36069342</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0225"><label>225</label><mixed-citation publication-type="journal" id="cac270067-cite-0226">
<string-name>
<surname>Zhu</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Yi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Dong</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>K</given-names>
</string-name>. <article-title>Roles of tumor&#x02010;associated macrophages in tumor progression: implications on therapeutic strategies</article-title>. <source>Exp Hematol Oncol</source>. <year>2021</year>;<volume>10</volume>(<issue>1</issue>):<fpage>60</fpage>.<pub-id pub-id-type="pmid">34965886</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0226"><label>226</label><mixed-citation publication-type="journal" id="cac270067-cite-0227">
<string-name>
<surname>Ohkuri</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Kosaka</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Ishibashi</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Kumai</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Hirata</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Ohara</surname>
<given-names>K</given-names>
</string-name>, et&#x000a0;al. <article-title>Intratumoral administration of cGAMP transiently accumulates potent macrophages for anti&#x02010;tumor immunity at a mouse tumor site</article-title>. <source>Cancer Immunol Immunother</source>. <year>2017</year>;<volume>66</volume>(<issue>6</issue>):<fpage>705</fpage>&#x02010;<lpage>16</lpage>.<pub-id pub-id-type="pmid">28243692</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0227"><label>227</label><mixed-citation publication-type="journal" id="cac270067-cite-0228">
<string-name>
<surname>Zhu</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Tang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Zhu</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Gong</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Tang</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Hu</surname>
<given-names>Y</given-names>
</string-name>, et&#x000a0;al. <article-title>STING activation in macrophages by vanillic acid exhibits antineoplastic potential</article-title>. <source>Biochem Pharmacol</source>. <year>2023</year>;<volume>213</volume>:<elocation-id>115618</elocation-id>.<pub-id pub-id-type="pmid">37211172</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0228"><label>228</label><mixed-citation publication-type="journal" id="cac270067-cite-0229">
<string-name>
<surname>Liu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Ding</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Zheng</surname>
<given-names>Q</given-names>
</string-name>, et&#x000a0;al. <article-title>STING&#x02010;IRG1 inhibits liver metastasis of colorectal cancer by regulating the polarization of tumor&#x02010;associated macrophages</article-title>. <source>iScience</source>. <year>2023</year>;<volume>26</volume>(<issue>8</issue>):<elocation-id>107376</elocation-id>.<pub-id pub-id-type="pmid">37554436</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0229"><label>229</label><mixed-citation publication-type="journal" id="cac270067-cite-0230">
<string-name>
<surname>Wang</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Bergholz</surname>
<given-names>JS</given-names>
</string-name>, <string-name>
<surname>Ding</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Lin</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Kabraji</surname>
<given-names>SK</given-names>
</string-name>, <string-name>
<surname>Hughes</surname>
<given-names>ME</given-names>
</string-name>, et&#x000a0;al. <article-title>STING agonism reprograms tumor&#x02010;associated macrophages and overcomes resistance to PARP inhibition in BRCA1&#x02010;deficient models of breast cancer</article-title>. <source>Nat Commun</source>. <year>2022</year>;<volume>13</volume>(<issue>1</issue>):<fpage>3022</fpage>.<pub-id pub-id-type="pmid">35641483</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0230"><label>230</label><mixed-citation publication-type="journal" id="cac270067-cite-0231">
<string-name>
<surname>Downey</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Aghaei</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Schwendener</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Jirik</surname>
<given-names>FR</given-names>
</string-name>. <article-title>DMXAA causes tumor site&#x02010;specific vascular disruption in murine non&#x02010;small cell lung cancer, and like the endogenous non&#x02010;canonical cyclic dinucleotide STING agonist, 2&#x02032;3&#x02032;&#x02010;cGAMP, induces M2 macrophage repolarization</article-title>. <source>PLoS One</source>. <year>2014</year>;<volume>9</volume>(<issue>6</issue>):<elocation-id>e99988</elocation-id>.<pub-id pub-id-type="pmid">24940883</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0231"><label>231</label><mixed-citation publication-type="journal" id="cac270067-cite-0232">
<string-name>
<surname>Petrovic</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Majchrzak</surname>
<given-names>OB</given-names>
</string-name>, <string-name>
<surname>Marecar</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Laingoniaina</surname>
<given-names>AC</given-names>
</string-name>, <string-name>
<surname>Walker</surname>
<given-names>PR</given-names>
</string-name>, <string-name>
<surname>Borchard</surname>
<given-names>G</given-names>
</string-name>, et&#x000a0;al. <article-title>Combining antimiR&#x02010;25 and cGAMP Nanocomplexes Enhances Immune Responses via M2 Macrophage Reprogramming</article-title>. <source>Int J Mol Sci</source>. <year>2024</year>;<volume>25</volume>(<issue>23</issue>):<elocation-id>12787</elocation-id>.<pub-id pub-id-type="pmid">39684497</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0232"><label>232</label><mixed-citation publication-type="journal" id="cac270067-cite-0233">
<string-name>
<surname>Sun</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Hu</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Gao</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Zhan</surname>
<given-names>X</given-names>
</string-name>, et&#x000a0;al. <article-title>Macrophage STING signaling promotes NK cell to suppress colorectal cancer liver metastasis via 4&#x02010;1BBL/4&#x02010;1BB co&#x02010;stimulation</article-title>. <source>J Immunother Cancer</source>. <year>2023</year>;<volume>11</volume>(<issue>3</issue>):<elocation-id>e006481</elocation-id>.<pub-id pub-id-type="pmid">36927529</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0233"><label>233</label><mixed-citation publication-type="journal" id="cac270067-cite-0234">
<string-name>
<surname>Knox</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Jeltema</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Dobbs</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Xing</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Song</surname>
<given-names>K</given-names>
</string-name>, et&#x000a0;al. <article-title>Dynamic STING repression orchestrates immune cell development and function</article-title>. <source>Sci Immunol</source>. <year>2025</year>;<volume>10</volume>(<issue>105</issue>):<elocation-id>eado9933</elocation-id>.<pub-id pub-id-type="pmid">40053603</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0234"><label>234</label><mixed-citation publication-type="journal" id="cac270067-cite-0235">
<string-name>
<surname>Benguigui</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Cooper</surname>
<given-names>TJ</given-names>
</string-name>, <string-name>
<surname>Kalkar</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Schif&#x02010;Zuck</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Halaban</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Bacchiocchi</surname>
<given-names>A</given-names>
</string-name>, et&#x000a0;al. <article-title>Interferon&#x02010;stimulated neutrophils as a predictor of immunotherapy response</article-title>. <source>Cancer Cell</source>. <year>2024</year>;<volume>42</volume>(<issue>2</issue>):<fpage>253</fpage>&#x02010;<lpage>65</lpage>.e12.<pub-id pub-id-type="pmid">38181798</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0235"><label>235</label><mixed-citation publication-type="journal" id="cac270067-cite-0236">
<string-name>
<surname>Tang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Cui</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Han</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Cai</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Feng</surname>
<given-names>Z</given-names>
</string-name>, et&#x000a0;al. <article-title>Converting &#x0201c;cold&#x0201d; to &#x0201c;hot&#x0201d;: epigenetics strategies to improve immune therapy effect by regulating tumor&#x02010;associated immune suppressive cells</article-title>. <source>Cancer Commun (Lond)</source>. <year>2024</year>;<volume>44</volume>(<issue>6</issue>):<fpage>601</fpage>&#x02010;<lpage>36</lpage>.<pub-id pub-id-type="pmid">38715348</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0236"><label>236</label><mixed-citation publication-type="journal" id="cac270067-cite-0237">
<string-name>
<surname>Lu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Luo</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Rao</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Lei</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>X</given-names>
</string-name>, et&#x000a0;al. <article-title>Myeloid&#x02010;derived suppressor cells in cancer: therapeutic targets to overcome tumor immune evasion</article-title>. <source>Exp Hematol Oncol</source>. <year>2024</year>;<volume>13</volume>(<issue>1</issue>):<fpage>39</fpage>.<pub-id pub-id-type="pmid">38609997</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0237"><label>237</label><mixed-citation publication-type="journal" id="cac270067-cite-0238">
<string-name>
<surname>Zhang</surname>
<given-names>CX</given-names>
</string-name>, <string-name>
<surname>Ye</surname>
<given-names>SB</given-names>
</string-name>, <string-name>
<surname>Ni</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>Cai</surname>
<given-names>TT</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>YN</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>DJ</given-names>
</string-name>, et&#x000a0;al. <article-title>STING signaling remodels the tumor microenvironment by antagonizing myeloid&#x02010;derived suppressor cell expansion</article-title>. <source>Cell Death Differ</source>. <year>2019</year>;<volume>26</volume>(<issue>11</issue>):<fpage>2314</fpage>&#x02010;<lpage>28</lpage>.<pub-id pub-id-type="pmid">30816302</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0238"><label>238</label><mixed-citation publication-type="journal" id="cac270067-cite-0239">
<string-name>
<surname>Chandra</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Quispe&#x02010;Tintaya</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Jahangir</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Asafu&#x02010;Adjei</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Ramos</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Sintim</surname>
<given-names>HO</given-names>
</string-name>, et&#x000a0;al. <article-title>STING ligand c&#x02010;di&#x02010;GMP improves cancer vaccination against metastatic breast cancer</article-title>. <source>Cancer Immunol Res</source>. <year>2014</year>;<volume>2</volume>(<issue>9</issue>):<fpage>901</fpage>&#x02010;<lpage>10</lpage>.<pub-id pub-id-type="pmid">24913717</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0239"><label>239</label><mixed-citation publication-type="journal" id="cac270067-cite-0240">
<string-name>
<surname>Ohkuri</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Ghosh</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Kosaka</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Zhu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Ikeura</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>David</surname>
<given-names>M</given-names>
</string-name>, et&#x000a0;al. <article-title>STING contributes to antiglioma immunity via triggering type I IFN signals in the tumor microenvironment</article-title>. <source>Cancer Immunol Res</source>. <year>2014</year>;<volume>2</volume>(<issue>12</issue>):<fpage>1199</fpage>&#x02010;<lpage>208</lpage>.<pub-id pub-id-type="pmid">25300859</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0240"><label>240</label><mixed-citation publication-type="journal" id="cac270067-cite-0241">
<string-name>
<surname>Huang</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Cha</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Lin</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Gafoor</surname>
<given-names>NA</given-names>
</string-name>, <string-name>
<surname>Kong</surname>
<given-names>T</given-names>
</string-name>, et&#x000a0;al. <article-title>Enhancing immunotherapy outcomes by targeted remodeling of the tumor microenvironment via combined cGAS&#x02010;STING pathway strategies</article-title>. <source>Front Immunol</source>. <year>2024</year>;<volume>15</volume>:<elocation-id>1399926</elocation-id>.<pub-id pub-id-type="pmid">38817608</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0241"><label>241</label><mixed-citation publication-type="journal" id="cac270067-cite-0242">
<string-name>
<surname>Wang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Lin</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Zhu</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Ye</surname>
<given-names>Z</given-names>
</string-name>. <article-title>GAS&#x02010;STING: a classical DNA recognition pathways to tumor therapy</article-title>. <source>Front Immunol</source>. <year>2023</year>;<volume>14</volume>:<elocation-id>1200245</elocation-id>.<pub-id pub-id-type="pmid">37920470</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0242"><label>242</label><mixed-citation publication-type="journal" id="cac270067-cite-0243">
<string-name>
<surname>Benoit&#x02010;Lizon</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Jacquin</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Rivera Vargas</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Richard</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Roussey</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Dal Zuffo</surname>
<given-names>L</given-names>
</string-name>, et&#x000a0;al. <article-title>CD4 T cell&#x02010;intrinsic STING signaling controls the differentiation and effector functions of T(H)1 and T(H)9 cells</article-title>. <source>J Immunother Cancer</source>. <year>2022</year>;<volume>10</volume>(<issue>1</issue>):<elocation-id>e003459</elocation-id>.<pub-id pub-id-type="pmid">35091453</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0243"><label>243</label><mixed-citation publication-type="journal" id="cac270067-cite-0244">
<string-name>
<surname>Li</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Lu</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Lu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Jin</surname>
<given-names>J</given-names>
</string-name>, et&#x000a0;al. <article-title>cGAS&#x02010;STING&#x02010;mediated DNA sensing maintains CD8(+) T cell stemness and promotes antitumor T cell therapy</article-title>. <source>Sci Transl Med</source>. <year>2020</year>;<volume>12</volume>(<issue>549</issue>):<elocation-id>eaay9013</elocation-id>.<pub-id pub-id-type="pmid">32581136</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0244"><label>244</label><mixed-citation publication-type="journal" id="cac270067-cite-0245">
<string-name>
<surname>Xu</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Hua</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Jiang</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Jin</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>R</given-names>
</string-name>, et&#x000a0;al. <article-title>Intrinsic STING of CD8&#x02009;+&#x02009;T cells regulates self&#x02010;metabolic reprogramming and memory to exert anti&#x02010;tumor effects</article-title>. <source>Cell Commun Signal</source>. <year>2025</year>;<volume>23</volume>(<issue>1</issue>):<fpage>99</fpage>.<pub-id pub-id-type="pmid">39972350</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0245"><label>245</label><mixed-citation publication-type="journal" id="cac270067-cite-0246">
<string-name>
<surname>Herbst</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>K&#x000f6;ksal</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Brunn</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Zanetti</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Domocos</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>De Stefani</surname>
<given-names>V</given-names>
</string-name>, et&#x000a0;al. <article-title>Cancer&#x02010;cell&#x02010;derived cGAMP limits the activity of tumor&#x02010;associated CD8(+) T cells</article-title>. <source>Cell Rep</source>. <year>2025</year>;<volume>44</volume>(<issue>4</issue>):<elocation-id>115510</elocation-id>.<pub-id pub-id-type="pmid">40178978</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0246"><label>246</label><mixed-citation publication-type="journal" id="cac270067-cite-0247">
<string-name>
<surname>Nicolai</surname>
<given-names>CJ</given-names>
</string-name>, <string-name>
<surname>Wolf</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Chang</surname>
<given-names>IC</given-names>
</string-name>, <string-name>
<surname>Kirn</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Marcus</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Ndubaku</surname>
<given-names>CO</given-names>
</string-name>, et&#x000a0;al. <article-title>NK cells mediate clearance of CD8(+) T cell&#x02010;resistant tumors in response to STING agonists</article-title>. <source>Sci Immunol</source>. <year>2020</year>;<volume>5</volume>(<issue>45</issue>):<elocation-id>eaaz2738</elocation-id>.<pub-id pub-id-type="pmid">32198222</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0247"><label>247</label><mixed-citation publication-type="journal" id="cac270067-cite-0248">
<string-name>
<surname>Marcus</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Mao</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Lensink&#x02010;Vasan</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Vance</surname>
<given-names>RE</given-names>
</string-name>, <article-title>Raulet DH. Tumor&#x02010;Derived cGAMP Triggers a STING&#x02010;Mediated Interferon Response in Non&#x02010;tumor Cells to Activate the NK Cell Response</article-title>. <source>Immunity</source>. <year>2018</year>;<volume>49</volume>(<issue>4</issue>):<fpage>754</fpage>&#x02010;<lpage>63</lpage> e4.<pub-id pub-id-type="pmid">30332631</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0248"><label>248</label><mixed-citation publication-type="journal" id="cac270067-cite-0249">
<string-name>
<surname>Lu</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Hong</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>W</given-names>
</string-name>, et&#x000a0;al. <article-title>STING signaling promotes NK cell antitumor immunity and maintains a reservoir of TCF&#x02010;1(+) NK cells</article-title>. <source>Cell Rep</source>. <year>2023</year>;<volume>42</volume>(<issue>9</issue>):<elocation-id>113108</elocation-id>.<pub-id pub-id-type="pmid">37708030</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0249"><label>249</label><mixed-citation publication-type="journal" id="cac270067-cite-0250">
<string-name>
<surname>Domvri</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Petanidis</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Zarogoulidis</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Anestakis</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Tsavlis</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Bai</surname>
<given-names>C</given-names>
</string-name>, et&#x000a0;al. <article-title>Treg&#x02010;dependent immunosuppression triggers effector T cell dysfunction via the STING/ILC2 axis</article-title>. <source>Clin Immunol</source>. <year>2021</year>;<volume>222</volume>:<elocation-id>108620</elocation-id>.<pub-id pub-id-type="pmid">33176208</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0250"><label>250</label><mixed-citation publication-type="journal" id="cac270067-cite-0251">
<string-name>
<surname>Zhang</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Zhan</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Duan</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>J</given-names>
</string-name>, et&#x000a0;al. <article-title>Treg&#x02010;derived TGF&#x02010;&#x003b2;1 dampens cGAS&#x02010;STING signaling to downregulate the expression of class I MHC complex in multiple myeloma</article-title>. <source>Sci Rep</source>. <year>2024</year>;<volume>14</volume>(<issue>1</issue>):<elocation-id>11593</elocation-id>.<pub-id pub-id-type="pmid">38773213</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0251"><label>251</label><mixed-citation publication-type="journal" id="cac270067-cite-0252">
<string-name>
<surname>Yan</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Lu</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>F</given-names>
</string-name>. <article-title>The cGAS&#x02010;STING pathway: a therapeutic target in chromosomally unstable cancers</article-title>. <source>Signal Transduct Target Ther</source>. <year>2023</year>;<volume>8</volume>(<issue>1</issue>):<fpage>45</fpage>.<pub-id pub-id-type="pmid">36717545</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0252"><label>252</label><mixed-citation publication-type="journal" id="cac270067-cite-0253">
<string-name>
<surname>Zhang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Jiang</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Zhong</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Jing</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Song</surname>
<given-names>J</given-names>
</string-name>, et&#x000a0;al. <article-title>STING is a cell&#x02010;intrinsic metabolic checkpoint restricting aerobic glycolysis by targeting HK2</article-title>. <source>Nat Cell Biol</source>. <year>2023</year>;<volume>25</volume>(<issue>8</issue>):<fpage>1208</fpage>&#x02010;<lpage>22</lpage>.<pub-id pub-id-type="pmid">37443289</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0253"><label>253</label><mixed-citation publication-type="journal" id="cac270067-cite-0254">
<string-name>
<surname>Giordo</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Wehbe</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Paliogiannis</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Eid</surname>
<given-names>AH</given-names>
</string-name>, <string-name>
<surname>Mangoni</surname>
<given-names>AA</given-names>
</string-name>, <string-name>
<surname>Pintus</surname>
<given-names>G</given-names>
</string-name>. <article-title>Nano&#x02010;targeting vascular remodeling in cancer: Recent developments and future directions</article-title>. <source>Semin Cancer Biol</source>. <year>2022</year>;<volume>86</volume>(<issue>Pt 2</issue>):<fpage>784</fpage>&#x02010;<lpage>804</lpage>.<pub-id pub-id-type="pmid">35257860</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0254"><label>254</label><mixed-citation publication-type="journal" id="cac270067-cite-0255">
<string-name>
<surname>Lv</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Zong</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Lv</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Xiang</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Xing</surname>
<given-names>F</given-names>
</string-name>, et&#x000a0;al. <article-title>TET2&#x02010;mediated tumor cGAS triggers endothelial STING activation to regulate vasculature remodeling and anti&#x02010;tumor immunity in liver cancer</article-title>. <source>Nat Commun</source>. <year>2024</year>;<volume>15</volume>(<issue>1</issue>):<fpage>6</fpage>.<pub-id pub-id-type="pmid">38177099</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0255"><label>255</label><mixed-citation publication-type="journal" id="cac270067-cite-0256">
<string-name>
<surname>Lee</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>WR</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>YS</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>WS</given-names>
</string-name>, <string-name>
<surname>Kong</surname>
<given-names>SJ</given-names>
</string-name>, et&#x000a0;al. <article-title>STING activation normalizes the intraperitoneal vascular&#x02010;immune microenvironment and suppresses peritoneal carcinomatosis of colon cancer</article-title>. <source>J Immunother Cancer</source>. <year>2021</year>;<volume>9</volume>(<issue>6</issue>):<elocation-id>e002195</elocation-id>.<pub-id pub-id-type="pmid">34145029</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0256"><label>256</label><mixed-citation publication-type="journal" id="cac270067-cite-0257">
<string-name>
<surname>Diamond</surname>
<given-names>MS</given-names>
</string-name>, <string-name>
<surname>Kinder</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Matsushita</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Mashayekhi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Dunn</surname>
<given-names>GP</given-names>
</string-name>, <string-name>
<surname>Archambault</surname>
<given-names>JM</given-names>
</string-name>, et&#x000a0;al. <article-title>Type I interferon is selectively required by dendritic cells for immune rejection of tumors</article-title>. <source>J Exp Med</source>. <year>2011</year>;<volume>208</volume>(<issue>10</issue>):<fpage>1989</fpage>&#x02010;<lpage>2003</lpage>.<pub-id pub-id-type="pmid">21930769</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0257"><label>257</label><mixed-citation publication-type="journal" id="cac270067-cite-0258">
<string-name>
<surname>Fuertes</surname>
<given-names>MB</given-names>
</string-name>, <string-name>
<surname>Kacha</surname>
<given-names>AK</given-names>
</string-name>, <string-name>
<surname>Kline</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Woo</surname>
<given-names>SR</given-names>
</string-name>, <string-name>
<surname>Kranz</surname>
<given-names>DM</given-names>
</string-name>, <string-name>
<surname>Murphy</surname>
<given-names>KM</given-names>
</string-name>, et&#x000a0;al. <article-title>Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8{alpha}+ dendritic cells</article-title>. <source>J Exp Med</source>. <year>2011</year>;<volume>208</volume>(<issue>10</issue>):<fpage>2005</fpage>&#x02010;<lpage>16</lpage>.<pub-id pub-id-type="pmid">21930765</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0258"><label>258</label><mixed-citation publication-type="journal" id="cac270067-cite-0259">
<string-name>
<surname>Lu</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Klement</surname>
<given-names>JD</given-names>
</string-name>, <string-name>
<surname>Ibrahim</surname>
<given-names>ML</given-names>
</string-name>, <string-name>
<surname>Xiao</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Redd</surname>
<given-names>PS</given-names>
</string-name>, <string-name>
<surname>Nayak&#x02010;Kapoor</surname>
<given-names>A</given-names>
</string-name>, et&#x000a0;al. <article-title>Type I interferon suppresses tumor growth through activating the STAT3&#x02010;granzyme B pathway in tumor&#x02010;infiltrating cytotoxic T lymphocytes</article-title>. <source>J Immunother Cancer</source>. <year>2019</year>;<volume>7</volume>(<issue>1</issue>):<fpage>157</fpage>.<pub-id pub-id-type="pmid">31228946</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0259"><label>259</label><mixed-citation publication-type="journal" id="cac270067-cite-0260">
<string-name>
<surname>Swann</surname>
<given-names>JB</given-names>
</string-name>, <string-name>
<surname>Hayakawa</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Zerafa</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Sheehan</surname>
<given-names>KC</given-names>
</string-name>, <string-name>
<surname>Scott</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Schreiber</surname>
<given-names>RD</given-names>
</string-name>, et&#x000a0;al. <article-title>Type I IFN contributes to NK cell homeostasis, activation, and antitumor function</article-title>. <source>J Immunol</source>. <year>2007</year>;<volume>178</volume>(<issue>12</issue>):<fpage>7540</fpage>&#x02010;<lpage>9</lpage>.<pub-id pub-id-type="pmid">17548588</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0260"><label>260</label><mixed-citation publication-type="journal" id="cac270067-cite-0261">
<string-name>
<surname>Hong</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Schubert</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Tijhuis</surname>
<given-names>AE</given-names>
</string-name>, <string-name>
<surname>Requesens</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Roorda</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>van den Brink</surname>
<given-names>A</given-names>
</string-name>, et&#x000a0;al. <article-title>cGAS&#x02010;STING drives the IL&#x02010;6&#x02010;dependent survival of chromosomally instable cancers</article-title>. <source>Nature</source>. <year>2022</year>;<volume>607</volume>(<issue>7918</issue>):<fpage>366</fpage>&#x02010;<lpage>73</lpage>.<pub-id pub-id-type="pmid">35705809</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0261"><label>261</label><mixed-citation publication-type="journal" id="cac270067-cite-0262">
<string-name>
<surname>Chen</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Liang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Peterson</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Munn</surname>
<given-names>DH</given-names>
</string-name>, <string-name>
<surname>Blazar</surname>
<given-names>BR</given-names>
</string-name>. <article-title>The indoleamine 2,3&#x02010;dioxygenase pathway is essential for human plasmacytoid dendritic cell&#x02010;induced adaptive T regulatory cell generation</article-title>. <source>J Immunol</source>. <year>2008</year>;<volume>181</volume>(<issue>8</issue>):<fpage>5396</fpage>&#x02010;<lpage>404</lpage>.<pub-id pub-id-type="pmid">18832696</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0262"><label>262</label><mixed-citation publication-type="journal" id="cac270067-cite-0263">
<string-name>
<surname>Gato&#x02010;Ca&#x000f1;as</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Zuazo</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Arasanz</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Iba&#x000f1;ez&#x02010;Vea</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Lorenzo</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Fernandez&#x02010;Hinojal</surname>
<given-names>G</given-names>
</string-name>, et&#x000a0;al. <article-title>PDL1 Signals through Conserved Sequence Motifs to Overcome Interferon&#x02010;Mediated Cytotoxicity</article-title>. <source>Cell Rep</source>. <year>2017</year>;<volume>20</volume>(<issue>8</issue>):<fpage>1818</fpage>&#x02010;<lpage>29</lpage>.<pub-id pub-id-type="pmid">28834746</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0263"><label>263</label><mixed-citation publication-type="journal" id="cac270067-cite-0264">
<string-name>
<surname>Li</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Duran</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Dhanota</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Chatila</surname>
<given-names>WK</given-names>
</string-name>, <string-name>
<surname>Bettigole</surname>
<given-names>SE</given-names>
</string-name>, <string-name>
<surname>Kwon</surname>
<given-names>J</given-names>
</string-name>, et&#x000a0;al. <article-title>Metastasis and Immune Evasion from Extracellular cGAMP Hydrolysis</article-title>. <source>Cancer Discov</source>. <year>2021</year>;<volume>11</volume>(<issue>5</issue>):<fpage>1212</fpage>&#x02010;<lpage>27</lpage>.<pub-id pub-id-type="pmid">33372007</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0264"><label>264</label><mixed-citation publication-type="journal" id="cac270067-cite-0265">
<string-name>
<surname>Cao</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Quazi</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Arora</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Osellame</surname>
<given-names>LD</given-names>
</string-name>, <string-name>
<surname>Burvenich</surname>
<given-names>IJ</given-names>
</string-name>, <string-name>
<surname>Janes</surname>
<given-names>PW</given-names>
</string-name>, et&#x000a0;al. <article-title>Cancer&#x02010;associated fibroblasts as therapeutic targets for cancer: advances, challenges, and future prospects</article-title>. <source>J Biomed Sci</source>. <year>2025</year>;<volume>32</volume>(<issue>1</issue>):<fpage>7</fpage>.<pub-id pub-id-type="pmid">39780187</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0265"><label>265</label><mixed-citation publication-type="journal" id="cac270067-cite-0266">
<string-name>
<surname>Raaijmakers</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Adema</surname>
<given-names>GJ</given-names>
</string-name>, <string-name>
<surname>Bussink</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Ansems</surname>
<given-names>M</given-names>
</string-name>. <article-title>Cancer&#x02010;associated fibroblasts, tumor and radiotherapy: interactions in the tumor micro&#x02010;environment</article-title>. <source>J Exp Clin Cancer Res</source>. <year>2024</year>;<volume>43</volume>(<issue>1</issue>):<fpage>323</fpage>.<pub-id pub-id-type="pmid">39696386</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0266"><label>266</label><mixed-citation publication-type="journal" id="cac270067-cite-0267">
<string-name>
<surname>Arpinati</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Carradori</surname>
<given-names>G</given-names>
</string-name>, <article-title>Scherz&#x02010;Shouval R. CAF&#x02010;induced physical constraints controlling T cell state and localization in solid tumours</article-title>. <source>Nat Rev Cancer</source>. <year>2024</year>;<volume>24</volume>(<issue>10</issue>):<fpage>676</fpage>&#x02010;<lpage>93</lpage>.<pub-id pub-id-type="pmid">39251836</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0267"><label>267</label><mixed-citation publication-type="journal" id="cac270067-cite-0268">
<string-name>
<surname>Ma</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Mao</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Wei</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>G</given-names>
</string-name>, et&#x000a0;al. <article-title>Interferon&#x02010;dependent SLC14A1(+) cancer&#x02010;associated fibroblasts promote cancer stemness via WNT5A in bladder cancer</article-title>. <source>Cancer Cell</source>. <year>2022</year>;<volume>40</volume>(<issue>12</issue>):<fpage>1550</fpage>&#x02010;<lpage>65</lpage> e7.<pub-id pub-id-type="pmid">36459995</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0268"><label>268</label><mixed-citation publication-type="journal" id="cac270067-cite-0269">
<string-name>
<surname>Liu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Ma</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Pan</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Chu</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Yao</surname>
<given-names>S</given-names>
</string-name>, et&#x000a0;al. <article-title>STING inhibitors sensitize platinum chemotherapy in ovarian cancer by inhibiting the CGAS&#x02010;STING pathway in cancer&#x02010;associated fibroblasts (CAFs)</article-title>. <source>Cancer Lett</source>. <year>2024</year>;<volume>588</volume>:<elocation-id>216700</elocation-id>.<pub-id pub-id-type="pmid">38373690</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0269"><label>269</label><mixed-citation publication-type="journal" id="cac270067-cite-0270">
<string-name>
<surname>Bruand</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Barras</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Mina</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ghisoni</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Morotti</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Lanitis</surname>
<given-names>E</given-names>
</string-name>, et&#x000a0;al. <article-title>Cell&#x02010;autonomous inflammation of BRCA1&#x02010;deficient ovarian cancers drives both tumor&#x02010;intrinsic immunoreactivity and immune resistance via STING</article-title>. <source>Cell Rep</source>. <year>2021</year>;<volume>36</volume>(<issue>3</issue>):<elocation-id>109412</elocation-id>.<pub-id pub-id-type="pmid">34289354</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0270"><label>270</label><mixed-citation publication-type="journal" id="cac270067-cite-0271">
<string-name>
<surname>Fu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Kanne</surname>
<given-names>DB</given-names>
</string-name>, <string-name>
<surname>Leong</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Glickman</surname>
<given-names>LH</given-names>
</string-name>, <string-name>
<surname>McWhirter</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Lemmens</surname>
<given-names>E</given-names>
</string-name>, et&#x000a0;al. <article-title>STING agonist formulated cancer vaccines can cure established tumors resistant to PD&#x02010;1 blockade</article-title>. <source>Sci Transl Med</source>. <year>2015</year>;<volume>7</volume>(<issue>283</issue>):<elocation-id>283ra52</elocation-id>.</mixed-citation></ref><ref id="cac270067-bib-0271"><label>271</label><mixed-citation publication-type="journal" id="cac270067-cite-0272">
<string-name>
<surname>Corrales</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Glickman</surname>
<given-names>LH</given-names>
</string-name>, <string-name>
<surname>McWhirter</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Kanne</surname>
<given-names>DB</given-names>
</string-name>, <string-name>
<surname>Sivick</surname>
<given-names>KE</given-names>
</string-name>, <string-name>
<surname>Katibah</surname>
<given-names>GE</given-names>
</string-name>, et&#x000a0;al. <article-title>Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity</article-title>. <source>Cell Rep</source>. <year>2015</year>;<volume>11</volume>(<issue>7</issue>):<fpage>1018</fpage>&#x02010;<lpage>30</lpage>.<pub-id pub-id-type="pmid">25959818</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0272"><label>272</label><mixed-citation publication-type="journal" id="cac270067-cite-0273">
<string-name>
<surname>Sivick</surname>
<given-names>KE</given-names>
</string-name>, <string-name>
<surname>Desbien</surname>
<given-names>AL</given-names>
</string-name>, <string-name>
<surname>Glickman</surname>
<given-names>LH</given-names>
</string-name>, <string-name>
<surname>Reiner</surname>
<given-names>GL</given-names>
</string-name>, <string-name>
<surname>Corrales</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Surh</surname>
<given-names>NH</given-names>
</string-name>, et&#x000a0;al. <article-title>Magnitude of Therapeutic STING Activation Determines CD8(+) T Cell&#x02010;Mediated Anti&#x02010;tumor Immunity</article-title>. <source>Cell Rep</source>. <year>2018</year>;<volume>25</volume>(<issue>11</issue>):<fpage>3074</fpage>&#x02010;<lpage>85</lpage>.e5.<pub-id pub-id-type="pmid">30540940</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0273"><label>273</label><mixed-citation publication-type="journal" id="cac270067-cite-0274">
<string-name>
<surname>Meric&#x02010;Bernstam</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Sweis</surname>
<given-names>RF</given-names>
</string-name>, <string-name>
<surname>Kasper</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Hamid</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Bhatia</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Dummer</surname>
<given-names>R</given-names>
</string-name>, et&#x000a0;al. <article-title>Combination of the STING Agonist MIW815 (ADU&#x02010;S100) and PD&#x02010;1 Inhibitor Spartalizumab in Advanced/Metastatic Solid Tumors or Lymphomas: An Open&#x02010;Label, Multicenter, Phase Ib Study</article-title>. <source>Clin Cancer Res</source>. <year>2023</year>;<volume>29</volume>(<issue>1</issue>):<fpage>110</fpage>&#x02010;<lpage>21</lpage>.<pub-id pub-id-type="pmid">36282874</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0274"><label>274</label><mixed-citation publication-type="journal" id="cac270067-cite-0275">
<string-name>
<surname>Ramanjulu</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Pesiridis</surname>
<given-names>GS</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Concha</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Singhaus</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>SY</given-names>
</string-name>, et&#x000a0;al. <article-title>Design of amidobenzimidazole STING receptor agonists with systemic activity</article-title>. <source>Nature</source>. <year>2018</year>;<volume>564</volume>(<issue>7736</issue>):<fpage>439</fpage>&#x02010;<lpage>43</lpage>.<pub-id pub-id-type="pmid">30405246</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0275"><label>275</label><mixed-citation publication-type="journal" id="cac270067-cite-0276">
<string-name>
<surname>Pan</surname>
<given-names>BS</given-names>
</string-name>, <string-name>
<surname>Perera</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>Piesvaux</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Presland</surname>
<given-names>JP</given-names>
</string-name>, <string-name>
<surname>Schroeder</surname>
<given-names>GK</given-names>
</string-name>, <string-name>
<surname>Cumming</surname>
<given-names>JN</given-names>
</string-name>, et&#x000a0;al. <article-title>An orally available non&#x02010;nucleotide STING agonist with antitumor activity</article-title>. <source>Science</source>. <year>2020</year>;<volume>369</volume>(<issue>6506</issue>):<elocation-id>eaba6098</elocation-id>.<pub-id pub-id-type="pmid">32820094</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0276"><label>276</label><mixed-citation publication-type="journal" id="cac270067-cite-0277">
<string-name>
<surname>Chin</surname>
<given-names>EN</given-names>
</string-name>, <string-name>
<surname>Yu</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Vartabedian</surname>
<given-names>VF</given-names>
</string-name>, <string-name>
<surname>Jia</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Kumar</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Gamo</surname>
<given-names>AM</given-names>
</string-name>, et&#x000a0;al. <article-title>Antitumor activity of a systemic STING&#x02010;activating non&#x02010;nucleotide cGAMP mimetic</article-title>. <source>Science</source>. <year>2020</year>;<volume>369</volume>(<issue>6506</issue>):<fpage>993</fpage>&#x02010;<lpage>9</lpage>.<pub-id pub-id-type="pmid">32820126</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0277"><label>277</label><mixed-citation publication-type="journal" id="cac270067-cite-0278">
<string-name>
<surname>Patel</surname>
<given-names>MN</given-names>
</string-name>, <string-name>
<surname>Tiwari</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>O'Neill</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Omo&#x02010;Lamai</surname>
<given-names>S</given-names>
</string-name>, et&#x000a0;al. <article-title>Safer non&#x02010;viral DNA delivery using lipid nanoparticles loaded with endogenous anti&#x02010;inflammatory lipids</article-title>. <source>Nat Biotechnol</source>. <year>2025</year>. <pub-id pub-id-type="doi">10.1038/s41587-025-02556-5</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0278"><label>278</label><mixed-citation publication-type="journal" id="cac270067-cite-0279">
<string-name>
<surname>Xu</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Liao</surname>
<given-names>YP</given-names>
</string-name>, <string-name>
<surname>Luo</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Nel</surname>
<given-names>AE</given-names>
</string-name>. <article-title>Reprogramming the Tolerogenic Immune Response Against Pancreatic Cancer Metastases by Lipid Nanoparticles Delivering a STING Agonist Plus Mutant KRAS mRNA</article-title>. <source>ACS Nano</source>. <year>2025</year>;<volume>19</volume>(<issue>9</issue>):<fpage>8579</fpage>&#x02010;<lpage>94</lpage>.<pub-id pub-id-type="pmid">40025875</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0279"><label>279</label><mixed-citation publication-type="journal" id="cac270067-cite-0280">
<string-name>
<surname>Khalifa</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Nakamura</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Sato</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Harashima</surname>
<given-names>H</given-names>
</string-name>. <article-title>Vaccination with a combination of STING agonist&#x02010;loaded lipid nanoparticles and CpG&#x02010;ODNs protects against lung metastasis via the induction of CD11b(high)CD27(low) memory&#x02010;like NK cells</article-title>. <source>Exp Hematol Oncol</source>. <year>2024</year>;<volume>13</volume>(<issue>1</issue>):<fpage>36</fpage>.<pub-id pub-id-type="pmid">38553761</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0280"><label>280</label><mixed-citation publication-type="journal" id="cac270067-cite-0281">
<string-name>
<surname>Li</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Dong</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Shen</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Guo</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Cao</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>K</given-names>
</string-name>, et&#x000a0;al. <article-title>Personalized Nanovaccine Based on STING&#x02010;Activating Nanocarrier for Robust Cancer Immunotherapy</article-title>. <source>ACS Nano</source>. <year>2025</year>;<volume>19</volume>(<issue>3</issue>):<fpage>3226</fpage>&#x02010;<lpage>39</lpage>.<pub-id pub-id-type="pmid">39817337</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0281"><label>281</label><mixed-citation publication-type="journal" id="cac270067-cite-0282">
<string-name>
<surname>Gao</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Ji</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Shen</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>D</given-names>
</string-name>, et&#x000a0;al. <article-title>In situ non&#x02010;canonical activation and sensitization of cGAS&#x02010;STING pathway with manganese telluride nanosheets</article-title>. <source>Biomaterials</source>. <year>2025</year>;<volume>318</volume>:<elocation-id>123170</elocation-id>.<pub-id pub-id-type="pmid">39933314</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0282"><label>282</label><mixed-citation publication-type="journal" id="cac270067-cite-0283">
<string-name>
<surname>Wu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Diao</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Peng</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Lv</surname>
<given-names>P</given-names>
</string-name>, et&#x000a0;al. <article-title>A Hybrid Manganese Nanoparticle Simultaneously Eliminates Cancer Stem Cells and Activates STING Pathway to Potentiate Cancer Immunotherapy</article-title>. <source>ACS Nano</source>. <year>2025</year>;<volume>19</volume>(<issue>12</issue>):<fpage>12237</fpage>&#x02010;<lpage>52</lpage>.<pub-id pub-id-type="pmid">40116158</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0283"><label>283</label><mixed-citation publication-type="journal" id="cac270067-cite-0284">
<string-name>
<surname>Chu</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Zheng</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Fu</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Liang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>L</given-names>
</string-name>, et&#x000a0;al. <article-title>Implanted Microneedles Loaded with Sparfloxacin and Zinc&#x02010;Manganese Sulfide Nanoparticles Activates Immunity for Postoperative Triple&#x02010;Negative Breast Cancer to Prevent Recurrence and Metastasis</article-title>. <source>Adv Sci (Weinh)</source>. <year>2025</year>;<volume>12</volume>(<issue>16</issue>):<elocation-id>e2416270</elocation-id>.<pub-id pub-id-type="pmid">40042034</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0284"><label>284</label><mixed-citation publication-type="journal" id="cac270067-cite-0285">
<string-name>
<surname>Li</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Su</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Shao</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>X</given-names>
</string-name>. <article-title>Unleashing the Potential of Metal Ions in cGAS&#x02010;STING Activation: Advancing Nanomaterial&#x02010;Based Tumor Immunotherapy</article-title>. <source>ACS Omega</source>. <year>2025</year>;<volume>10</volume>(<issue>12</issue>):<fpage>11723</fpage>&#x02010;<lpage>42</lpage>.<pub-id pub-id-type="pmid">40191377</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0285"><label>285</label><mixed-citation publication-type="journal" id="cac270067-cite-0286">
<string-name>
<surname>Xu</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Dobson</surname>
<given-names>HE</given-names>
</string-name>, <string-name>
<surname>Yu</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Gong</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Park</surname>
<given-names>KS</given-names>
</string-name>, et&#x000a0;al. <article-title>STING agonist&#x02010;loaded mesoporous manganese&#x02010;silica nanoparticles for vaccine applications</article-title>. <source>J Control Release</source>. <year>2023</year>;<volume>357</volume>:<fpage>84</fpage>&#x02010;<lpage>93</lpage>.<pub-id pub-id-type="pmid">36948420</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0286"><label>286</label><mixed-citation publication-type="journal" id="cac270067-cite-0287">
<string-name>
<surname>Chen</surname>
<given-names>YP</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Tang</surname>
<given-names>TW</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>CH</given-names>
</string-name>, <string-name>
<surname>Zheng</surname>
<given-names>QH</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>TP</given-names>
</string-name>, et&#x000a0;al. <article-title>STING Activator c&#x02010;di&#x02010;GMP&#x02010;Loaded Mesoporous Silica Nanoparticles Enhance Immunotherapy Against Breast Cancer</article-title>. <source>ACS Appl Mater Interfaces</source>. <year>2020</year>;<volume>12</volume>(<issue>51</issue>):<fpage>56741</fpage>&#x02010;<lpage>52</lpage>.<pub-id pub-id-type="pmid">33305564</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0287"><label>287</label><mixed-citation publication-type="journal" id="cac270067-cite-0288">
<string-name>
<surname>Guo</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Guan</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Ke</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Lin</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Tai</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Ye</surname>
<given-names>J</given-names>
</string-name>, et&#x000a0;al. <article-title>Biologically logic&#x02010;gated Trojan&#x02010;horse strategy for personalized triple&#x02010;negative breast cancer precise therapy by selective ferroptosis and STING pathway provoking</article-title>. <source>Biomaterials</source>. <year>2025</year>;<volume>315</volume>:<elocation-id>122905</elocation-id>.<pub-id pub-id-type="pmid">39471713</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0288"><label>288</label><mixed-citation publication-type="journal" id="cac270067-cite-0289">
<string-name>
<surname>Liu</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Ye</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Jing</surname>
<given-names>X</given-names>
</string-name>, et&#x000a0;al. <article-title>cGAMP&#x02010;targeting injectable hydrogel system promotes periodontal restoration by alleviating cGAS&#x02010;STING pathway activation</article-title>. <source>Bioact Mater</source>. <year>2025</year>;<volume>48</volume>:<fpage>55</fpage>&#x02010;<lpage>70</lpage>.<pub-id pub-id-type="pmid">40303968</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0289"><label>289</label><mixed-citation publication-type="journal" id="cac270067-cite-0290">
<string-name>
<surname>Yang</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Liao</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Yao</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>He</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Zhong</surname>
<given-names>W</given-names>
</string-name>, et&#x000a0;al. <article-title>Multifunctional nanoparticles and collagenase dual loaded thermosensitive hydrogel system for enhanced tumor&#x02010;penetration, reversed immune suppression and photodynamic&#x02010;immunotherapy</article-title>. <source>Bioact Mater</source>. <year>2025</year>;<volume>48</volume>:<fpage>1</fpage>&#x02010;<lpage>17</lpage>.<pub-id pub-id-type="pmid">40028237</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0290"><label>290</label><mixed-citation publication-type="journal" id="cac270067-cite-0291">
<string-name>
<surname>Huo</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Xiao</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Cai</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Shi</surname>
<given-names>C</given-names>
</string-name>, et&#x000a0;al. <article-title>Specific Activation of the STING Pathway by Engineering Piezoelectric Hydrogel Microspheres for Boosting Implant Infection Immunotherapy</article-title>. <source>ACS Nano</source>. <year>2025</year>;<volume>19</volume>(<issue>17</issue>):<fpage>16383</fpage>&#x02010;<lpage>404</lpage>.<pub-id pub-id-type="pmid">40272483</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0291"><label>291</label><mixed-citation publication-type="journal" id="cac270067-cite-0292">
<string-name>
<surname>Song</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Phuengkham</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>YS</given-names>
</string-name>, <string-name>
<surname>Dinh</surname>
<given-names>VV</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Shin</surname>
<given-names>IW</given-names>
</string-name>, et&#x000a0;al. <article-title>Syringeable immunotherapeutic nanogel reshapes tumor microenvironment and prevents tumor metastasis and recurrence</article-title>. <source>Nat Commun</source>. <year>2019</year>;<volume>10</volume>(<issue>1</issue>):<fpage>3745</fpage>.<pub-id pub-id-type="pmid">31431623</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0292"><label>292</label><mixed-citation publication-type="journal" id="cac270067-cite-0293">
<string-name>
<surname>Yan</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Deng</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Zeng</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Tong</surname>
<given-names>Z</given-names>
</string-name>, et&#x000a0;al. <article-title>Biopolymer&#x02010;based bone scaffold for controlled Pt (IV) prodrug release and synergistic photothermal&#x02010;chemotherapy and immunotherapy in osteosarcoma</article-title>. <source>J Nanobiotechnology</source>. <year>2025</year>;<volume>23</volume>(<issue>1</issue>):<fpage>286</fpage>.<pub-id pub-id-type="pmid">40205459</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0293"><label>293</label><mixed-citation publication-type="journal" id="cac270067-cite-0294">
<string-name>
<surname>Wang</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Tang</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Yuan</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Hu</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Bai</surname>
<given-names>X</given-names>
</string-name>, et&#x000a0;al. <article-title>Targeted delivery of a STING agonist to brain tumors using bioengineered protein nanoparticles for enhanced immunotherapy</article-title>. <source>Bioact Mater</source>. <year>2022</year>;<volume>16</volume>:<fpage>232</fpage>&#x02010;<lpage>48</lpage>.<pub-id pub-id-type="pmid">35386310</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0294"><label>294</label><mixed-citation publication-type="journal" id="cac270067-cite-0295">
<string-name>
<surname>Rudicell</surname>
<given-names>RS</given-names>
</string-name>, <string-name>
<surname>Garinot</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kanekiyo</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kamp</surname>
<given-names>HD</given-names>
</string-name>, <string-name>
<surname>Swanson</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Chou</surname>
<given-names>TH</given-names>
</string-name>, et&#x000a0;al. <article-title>Comparison of adjuvants to optimize influenza neutralizing antibody responses</article-title>. <source>Vaccine</source>. <year>2019</year>;<volume>37</volume>(<issue>42</issue>):<fpage>6208</fpage>&#x02010;<lpage>20</lpage>.<pub-id pub-id-type="pmid">31493950</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0295"><label>295</label><mixed-citation publication-type="journal" id="cac270067-cite-0296">
<string-name>
<surname>Wang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Peng</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Xiao</surname>
<given-names>X</given-names>
</string-name>, et&#x000a0;al. <article-title>Nanomaterial&#x02010;mediated modulation of the cGAS&#x02010;STING signaling pathway for enhanced cancer immunotherapy</article-title>. <source>Acta Biomater</source>. <year>2024</year>;<volume>176</volume>:<fpage>51</fpage>&#x02010;<lpage>76</lpage>.<pub-id pub-id-type="pmid">38237711</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0296"><label>296</label><mixed-citation publication-type="journal" id="cac270067-cite-0297">
<string-name>
<surname>Wang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>Z</given-names>
</string-name>, et&#x000a0;al. <article-title>STING licensing of type I dendritic cells potentiates antitumor immunity</article-title>. <source>Sci Immunol</source>. <year>2024</year>;<volume>9</volume>(<issue>92</issue>):<elocation-id>eadj3945</elocation-id>.<pub-id pub-id-type="pmid">38363830</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0297"><label>297</label><mixed-citation publication-type="journal" id="cac270067-cite-0298">
<string-name>
<surname>Li</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Yi</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Ma</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Lou</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Dong</surname>
<given-names>Y</given-names>
</string-name>, et&#x000a0;al. <article-title>A polymeric nanoplatform enhances the cGAS&#x02010;STING pathway in macrophages to potentiate phagocytosis for cancer immunotherapy</article-title>. <source>J Control Release</source>. <year>2024</year>;<volume>373</volume>:<fpage>447</fpage>&#x02010;<lpage>62</lpage>.<pub-id pub-id-type="pmid">39038546</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0298"><label>298</label><mixed-citation publication-type="journal" id="cac270067-cite-0299">
<string-name>
<surname>Jang</surname>
<given-names>SC</given-names>
</string-name>, <string-name>
<surname>Economides</surname>
<given-names>KD</given-names>
</string-name>, <string-name>
<surname>Moniz</surname>
<given-names>RJ</given-names>
</string-name>, <string-name>
<surname>Sia</surname>
<given-names>CL</given-names>
</string-name>, <string-name>
<surname>Lewis</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>McCoy</surname>
<given-names>C</given-names>
</string-name>, et&#x000a0;al. <article-title>ExoSTING, an extracellular vesicle loaded with STING agonists, promotes tumor immune surveillance</article-title>. <source>Commun Biol</source>. <year>2021</year>;<volume>4</volume>(<issue>1</issue>):<fpage>497</fpage>.<pub-id pub-id-type="pmid">33888863</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0299"><label>299</label><mixed-citation publication-type="journal" id="cac270067-cite-0300">
<string-name>
<surname>Appleman</surname>
<given-names>VA</given-names>
</string-name>, <string-name>
<surname>Matsuda</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Ganno</surname>
<given-names>ML</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>DM</given-names>
</string-name>, <string-name>
<surname>Rosentrater</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Maldonado Lopez</surname>
<given-names>AE</given-names>
</string-name>, et&#x000a0;al. <article-title>Selective STING Activation in Intratumoral Myeloid Cells via CCR2&#x02010;Directed Antibody Drug Conjugate TAK&#x02010;500</article-title>. <source>Cancer Immunol Res</source>. <year>2025</year>;<volume>13</volume>(<issue>5</issue>):<fpage>661</fpage>&#x02010;<lpage>79</lpage>.<pub-id pub-id-type="pmid">39918395</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0300"><label>300</label><mixed-citation publication-type="journal" id="cac270067-cite-0301">
<string-name>
<surname>Bukhalid</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Duvall</surname>
<given-names>JR</given-names>
</string-name>, <string-name>
<surname>Lancaster</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Catcott</surname>
<given-names>KC</given-names>
</string-name>, <string-name>
<surname>Malli Cetinbas</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Monnell</surname>
<given-names>T</given-names>
</string-name>, et&#x000a0;al. <article-title>XMT&#x02010;2056, a HER2&#x02010;Directed STING Agonist Antibody&#x02010;Drug Conjugate, Induces Innate Anti&#x02010;Tumor Immune Responses by Acting on Cancer Cells and Tumor&#x02010;Resident Immune Cells</article-title>. <source>Clin Cancer Res</source>. <year>2025</year>;<volume>31</volume>(<issue>9</issue>):<fpage>1766</fpage>&#x02010;<lpage>82</lpage>.<pub-id pub-id-type="pmid">40029253</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0301"><label>301</label><mixed-citation publication-type="journal" id="cac270067-cite-0302">
<string-name>
<surname>Leventhal</surname>
<given-names>DS</given-names>
</string-name>, <string-name>
<surname>Sokolovska</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Plescia</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Kolodziej</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>Gallant</surname>
<given-names>CW</given-names>
</string-name>, et&#x000a0;al. <article-title>Immunotherapy with engineered bacteria by targeting the STING pathway for anti&#x02010;tumor immunity</article-title>. <source>Nat Commun</source>. <year>2020</year>;<volume>11</volume>(<issue>1</issue>):<fpage>2739</fpage>.<pub-id pub-id-type="pmid">32483165</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0302"><label>302</label><mixed-citation publication-type="journal" id="cac270067-cite-0303">
<string-name>
<surname>Luke</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>Piha&#x02010;Paul</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>Medina</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Verschraegen</surname>
<given-names>CF</given-names>
</string-name>, <string-name>
<surname>Varterasian</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Brennan</surname>
<given-names>AM</given-names>
</string-name>, et&#x000a0;al. <article-title>Phase I Study of SYNB1891, an Engineered E. coli Nissle Strain Expressing STING Agonist, with and without Atezolizumab in Advanced Malignancies</article-title>. <source>Clin Cancer Res</source>. <year>2023</year>;<volume>29</volume>(<issue>13</issue>):<fpage>2435</fpage>&#x02010;<lpage>44</lpage>.<pub-id pub-id-type="pmid">37227176</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0303"><label>303</label><mixed-citation publication-type="journal" id="cac270067-cite-0304">
<string-name>
<surname>Liu</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Du</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>Z</given-names>
</string-name>, et&#x000a0;al. <article-title>Engineered bacterial membrane vesicle as safe and efficient nano&#x02010;heaters to reprogram tumor microenvironment for enhanced immunotherapy</article-title>. <source>J Control Release</source>. <year>2024</year>;<volume>374</volume>:<fpage>127</fpage>&#x02010;<lpage>39</lpage>.<pub-id pub-id-type="pmid">39122216</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0304"><label>304</label><mixed-citation publication-type="journal" id="cac270067-cite-0305">
<string-name>
<surname>Sun</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Ma</surname>
<given-names>YY</given-names>
</string-name>, <string-name>
<surname>Shangguan</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Ruan</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Bai</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Xue</surname>
<given-names>P</given-names>
</string-name>, et&#x000a0;al. <article-title>Metal ions&#x02010;anchored bacterial outer membrane vesicles for enhanced ferroptosis induction and immune stimulation in targeted antitumor therapy</article-title>. <source>J Nanobiotechnology</source>. <year>2024</year>;<volume>22</volume>(<issue>1</issue>):<fpage>474</fpage>.<pub-id pub-id-type="pmid">39123234</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0305"><label>305</label><mixed-citation publication-type="journal" id="cac270067-cite-0306">
<string-name>
<surname>Pu</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Cui</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Yu</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Cheng</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Qin</surname>
<given-names>L</given-names>
</string-name>, et&#x000a0;al. <article-title>Oral ENPP1 inhibitor designed using generative AI as next generation STING modulator for solid tumors</article-title>. <source>Nat Commun</source>. <year>2025</year>;<volume>16</volume>(<issue>1</issue>):<fpage>4793</fpage>.<pub-id pub-id-type="pmid">40410143</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0306"><label>306</label><mixed-citation publication-type="journal" id="cac270067-cite-0307">
<string-name>
<surname>Ruiz&#x02010;Fern&#x000e1;ndez de C&#x000f3;rdoba</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Valencia</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Welch</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Moreno</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Mart&#x000ed;nez&#x02010;Canarias</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Zandueta</surname>
<given-names>C</given-names>
</string-name>, et&#x000a0;al. <article-title>Dual ENPP1/ATM depletion blunts DNA damage repair boosting radioimmune efficacy to abrogate triple&#x02010;negative breast cancer</article-title>. <source>Signal Transduct Target Ther</source>. <year>2025</year>;<volume>10</volume>(<issue>1</issue>):<fpage>185</fpage>.<pub-id pub-id-type="pmid">40506449</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0307"><label>307</label><mixed-citation publication-type="journal" id="cac270067-cite-0308">
<string-name>
<surname>Ke</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Lan</surname>
<given-names>TH</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>Y</given-names>
</string-name>. <article-title>Optogenetic engineering for precision cancer immunotherapy</article-title>. <source>Trends Pharmacol Sci</source>. <year>2025</year>;<volume>10</volume>:S0165&#x02010;6147(25)00092&#x02010;6.</mixed-citation></ref><ref id="cac270067-bib-0308"><label>308</label><mixed-citation publication-type="journal" id="cac270067-cite-0309">
<string-name>
<surname>Dou</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>YT</given-names>
</string-name>, <string-name>
<surname>Jing</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>X</given-names>
</string-name>, et&#x000a0;al. <article-title>Optogenetic engineering of STING signaling allows remote immunomodulation to enhance cancer immunotherapy</article-title>. <source>Nat Commun</source>. <year>2023</year>;<volume>14</volume>(<issue>1</issue>):<fpage>5461</fpage>.<pub-id pub-id-type="pmid">37673917</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0309"><label>309</label><mixed-citation publication-type="journal" id="cac270067-cite-0310">
<string-name>
<surname>Kang</surname>
<given-names>DY</given-names>
</string-name>, <string-name>
<surname>Jang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Kang</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>DW</given-names>
</string-name>, et&#x000a0;al. <article-title>Optogenetic STING clustering system through nanobody&#x02010;fused photoreceptor for innate immune regulation</article-title>. <source>Sensors and Actuators B: Chemical</source>. <year>2024</year>;<volume>399</volume>:<elocation-id>134822</elocation-id>.</mixed-citation></ref><ref id="cac270067-bib-0310"><label>310</label><mixed-citation publication-type="journal" id="cac270067-cite-0311">
<string-name>
<surname>Liu</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Hou</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Cui</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>X</given-names>
</string-name>, et&#x000a0;al. <article-title>The mechanism of STING autoinhibition and activation</article-title>. <source>Mol Cell</source>. <year>2023</year>;<volume>83</volume>(<issue>9</issue>):<fpage>1502</fpage>&#x02010;<lpage>18</lpage>.e10.<pub-id pub-id-type="pmid">37086726</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0311"><label>311</label><mixed-citation publication-type="journal" id="cac270067-cite-0312">
<string-name>
<surname>Yi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Niu</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Ge</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Jiao</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Zhu</surname>
<given-names>S</given-names>
</string-name>, et&#x000a0;al. <article-title>Combination of oral STING agonist MSA&#x02010;2 and anti&#x02010;TGF&#x02010;&#x003b2;/PD&#x02010;L1 bispecific antibody YM101: a novel immune cocktail therapy for non&#x02010;inflamed tumors</article-title>. <source>J Hematol Oncol</source>. <year>2022</year>;<volume>15</volume>(<issue>1</issue>):<fpage>142</fpage>.<pub-id pub-id-type="pmid">36209176</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0312"><label>312</label><mixed-citation publication-type="journal" id="cac270067-cite-0313">
<string-name>
<surname>Ghaffari</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Peterson</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Khalaj</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Vitkin</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Robinson</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Francis</surname>
<given-names>JA</given-names>
</string-name>, et&#x000a0;al. <article-title>STING agonist therapy in combination with PD&#x02010;1 immune checkpoint blockade enhances response to carboplatin chemotherapy in high&#x02010;grade serous ovarian cancer</article-title>. <source>Br J Cancer</source>. <year>2018</year>;<volume>119</volume>(<issue>4</issue>):<fpage>440</fpage>&#x02010;<lpage>9</lpage>.<pub-id pub-id-type="pmid">30046165</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0313"><label>313</label><mixed-citation publication-type="journal" id="cac270067-cite-0314">
<string-name>
<surname>Conde</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Vercher</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Soria&#x02010;Castellano</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Suarez&#x02010;Olmos</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Manche&#x000f1;o</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Elizalde</surname>
<given-names>E</given-names>
</string-name>, et&#x000a0;al. <article-title>Epitope spreading driven by the joint action of CART cells and pharmacological STING stimulation counteracts tumor escape via antigen&#x02010;loss variants</article-title>. <source>J Immunother Cancer</source>. <year>2021</year>;<volume>9</volume>(<issue>11</issue>):<elocation-id>e003351</elocation-id>.<pub-id pub-id-type="pmid">34810235</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0314"><label>314</label><mixed-citation publication-type="journal" id="cac270067-cite-0315">
<string-name>
<surname>Xu</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Palmer</surname>
<given-names>DC</given-names>
</string-name>, <string-name>
<surname>Robeson</surname>
<given-names>AC</given-names>
</string-name>, <string-name>
<surname>Shou</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Bommiasamy</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Laurie</surname>
<given-names>SJ</given-names>
</string-name>, et&#x000a0;al. <article-title>STING agonist promotes CAR T cell trafficking and persistence in breast cancer</article-title>. <source>J Exp Med</source>. <year>2021</year>;<volume>218</volume>(<issue>2</issue>):<elocation-id>e20200844</elocation-id>.<pub-id pub-id-type="pmid">33382402</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0315"><label>315</label><mixed-citation publication-type="journal" id="cac270067-cite-0316">
<string-name>
<surname>Uslu</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Castelli</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Finck</surname>
<given-names>AV</given-names>
</string-name>, <string-name>
<surname>Assenmacher</surname>
<given-names>CA</given-names>
</string-name>, <string-name>
<surname>Young</surname>
<given-names>RM</given-names>
</string-name>, et&#x000a0;al. <article-title>The STING agonist IMSA101 enhances chimeric antigen receptor T cell function by inducing IL&#x02010;18 secretion</article-title>. <source>Nat Commun</source>. <year>2024</year>;<volume>15</volume>(<issue>1</issue>):<fpage>3933</fpage>.<pub-id pub-id-type="pmid">38730243</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0316"><label>316</label><mixed-citation publication-type="journal" id="cac270067-cite-0317">
<string-name>
<surname>Da</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Hu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Ma</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Lu</surname>
<given-names>N</given-names>
</string-name>, et&#x000a0;al. <article-title>STING agonist cGAMP enhances anti&#x02010;tumor activity of CAR&#x02010;NK cells against pancreatic cancer</article-title>. <source>Oncoimmunology</source>. <year>2022</year>;<volume>11</volume>(<issue>1</issue>):<elocation-id>2054105</elocation-id>.<pub-id pub-id-type="pmid">35371622</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0317"><label>317</label><mixed-citation publication-type="journal" id="cac270067-cite-0318">
<string-name>
<surname>Knelson</surname>
<given-names>EH</given-names>
</string-name>, <string-name>
<surname>Ivanova</surname>
<given-names>EV</given-names>
</string-name>, <string-name>
<surname>Tarannum</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Campisi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Lizotte</surname>
<given-names>PH</given-names>
</string-name>, <string-name>
<surname>Booker</surname>
<given-names>MA</given-names>
</string-name>, et&#x000a0;al. <article-title>Activation of Tumor&#x02010;Cell STING Primes NK&#x02010;Cell Therapy</article-title>. <source>Cancer Immunol Res</source>. <year>2022</year>;<volume>10</volume>(<issue>8</issue>):<fpage>947</fpage>&#x02010;<lpage>61</lpage>.<pub-id pub-id-type="pmid">35678717</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0318"><label>318</label><mixed-citation publication-type="journal" id="cac270067-cite-0319">
<string-name>
<surname>Dang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Ma</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Cao</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Su</surname>
<given-names>H</given-names>
</string-name>, et&#x000a0;al. <article-title>Carvedilol sensitizes chemotherapy by targeting STING to boost anti&#x02010;tumor immunity</article-title>. <source>Cell Rep</source>. <year>2025</year>;<volume>44</volume>(<issue>5</issue>):<elocation-id>115572</elocation-id>.<pub-id pub-id-type="pmid">40249703</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0319"><label>319</label><mixed-citation publication-type="journal" id="cac270067-cite-0320">
<string-name>
<surname>Fu</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Guo</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Fang</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>X</given-names>
</string-name>, et&#x000a0;al. <article-title>STING pathway activation with cisplatin polyprodrug nanoparticles for chemo&#x02010;immunotherapy in ovarian cancer</article-title>. <source>J Control Release</source>. <year>2025</year>;<volume>381</volume>:<elocation-id>113565</elocation-id>.<pub-id pub-id-type="pmid">39993638</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0320"><label>320</label><mixed-citation publication-type="journal" id="cac270067-cite-0321">
<string-name>
<surname>Huang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Lu</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Ou</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>J</given-names>
</string-name>, et&#x000a0;al. <article-title>Interferon&#x02010;driven CAF reprogramming augments immunogenic response to neoadjuvant radiotherapy in colorectal cancer</article-title>. <source>Cell Rep Med</source>. <year>2025</year>:<elocation-id>102251</elocation-id>.<pub-id pub-id-type="pmid">40730191</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0321"><label>321</label><mixed-citation publication-type="journal" id="cac270067-cite-0322">
<string-name>
<surname>Sun</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>He</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Cui</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Zheng</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Ye</surname>
<given-names>C</given-names>
</string-name>, et&#x000a0;al. <article-title>Co&#x02010;activating STING&#x02010;TLR9 pathways promotes radiotherapy&#x02010;induced cancer vaccination</article-title>. <source>J Control Release</source>. <year>2025</year>;<volume>379</volume>:<fpage>327</fpage>&#x02010;<lpage>43</lpage>.<pub-id pub-id-type="pmid">39778743</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0322"><label>322</label><mixed-citation publication-type="journal" id="cac270067-cite-0323">
<string-name>
<surname>Wu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Yi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Niu</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Mei</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>K</given-names>
</string-name>. <article-title>Beyond success: unveiling the hidden potential of radiotherapy and immunotherapy in solid tumors</article-title>. <source>Cancer Commun (Lond)</source>. <year>2024</year>;<volume>44</volume>(<issue>7</issue>):<fpage>739</fpage>&#x02010;<lpage>60</lpage>.<pub-id pub-id-type="pmid">38837878</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0323"><label>323</label><mixed-citation publication-type="journal" id="cac270067-cite-0324">
<string-name>
<surname>Cao</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Tian</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Fang</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Tang</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>J</given-names>
</string-name>, et&#x000a0;al. <article-title>Activating cGAS&#x02010;STING pathway with ROS&#x02010;responsive nanoparticles delivering a hybrid prodrug for enhanced chemo&#x02010;immunotherapy</article-title>. <source>Biomaterials</source>. <year>2022</year>;<volume>290</volume>:<elocation-id>121856</elocation-id>.<pub-id pub-id-type="pmid">36306685</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0324"><label>324</label><mixed-citation publication-type="journal" id="cac270067-cite-0325">
<string-name>
<surname>Lu</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Hua</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Zhan</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Hu</surname>
<given-names>Q</given-names>
</string-name>, et&#x000a0;al. <article-title>Targeting the cGAS&#x02010;STING Pathway Inhibits Peripheral T&#x02010;cell Lymphoma Progression and Enhances the Chemotherapeutic Efficacy</article-title>. <source>Adv Sci (Weinh)</source>. <year>2024</year>;<volume>11</volume>(<issue>10</issue>):<elocation-id>e2306092</elocation-id>.<pub-id pub-id-type="pmid">38145335</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0325"><label>325</label><mixed-citation publication-type="journal" id="cac270067-cite-0326">
<string-name>
<surname>Yi</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Brendel</surname>
<given-names>VP</given-names>
</string-name>, <string-name>
<surname>Shu</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Palanathan</surname>
<given-names>S, Cheng</given-names>
</string-name>
<string-name>
<surname>Kao</surname>
<given-names>C</given-names>
</string-name>. <article-title>Single nucleotide polymorphisms of human STING can affect innate immune response to cyclic dinucleotides</article-title>. <source>PLoS One</source>. <year>2013</year>;<volume>8</volume>(<issue>10</issue>):<elocation-id>e77846</elocation-id>.<pub-id pub-id-type="pmid">24204993</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0326"><label>326</label><mixed-citation publication-type="journal" id="cac270067-cite-0327">
<string-name>
<surname>Patel</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Blaauboer</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Tucker</surname>
<given-names>HR</given-names>
</string-name>, <string-name>
<surname>Mansouri</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Ruiz&#x02010;Moreno</surname>
<given-names>JS</given-names>
</string-name>, <string-name>
<surname>Hamann</surname>
<given-names>L</given-names>
</string-name>, et&#x000a0;al. <article-title>The Common R71H&#x02010;G230A&#x02010;R293Q Human TMEM173 Is a Null Allele</article-title>. <source>J Immunol</source>. <year>2017</year>;<volume>198</volume>(<issue>2</issue>):<fpage>776</fpage>&#x02010;<lpage>87</lpage>.<pub-id pub-id-type="pmid">27927967</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0327"><label>327</label><mixed-citation publication-type="journal" id="cac270067-cite-0328">
<string-name>
<surname>Tsuchida</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Zou</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Saitoh</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Kumar</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Abe</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Matsuura</surname>
<given-names>Y</given-names>
</string-name>, et&#x000a0;al. <article-title>The ubiquitin ligase TRIM56 regulates innate immune responses to intracellular double&#x02010;stranded DNA</article-title>. <source>Immunity</source>. <year>2010</year>;<volume>33</volume>(<issue>5</issue>):<fpage>765</fpage>&#x02010;<lpage>76</lpage>.<pub-id pub-id-type="pmid">21074459</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0328"><label>328</label><mixed-citation publication-type="journal" id="cac270067-cite-0329">
<string-name>
<surname>Zhang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Hu</surname>
<given-names>MM</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>YY</given-names>
</string-name>, <string-name>
<surname>Shu</surname>
<given-names>HB</given-names>
</string-name>. <article-title>TRIM32 protein modulates type I interferon induction and cellular antiviral response by targeting MITA/STING protein for K63&#x02010;linked ubiquitination</article-title>. <source>J Biol Chem</source>. <year>2012</year>;<volume>287</volume>(<issue>34</issue>):<fpage>28646</fpage>&#x02010;<lpage>55</lpage>.<pub-id pub-id-type="pmid">22745133</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0329"><label>329</label><mixed-citation publication-type="journal" id="cac270067-cite-0330">
<string-name>
<surname>Kong</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Sui</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Zheng</surname>
<given-names>Y</given-names>
</string-name>, et&#x000a0;al. <article-title>The ubiquitin E3 ligase TRIM10 promotes STING aggregation and activation in the Golgi apparatus</article-title>. <source>Cell Rep</source>. <year>2023</year>;<volume>42</volume>(<issue>4</issue>):<elocation-id>112306</elocation-id>.<pub-id pub-id-type="pmid">36972172</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0330"><label>330</label><mixed-citation publication-type="journal" id="cac270067-cite-0331">
<string-name>
<surname>Zhang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Wei</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Cui</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Hong</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>Q</given-names>
</string-name>, et&#x000a0;al. <article-title>The deubiquitinase CYLD is a specific checkpoint of the STING antiviral signaling pathway</article-title>. <source>PLoS Pathog</source>. <year>2018</year>;<volume>14</volume>(<issue>11</issue>):<elocation-id>e1007435</elocation-id>.<pub-id pub-id-type="pmid">30388174</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0331"><label>331</label><mixed-citation publication-type="journal" id="cac270067-cite-0332">
<string-name>
<surname>Guo</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Jiang</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Kong</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>X</given-names>
</string-name>, et&#x000a0;al. <article-title>OTUD5 promotes innate antiviral and antitumor immunity through deubiquitinating and stabilizing STING</article-title>. <source>Cell Mol Immunol</source>. <year>2021</year>;<volume>18</volume>(<issue>8</issue>):<fpage>1945</fpage>&#x02010;<lpage>55</lpage>.<pub-id pub-id-type="pmid">32879469</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0332"><label>332</label><mixed-citation publication-type="journal" id="cac270067-cite-0333">
<string-name>
<surname>Zhang</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>MX</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Zhu</surname>
<given-names>GF</given-names>
</string-name>, <string-name>
<surname>Yuan</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>DE</given-names>
</string-name>, et&#x000a0;al. <article-title>USP18 recruits USP20 to promote innate antiviral response through deubiquitinating STING/MITA</article-title>. <source>Cell Res</source>. <year>2016</year>;<volume>26</volume>(<issue>12</issue>):<fpage>1302</fpage>&#x02010;<lpage>19</lpage>.<pub-id pub-id-type="pmid">27801882</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0333"><label>333</label><mixed-citation publication-type="journal" id="cac270067-cite-0334">
<string-name>
<surname>Zhang</surname>
<given-names>HY</given-names>
</string-name>, <string-name>
<surname>Liao</surname>
<given-names>BW</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>ZS</given-names>
</string-name>, <string-name>
<surname>Ran</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>DP</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>Y</given-names>
</string-name>, et&#x000a0;al. <article-title>USP44 positively regulates innate immune response to DNA viruses through deubiquitinating MITA</article-title>. <source>PLoS Pathog</source>. <year>2020</year>;<volume>16</volume>(<issue>1</issue>):<elocation-id>e1008178</elocation-id>.<pub-id pub-id-type="pmid">31968013</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0334"><label>334</label><mixed-citation publication-type="journal" id="cac270067-cite-0335">
<string-name>
<surname>Fang</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Han</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Lin</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Ye</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Qu</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</string-name>, et&#x000a0;al. <article-title>Deubiquitinase OTUD6a drives cardiac inflammation and hypertrophy by deubiquitination of STING</article-title>. <source>Biochim Biophys Acta Mol Basis Dis</source>. <year>2024</year>;<volume>1870</volume>(<issue>4</issue>):<elocation-id>167061</elocation-id>.<pub-id pub-id-type="pmid">38342418</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0335"><label>335</label><mixed-citation publication-type="journal" id="cac270067-cite-0336">
<string-name>
<surname>Zhang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Weng</surname>
<given-names>L</given-names>
</string-name>, et&#x000a0;al. <article-title>Deubiquitinase USP35 restrains STING&#x02010;mediated interferon signaling in ovarian cancer</article-title>. <source>Cell Death Differ</source>. <year>2021</year>;<volume>28</volume>(<issue>1</issue>):<fpage>139</fpage>&#x02010;<lpage>55</lpage>.<pub-id pub-id-type="pmid">32678307</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0336"><label>336</label><mixed-citation publication-type="journal" id="cac270067-cite-0337">
<string-name>
<surname>Jia</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Gao</surname>
<given-names>X</given-names>
</string-name>, et&#x000a0;al. <article-title>Interaction between the SFTSV envelope glycoprotein Gn and STING inhibits the formation of the STING&#x02010;TBK1 complex and suppresses the NF&#x02010;kappaB signaling pathway</article-title>. <source>J Virol</source>. <year>2024</year>;<volume>98</volume>(<issue>3</issue>):<elocation-id>e0181523</elocation-id>.<pub-id pub-id-type="pmid">38421179</pub-id>
</mixed-citation></ref><ref id="cac270067-bib-0337"><label>337</label><mixed-citation publication-type="journal" id="cac270067-cite-0338">
<string-name>
<surname>Sun</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Jing</surname>
<given-names>YY</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>HY</given-names>
</string-name>, <string-name>
<surname>Cai</surname>
<given-names>Z</given-names>
</string-name>, et&#x000a0;al. <article-title>USP13 negatively regulates antiviral responses by deubiquitinating STING</article-title>. <source>Nat Commun</source>. <year>2017</year>;<volume>8</volume>:<elocation-id>15534</elocation-id>.<pub-id pub-id-type="pmid">28534493</pub-id>
</mixed-citation></ref></ref-list></back></article>
